Updated on 2024/09/20

写真a

 
OKA Takashi
 
Organization
Faculty of Medicine, Dentistry and Pharmaceutical Sciences Special-Appointment Lecturer
Position
Special-Appointment Lecturer
External link

Degree

  • PhD.Ç ( Osaka University )

  • Doctor of Medical Science ( Kochi Medical School )

Research Interests

  • HTLV-1

  • Lymphoma

  • Leukemia

  • Epigenetics

  • retrovirus

  • リンパ腫

  • 白血病

  • エピジェネテイックス

  • Photo-Dynamic Therapy,(PDT)

  • Tumorigenesis and aberrant DNA methylation

Research Areas

  • Life Science / Biophysics

  • Life Science / Molecular biology

  • Life Science / Human pathology

  • Life Science / Experimental pathology

  • Life Science / Virology

Education

  • Osaka University, Graduate School of Engineering Science, Dept of Biophysical Engineering    

    - 1983

      More details

    Country: Japan

    researchmap

Research History

  • Academic Field of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University,   Department of Hematology, Oncology and Respiratory Medicine,   Senior Assistant Professor   Senior Assistant Professor

    2019.4

      More details

    Country:Japan

    researchmap

  • Academic Field of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University,   Department of Hematology, Oncology and Respiratory Medicine,   Senir Assistant Professor   Senir Assistant Professor

    2019.4

      More details

  • Academic Field of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University,   Department of Virology   Senior Assistant Professor   特任講師

    2017.4 - 2019.3

      More details

    Country:Japan

    researchmap

  • - Senior Assistant Professor,Department of Virology,Social and Environmental Sciences,Graduate School of Medicine, Dentistry and Pharmaceutical Sciences,Okayama University

    2017 - 2019

      More details

  • 岡山大学医歯薬学総合研究科病態制御科学専攻腫瘍病理学分野 講師

    2016 - 2017

      More details

  • Senior Assistant Professor,Department of Pathology and Oncology,Biopathological Sciences,Graduate School of Medicine, Dentistry and Pharmaceutical Sciences,Okayama University

    2016 - 2017

      More details

  • 岡山大学医歯薬学総合研究科 助教

    2004 - 2016

      More details

  • Assistant Professor,Graduate School of Medicine, Dentistry and Pharmaceutical Sciences,Okayama University

    2004 - 2016

      More details

  • Research Associate,Medical School,Okayama University

    1996 - 2004

      More details

  • 岡山大学医学部第二病理学教室 助手

    1996 - 2004

      More details

  • アメリカ ハーバード大学・ハーバードAIDS研究所 細胞生物学部門 客員研究員

    1994 - 1995

      More details

  • Visiting Scientist,Harvard University, AIDS Insititut, Department of Cell Biology

    1994 - 1995

      More details

  • アメリカ テキサス大学M.D.アンダーソン癌センター、分子病理学部門 客員助教授

    1992 - 1994

      More details

  • Visiting Assistant Professor,Texas University, MD. Anderson Cancer Center, Department of Molecular Pathology

    1992 - 1994

      More details

  • Osaka University   Research Institute for Microbial Diseases

    1983 - 1984

      More details

  • Kochi Medical School   Department of Pathology,   Research associate

    1982.12 - 1995.12

      More details

▼display all

Professional Memberships

  • 日本免疫学会

      More details

  • The Society of Japanese Virologists.

      More details

  • (International Retrovirology Association

      More details

  • International association for comparative research on leukemia and Related Diseases

      More details

  • American Association of Cancer Research

      More details

  • International union of microbiological societies

      More details

  • 日本癌学会

      More details

  • 日本ウイルス学会

      More details

  • 日本病理学会

      More details

  • 国際HTLV学会(International Retrovirology Association)

      More details

  • 国際比較白血病・関連疾患学会(International association for comparative research on leukemia and Related Disease)

      More details

  • アメリカ癌学会(American Association of Cancer Research)

      More details

  • エピジェネテイックス研究会

      More details

  • 国際微生物学会連合(International Union of Microbiological Societies)

      More details

  • 日本分子生物学会

      More details

  • American Association for the Advancement of Science

      More details

▼display all

Committee Memberships

  • HTLV1学会   評議員  

    2015.4 - 2018.3   

      More details

    Committee type:Academic society

    researchmap

  • 日本病理学会   評議員  

    2004 - 2017   

      More details

    Committee type:Academic society

    日本病理学会

    researchmap

 

Papers

  • Author Correction: 5-aminolevulinic acid-mediated photodynamic therapy can target aggressive adult T cell leukemia/lymphoma resistant to conventional chemotherapy. Reviewed International journal

    Yasuhisa Sando, Ken-Ichi Matsuoka, Yuichi Sumii, Takumi Kondo, Shuntaro Ikegawa, Hiroyuki Sugiura, Makoto Nakamura, Miki Iwamoto, Yusuke Meguri, Noboru Asada, Daisuke Ennishi, Hisakazu Nishimori, Keiko Fujii, Nobuharu Fujii, Atae Utsunomiya, Takashi Oka, Yoshinobu Maeda

    Scientific reports   11 ( 1 )   6420 - 6420   2021.3

     More details

    Authorship:Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1038/s41598-021-86066-9

    PubMed

    researchmap

  • Sensitive Photodynamic Detection of Adult T-cell Leukemia/Lymphoma and Specific Leukemic Cell Death Induced by Photodynamic Therapy: Current Status in Hematopoietic Malignancies Reviewed

    Takashi Oka, Ken-ichi Matsuoka, Atae Utsunomiya

    Cancers   12 ( 2 )   335 - 335   2020.2

     More details

    Authorship:Lead author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:MDPI AG  

    Adult T-cell leukemia/lymphoma (ATL), an aggressive type of T-cell malignancy, is caused by the human T-cell leukemia virus type I (HTLV-1) infections. The outcomes, following therapeutic interventions for ATL, have not been satisfactory. Photodynamic therapy (PDT) exerts selective cytotoxic activity against malignant cells, as it is considered a minimally invasive therapeutic procedure. In PDT, photosensitizing agent administration is followed by irradiation at an absorbance wavelength of the sensitizer in the presence of oxygen, with ultimate direct tumor cell death, microvasculature injury, and induced local inflammatory reaction. This review provides an overview of the present status and state-of-the-art ATL treatments. It also focuses on the photodynamic detection (PDD) of hematopoietic malignancies and the recent progress of 5-Aminolevulinic acid (ALA)-PDT/PDD, which can efficiently induce ATL leukemic cell-specific death with minor influence on normal lymphocytes. Further consideration of the ALA-PDT/PDD system along with the circulatory system regarding the clinical application in ATL and others will be discussed. ALA-PDT/PDD can be promising as a novel treatment modality that overcomes unmet medical needs with the optimization of PDT parameters to increase the effectiveness of the tumor-killing activity and enhance the innate and adaptive anti-tumor immune responses by the optimized immunogenic cell death.

    DOI: 10.3390/cancers12020335

    researchmap

  • 5-aminolevulinic acid-mediated photodynamic therapy can target aggressive adult T cell leukemia/lymphoma resistant to conventional chemotherapy. Reviewed

    Yasuhisa Sando, Ken-ichi Matsuoka, Yuichi Sumii, Takumi Kondo, Shuntaro Ikegawa, Hiroyuki Sugiura, Makoto Nakamura, Miki Iwamoto, Yusuke Meguri, Noboru Asada, Daisuke Ennishi, Hisakazu Nishimori, Keiko Fujii, Nobuharu Fujii, Atae Utsunomiya, Takashi Oka, Yoshinobu Maeda

    Scientific Reports   10 ( 1 )   17237   2020

     More details

    Authorship:Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1038/s41598-020-74174-x.

    researchmap

  • Metabolic abnormalities in adult T-cell leukemia/lymphoma and induction of specific leukemic cell death using photodynamic therapy. Reviewed

    Oka T, Mizuno H, Sakata M, Fujita H, Yoshino T, Yamano Y, Utsumi K, Masujima T, Utsunomiya A

    Scientific reports   8 ( 1 )   14979   2018.10

  • Merkel cell polyomavirus and Langerhans cell neoplasm. International journal

    Ichiro Murakami, Noriko Wada, Junko Nakashima, Mitsuko Iguchi, Makoto Toi, Yumiko Hashida, Tomonori Higuchi, Masanori Daibata, Michiko Matsushita, Takeshi Iwasaki, Satoshi Kuwamoto, Yasushi Horie, Keiko Nagata, Kazuhiko Hayashi, Takashi Oka, Tadashi Yoshino, Toshihiko Imamura, Akira Morimoto, Shinsaku Imashuku, Jean Gogusev, Francis Jaubert

    Cell communication and signaling : CCS   16 ( 1 )   49 - 61   2018

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: The relationship between various external agents such as pollen, food, and infectious agents and human sensitivity exists and is variable depending upon individual's health conditions. For example, we believe that the pathogenetic potential of the Merkel cell polyomavirus (MCPyV), the resident virus in skin, is variable and depends from the degree of individual's reactivity. MCPyV as well as Epstein-Barr virus, which are normally connected with humans under the form of subclinical infection, are thought to be involved at various degrees in several neoplastic and inflammatory diseases. In this review, we cover two types of Langerhans cell neoplasms, the Langerhans cell sarcoma (LCS) and Langerhans cell histiocytosis (LCH), represented as either neoplastic or inflammatory diseases caused by MCPyV. METHODS: We meta-analyzed both our previous analyses, composed of quantitative PCR for MCPyV-DNA, proteomics, immunohistochemistry which construct IL-17 endocrine model and interleukin-1 (IL-1) activation loop model, and other groups' data. RESULTS: We have shown that there were subgroups associated with the MCPyV as a causal agent in these two different neoplasms. Comparatively, LCS, distinct from the LCH, is a neoplastic lesion (or sarcoma) without presence of inflammatory granuloma frequently observed in the elderly. LCH is a proliferative disease of Langerhans-like abnormal cells which carry mutations of genes involved in the RAS/MAPK signaling pathway. We found that MCPyV may be involved in the development of LCH. CONCLUSION: We hypothesized that a subgroup of LCS developed according the same mechanism involved in Merkel cell carcinoma pathogenesis. We proposed LCH developed from an inflammatory process that was sustained due to gene mutations. We hypothesized that MCPyV infection triggered an IL-1 activation loop that lies beneath the pathogenesis of LCH and propose a new triple-factor model.

    DOI: 10.1186/s12964-018-0261-y

    PubMed

    researchmap

  • Gene expression analysis of hypersensitivity to mosquito bite, chronic active EBV infection and NK/T-lymphoma/leukemia. Reviewed

    Kana Washio, Takashi Oka, Lamia Abdalkader, Michiko Muraoka, Akira Shimada, Megumi Oda, Hiaki Sato, Katsuyoshi Takata, Yoshitoyo Kagami, Norio Shimizu, Seiichi Kato, Hiroshi Kimura, Kazunori Nishizaki, Tadashi Yoshino, Hirokazu Tsukahara

    Leuk. Lymphoma   1 - 12   2017.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    The human herpes virus, Epstein-Barr virus (EBV), is a known oncogenic virus and plays important roles in life-threatening T/NK-cell lymphoproliferative disorders (T/NK-cell LPD) such as hypersensitivity to mosquito bite (HMB), chronic active EBV infection (CAEBV), and NK/T-cell lymphoma/leukemia. During the clinical courses of HMB and CAEBV, patients frequently develop malignant lymphomas and the diseases passively progress sequentially. In the present study, gene expression of CD16((-))CD56((+))-, EBV((+)) HMB, CAEBV, NK-lymphoma, and NK-leukemia cell lines, which were established from patients, was analyzed using oligonucleotide microarrays and compared to that of CD56(bright)CD16(dim/-) NK cells from healthy donors. Principal components analysis showed that CAEBV and NK-lymphoma cells were relatively closely located, indicating that they had similar expression profiles. Unsupervised hierarchal clustering analyses of microarray data and gene ontology analysis revealed specific gene clusters and identified several candidate genes responsible for disease that can be used to discriminate each category of NK-LPD and NK-cell lymphoma/leukemia.

    DOI: 10.1080/10428194.2017.1304762

    PubMed

    researchmap

  • ランゲルハンス細胞組織球症患者血清の質量分析計による解析及び新規トリプルファクター発症モデルの提唱

    村上 一郎, 松下 倫子, 岩崎 健, 桑本 聡史, 加藤 雅子, 長田 佳子, 堀江 靖, 林 一彦, 岡 剛史, 吉野 正

    日本病理学会会誌   106 ( 1 )   354 - 354   2017.3

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    researchmap

  • Ecology of Merkel Cell Polyomavirus in Healthy Skin Shows a Close Agreement with Interleukin-1 Loop Model in Langerhans Cell Histiocytosis

    Ichiro Murakami, Junko Nakashima, Yumiko Hashida, Masanori Daibata, Michiko Matsushita, Takeshi Iwasaki, Satoshi Kuwamoto, Masako Kato, Keiko Nagata, Kazuhiko Hayashi, Takashi Oka, Tadashi Yoshino, Toshihiko Imamura, Akira Morimoto, Shinsaku Imashuku, Jean Gogusev, Francis Jaubert

    PEDIATRIC BLOOD & CANCER   63   S26 - S27   2016.11

     More details

    Language:English   Publisher:WILEY-BLACKWELL  

    Web of Science

    researchmap

  • Aberrant differential expression of EZH1 and EZH2 in Polycomb repressive complex 2 among B- and T/NK-cell neoplasms

    Lamia Abdalkader, Takashi Oka, Katsuyoshi Takata, Hiaki Sato, Ichiro Murakami, Arie P. Otte, Tadashi Yoshino

    PATHOLOGY   48 ( 5 )   467 - 482   2016.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:ELSEVIER SCIENCE BV  

    The Polycomb repressive complex-2 members (EZH2, EED, SUZ12 and EZH1) are important regulators of haematopoiesis, cell cycle and differentiation. Over expression of EZH2 has been linked to cancer metastases and poor prognosis. Detailed information on the expression of other members in normal and neoplastic lymphoid tissue remains to be elucidated. Immunohistochemical and immunofluorescent analyses of 156 samples from haematopoietic neoplasms patients and 27 haematopoietic cell lines were used.
    B-cell neoplasms showed a significant over-expression of EZH2, EED and SUZ12 in the aggressive subtypes compared to the indolent subtypes and normal tissue (p = 0.000-0.046) while expression of EZH1 was decreased in mantle cell lymphoma compared to normal tissue (p = 0.011). T/NK-cell neoplasms also showed significant over expression of EZH2, EED and SUZ12 (p = 0.000-0.002) and decreased expression of EZH1 (p = 0.001) compared to normal cells. EZH2 and EZH1 have opposite expression patterns both in normal and neoplastic lymphoid tissues as well as an opposite relation to Ki-67. These results were supported by western blotting analyses. Immunofluorescent staining revealed a difference in the intracellular localisation of EZH1 compared to other members.
    These evidences suggest that EZH2 and EZH1 are important in the counter-balancing mechanisms controlling proliferation/resting of lymphoid cells. The disruption of the balanced EZH2/EZH1 ratio may play important roles in the pathogenesis of lymphomas.

    DOI: 10.1016/j.pathol.2016.05.002

    Web of Science

    researchmap

  • Acute-phase ITIH4 levels distinguish multi-system from single-system Langerhans cell histiocytosis via plasma peptidomics

    Ichiro Murakami, Yukiko Oh, Akira Morimoto, Hitoshi Sano, Susumu Kanzaki, Michiko Matsushita, Takeshi Iwasaki, Satoshi Kuwamoto, Masako Kato, Keiko Nagata, Kazuhiko Hayashi, Shinsaku Imashuku, Jean Gogusev, Francis Jaubert, Takashi Oka, Tadashi Yoshino

    CLINICAL PROTEOMICS   12   16 - 23   2015.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:BIOMED CENTRAL LTD  

    Background: Langerhans cell histiocytosis (LCH) is a proliferative disorder in which abnormal Langerhans cell (LC)-like cells (LCH cells) intermingle with inflammatory cells. Whether LCH is reactive or neoplastic remains a controversial matter. We recently described Merkel cell polyomavirus (MCPyV) as a possible causative agent of LCH and proposed interleukin-1 loop model: LCH is a reactive disorder with an underlying oncogenic potential and we now propose to test this theory by looking for acute markers of inflammation. We detected MCPyV-DNA in the peripheral blood cells of patients with high-risk organ-type (LCH-risk organ (RO) (+)) but not those with non-high-risk organ-type LCH (LCH-RO (-)); this difference was significant. LCH-RO (-) is further classified by its involvement of either a single organ system (SS-LCH) or multiple organ systems (MS-LCH). In patients with LCH-RO (-), MCPyV-DNA sequences were present in LCH tissues, and significant differences were observed between LCH tissues and control tissues associated with conditions such as dermatopathic lymphadenopathy and reactive lymphoid hyperplasia. Although MCPyV causes subclinical infection in nearly all people and 22 % of healthy adults will harbor MCPyV in their buffy coats, circulating monocytes could serve as MCPyV reservoirs and cause disseminated skin lesions.
    Methods: Plasma sample from 12 patients with LCH-RO (-) (5 MS-LCH and 7 SS-LCH) and 5 non-LCH patients were analyzed by peptidomics. Mass spectrometry (MS) spectra were acquired and peptides exhibiting quantitative differences between MS-LCH and SS-LCH patients were targeted.
    Results: One new candidate biomarker, m/z 3145 was selected and identified after obtaining a MS/MS fragmentation pattern using liquid chromatography-MS/MS. This peak was identified as a proteolytic fragment derived from interalpha- trypsin inhibitor heavy chain 4 (ITIH4, [PDB: Q14624]).
    Conclusions: Peptidomics of LCH have revealed that the level of acute-phase ITIH4 distinguishes MS-LCH-RO (-) from SS-LCH-RO (-). Acute-phase proteins serve non-specific, physiological immune functions within the innate immune system. LCH may be a reactive disorder with both underlying neoplastic potential of antigen presenting cells harboring BRAF mutations and hyper-immunity of other inflammatory cells against MCPyV infection. Among LCH-RO (-), MCPyV-DNA sequences were present in both MS-LCH tissues and SS-LCH tissues without significant differences. ITIH4 may show that LCH activity or LCH subtypes correlates with the systemic or localized reactions of MCPyV infection.

    DOI: 10.1186/s12014-015-9089-2

    Web of Science

    researchmap

  • 成人T細胞白血病/リンパ腫(ATL)における特異的DNAメチル化と病態との関連

    佐藤 妃映, 岡 剛史, 神農 陽子, 鷲尾 佳奈, 村上 一郎, 大内田 守, 大島 孝一, 宇都宮 與, 吉野 正

    日本病理学会会誌   104 ( 1 )   494 - 494   2015.3

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    researchmap

  • ランゲルハンス細胞組織球症患者血清の質量分析器による解析

    村上 一郎, 松下 倫子, 岩崎 健, 桑本 聡史, 加藤 雅子, 堀江 靖, 林 一彦, 岡 剛史, 吉野 正

    日本病理学会会誌   104 ( 1 )   282 - 282   2015.3

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    researchmap

  • Interleukin-1 loop model for pathogenesis of Langerhans cell histiocytosis

    Ichiro Murakami, Michiko Matsushita, Takeshi Iwasaki, Satoshi Kuwamoto, Masako Kato, Keiko Nagata, Yasushi Horie, Kazuhiko Hayashi, Toshihiko Imamura, Akira Morimoto, Shinsaku Imashuku, Jean Gogusev, Francis Jaubert, Katsuyoshi Takata, Takashi Oka, Tadashi Yoshino

    CELL COMMUNICATION AND SIGNALING   13   13   2015.2

     More details

    Language:English   Publisher:BIOMED CENTRAL LTD  

    We propose Langerhans cell histiocytosis (LCH) is an inflammatory process that is prolonged by mutations. We hypothesize that Merkel cell polyomavirus (MCPyV) infection triggers an interleukin-1 (IL-1) activation loop that underlies the pathogenesis of LCH. Langerhans cells (LCs) are antigen presenting cells in the skin. When LCs encounter exogenous antigens, they migrate from the epidermis into draining lymphoid tissues to initiate T-cell activity. It has been proposed that LC migration-related factors, including E-cadherin, matrix metalloproteinase, and Notch ligand induce LCH activity. We found that the tyrosine phosphatase SHP-1, which binds IL-1 receptor-associated kinase 1, is expressed at a significantly higher level in LCH affecting multiple organ systems (MS-LCH) than in LCH affecting a single organ system (SS-LCH). IL-1 stimulates T helper 17 cells and their signature cytokine IL-17 had been a matter of controversy. We detected higher levels of IL-17A receptor expression in MS-LCH than in SS-LCH and proposed an IL-17 endocrine model that could settle the controversy. IL-1 is the first cytokine secreted in response to sensitizers and promotes LC migration from sentinel tissues. Myeloid differentiation primary response 88 (MyD88), downstream of the IL-1 receptor, has functions in both RAS signaling and inflammation, leading to human cell transformation. In 2010, an activating mutation in the B-rapidly accelerated fibrosarcoma gene (BRAF) V600E was found in LCH. This BRAF mutation induces phosphorylation of the extracellular signal-regulated kinase (ERK) that may play an important role with MyD88 in LCH pathogenesis. However, phosphorylated ERK (pERK) is rapidly dephosphorylated by dual specificity phosphatase 6 (DUSP6), and limited proliferation is predicted in BRAF mutant cells. MyD88 binds pERK via its D-domain, thereby preventing pERK-DUSP6 interaction and maintaining ERK in an active, phosphorylated state. We detected MCPyV-DNA in the peripheral blood cells of two out of three patients with LCH in high-risk organs but not in those of patients with LCH in non-high-risk organs (0/12; P = .029). MCPyV infection can trigger precursor LCH cells with BRAF mutation to produce IL-1; the IL-1 loop is amplified in all LCH subclasses. Our model indicates both BRAF mutation and IL-1 loop regulation as potential therapeutic targets.

    DOI: 10.1186/s12964-015-0092-z

    Web of Science

    researchmap

  • Establishment of a Langerhans cell histiocytosis lesion cell line with dermal dendritic cell characteristics

    Ichiro Murakami, Jean Gogusev, Francis Jaubert, Michiko Matsushita, Kazuhiko Hayashi, Ikuo Miura, Takehiro Tanaka, Takashi Oka, Tadashi Yoshino

    ONCOLOGY REPORTS   33 ( 1 )   171 - 178   2015.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:SPANDIDOS PUBL LTD  

    A cell line named PRU-1, derived from a Langerhans cell (LC) histiocytosis (LCH) skull lesion of a 7-year-old boy, was established and characterized. PRU-1 is an adherent spindle-shaped cell line that shows no Birbeck granules on electron microscopy. Flow cytometric analysis of cells collected from the early seventh passage showed no LC phenotypes of CD1a and S100 protein. Immunostaining of PRU-1 cells also revealed no expression of LC markers but showed expression of CD11c, CD54 (ICAM-1) and CD68, which was also observed in some peripherally located cells of the original LCH lesion. The PRU-1 cells stained positive for factor XIIIa and negative for CD34, suggesting a dermal dendritic cell phenotype. Cytogenetic analyses revealed abnormalities such as 39, XY, -2, -4, -8, -12, -12, -14, add (18)(q21), 20, +mar and 44, XY, -11, -14, add(18)(q21). TCR rearrangement in the PRU-1 cells was not amplified by PCR. Tumorigenicity was not proven by xenografting into SCID mice. A conditioned medium from PRU-1 culture induced the proliferation of peripheral blood lymphocytes as well as the activation of monocytes from a healthy donor into CD1a-positive LC-like cells. Because the phenotypic characteristics of PRU-1 differed from those of CD1a-positive abnormal LC-like cells (LCH cells), it was likely that the PRU-1 cells were derived from peripherally located cells of the LCH lesion rather than LCH cells. LCH has been regarded as a type of granulomatous neoplasm with several intermingled inflammatory cells and influenced by stimuli such as Merkel cell polyomavirus (MCPyV) infection or cigarette smoking. However, in the PRU-1 cells, MCPyV-DNA was not detected by PCR. Stromal cell-like PRU-1 cells are likely to produce some growth or differentiation factors, which may play important roles in LCH lesion formation, cell maintenance and LC-like cell induction.

    DOI: 10.3892/or.2014.3567

    Web of Science

    researchmap

  • Detection of T-cell receptor gamma gene rearrangement in paraffin-embedded T or natural killer/T-cell lymphoma samples using the BIOMED-2 protocol

    Tomoko Miyata-Takata, Katsuyoshi Takata, Sachiko Yamanouchi, Yasuharu Sato, Mai Harada, Takashi Oka, Takehiro Tanaka, Yoshinobu Maeda, Mitsune Tanimoto, Tadashi Yoshino

    LEUKEMIA & LYMPHOMA   55 ( 9 )   2161 - 2164   2014.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:INFORMA HEALTHCARE  

    While the use of polymerase chain reaction (PCR)-based clonality analysis of formalin-fixed paraffin-embedded (FFPE) tissue has recently become widespread, the detection sensitivity for lymphoma subtypes using FFPE samples is not well known. Here, we analyzed T-cell receptor gamma chain (TCRG) gene rearrangement clonality in 100 cases of T-or natural killer (NK)/T-cell lymphoma and examined detection sensitivity according to lymphoma subtype. Clonality was detected in approximately 80% of the major T-cell lymphoma subtypes: peripheral T-cell lymphoma, not otherwise specified, 84% (21/25 cases); angioimmunoblastic T-cell lymphoma, 71% (15/21 cases); and adult T-cell leukemia/lymphoma, 80% (8/10 cases). The number of clonal peaks differed according to subtype. TCRG gene rearrangement was not detected in 63 cases of B-cell lymphoma or reactive lesions. Thus, clonality analysis can effectively and reliably detect TCRG gene rearrangement in T-cell lymphoma cases and could, therefore, be a useful diagnostic tool in routine practice.

    DOI: 10.3109/10428194.2013.871634

    Web of Science

    researchmap

  • High viral load of Merkel cell polyomavirus DNA sequences in Langerhans cell sarcoma tissues

    Ichiro Murakami, Michiko Matsushita, Takeshi Iwasaki, Satoshi Kuwamoto, Masako Kato, Yasushi Horie, Kazuhiko Hayashi, Jean Gogusev, Francis Jaubert, Shu Nakamoto, Mitsunori Yamakawa, Hirokazu Nakamine, Katsuyoshi Takata, Takashi Oka, Tadashi Yoshino

    INFECTIOUS AGENTS AND CANCER   9   15 - 18   2014.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:BIOMED CENTRAL LTD  

    Background: Langerhans cell (LC) sarcoma (LCS) is a high-grade neoplasm with overtly malignant cytologic features and an LC phenotype. We very recently suggested that LC behaves as a reservoir for common dermotropic Merkel cell polyomavirus (MCPyV) and determined the relationship between LC histiocytosis (LCH), which has an underlining oncogenic capacity, and MCPyV as a trigger for a reactive process rather than a neoplastic process. We propose LC to be a reservoir for MCPyV and hypothesize that some LCS subtypes may be related to the MCPyV agent.
    Findings: We examined seven LCS tissues using multiplex quantitative PCR (Q-PCR) and immunohistochemistry with anti MCPyV large-T (LT) antigen antibody. High viral loads of MCPyV DNA sequences (viral load = relative levels of MCPyV) were detected (0.328-0.772 copies/cell (Merkel cell carcinoma (MCC) = 1.0)) using Q-PCR in 43% (3/7) tissues, but LT antigen expression was not observed (0/7).
    Conclusions: Frequent MCPyV-DNA amplification suggests that LCS in some patients may be related to MCPyV infection. Moreover, the higher viral load of LCS (median, 0.453 copies/cell) than low load of LCH (0.003, median of 12 cases) (P < 0.01) may suggest a virally induced tumorigenic process in some LCS. Although the absence of LT antigen expression may indicate a different role for MCPyV in this pathology, some subtypes of LCS may develop in the background of MCPyV-infected LC. To the best of our knowledge, this is the first report on the relationship between MCPyV and LCS. The recent discovery of MCPyV opened new therapeutic avenues for MCC. These data open novel possibilities for therapeutic interventions against LCS.

    DOI: 10.1186/1750-9378-9-15

    Web of Science

    researchmap

  • メルケル細胞ポリオーマウイルス解析に依るランゲルハンス細胞肉腫の疾患モデル

    村上 一郎, 松下 倫子, 岩崎 健, 桑本 聡史, 加藤 雅子, 堀江 靖, 林 一彦, 前田 智治, 中本 周, 山川 光徳, 中峯 寛和, 高田 尚良, 岡 剛史, 吉野 正

    日本病理学会会誌   103 ( 1 )   269 - 269   2014.3

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    researchmap

  • Gene expression analysis in children with complex seizures due to influenza A(H1N1)pdm09 or rotavirus gastroenteritis

    Mitsuru Tsuge, Takashi Oka, Nobuko Yamashita, Yukie Saito, Yosuke Fujii, Yoshiharu Nagaoka, Masato Yashiro, Hirokazu Tsukahara, Tsuneo Morishima

    JOURNAL OF NEUROVIROLOGY   20 ( 1 )   73 - 84   2014.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:SPRINGER  

    Viral infections have been implicated as a cause of complex seizures in children. The pathogenic differences in complex seizures due to influenza A(H1N1)pdm09 or rotavirus gastroenteritis remain unclear. This study analyzed the gene expression profiles in the peripheral whole blood from pediatric patients with complex seizures due to influenza A(H1N1)pdm09 or rotavirus gastroenteritis. The gene expression profiles of ten patients (five with seizures and five without) with influenza A(H1N1)pdm09 and six patients (three with seizures and three without) with rotavirus gastroenteritis were examined. Gene expression profiles in the whole blood were different in complex seizures due to influenza A(H1N1)pdm09 or rotavirus gastroenteritis. Transcripts related to the immune response were significantly differentially expressed in complex seizures with influenza A(H1N1)pdm09, and transcripts related to the stress response were significantly differentially expressed in complex seizures with rotavirus gastroenteritis. Pathway analysis showed that the mitogen-activated protein kinases in the T cell receptor signaling pathway were activated in complex seizures due to influenza A(H1N1)pdm09. Dysregulation of the genes related to immune response or stress response could contribute to the pathogenic differences of the complex seizures due to influenza A(H1N1)pdm09 or rotavirus gastroenteritis.

    DOI: 10.1007/s13365-013-0231-5

    Web of Science

    researchmap

  • Merkel cell polyomavirus DNA sequences in peripheral blood and tissues from patients with Langerhans cell histiocytosis

    Ichiro Murakami, Michiko Matsushita, Takeshi Iwasaki, Satoshi Kuwamoto, Masako Kato, Yasushi Horie, Kazuhiko Hayashi, Toshihiko Imamura, Akira Morimoto, Shinsaku Imashuku, Jean Gogusev, Francis Jaubert, Katsuyoshi Takata, Takashi Oka, Tadashi Yoshino

    HUMAN PATHOLOGY   45 ( 1 )   119 - 126   2014.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:W B SAUNDERS CO-ELSEVIER INC  

    Langerhans cell histiocytosis (LCH) is a group of granulomatous disorders in which abnormal Langerhans cells proliferate as either a localized lesion in a single bone or disseminated disease involving two or more organs or systems. Because the different LCH forms exhibit significantly elevated levels of inflammatory molecules, including pro-inflammatory cytokines and tissue-degrading enzymes, we investigated for a possible viral trigger in LCH pathogenesis. We looked for Merkel cell polyomavirus (MCPyV) in peripheral blood cells and tissues using quantitative real-time PCR and immunohistochemistry staining with anti-MCPyV large T-antigen antibody. Our findings revealed elevated amounts of MCPyV DNA in the peripheral blood cells of 2 of 3 patients affected by LCH with high-risk organ involvement (RO+) and absence of MCPyV DNA in the blood cells in all 12 LCH-RO-patients (P = .029). With lower viral loads (0.002-0.033 copies/cell), an elevated number of MCPyV DNA sequences was detected in 12 LCH tissues in comparison with control tissues obtained from patients with reactive lymphoid hyperplasia (0/5; P = .0007), skin diseases not related to LCH in children younger than 2 years (0/11; P = .0007), or dermatopathic lymphadenopathy (5/20; P = .0002). The data, including frequent but lower viral loads and low large-T antigen expression rate (2/13 LCH tissues), suggest that development of LCH as a reactive rather than a neoplastic process may be related to MCPyV infection. (C) 2014 Elsevier Inc. All rights reserved.

    DOI: 10.1016/j.humpath.2013.05.028

    Web of Science

    researchmap

  • Necrotic and apoptotic cells serve as nuclei for calcification on osteoblastic differentiation of human mesenchymal stem cells in vitro

    Hirofumi Fujita, Masanao Yamamoto, Tetsuya Ogino, Hirotsugu Kobuchi, Naoko Ohmoto, Eriko Aoyama, Takashi Oka, Tohru Nakanishi, Keiji Inoue, Junzo Sasaki

    CELL BIOCHEMISTRY AND FUNCTION   32 ( 1 )   77 - 86   2014.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:WILEY-BLACKWELL  

    A close relationship between cell death and pathological calcification has recently been reported, such as vascular calcification in atherosclerosis. However, the roles of cell death in calcification by osteoblast lineage have not been elucidated in detail. In this study, we investigated whether cell death is involved in the calcification on osteoblastic differentiation of human bone marrow mesenchymal stem cells (hMSC) under osteogenic culture in vitro. Apoptosis and necrosis occurred in an osteogenic culture of hMSC, and cell death preceded calcification. The generation of intracellular reactive oxygen species, chromatin condensation and fragmentation, and caspase-3 activation increased in this culture. A pan-caspase inhibitor (Z-VAD-FMK) and anti-oxidants (Tiron and n-acetylcysteine) inhibited osteogenic culture-induced cell death and calcification. Furthermore, calcification was significantly promoted by the addition of necrotic dead cells or its membrane fraction. Spontaneously dead cells by osteogenic culture and exogenously added necrotic cells were surrounded by calcium deposits. Induction of localized cell death by photodynamic treatment in the osteogenic culture resulted in co-localized calcification. These findings show that necrotic and apoptotic cell deaths were induced in an osteogenic culture of hMSC and indicated that both necrotic and apoptotic cells of osteoblast lineage served as nuclei for calcification on osteoblastic differentiation of hMSC in vitro. Copyright (c) 2013 John Wiley & Sons, Ltd.

    DOI: 10.1002/cbf.2974

    Web of Science

    researchmap

  • In aggressive variants of non-Hodgkin lymphomas, Ezh2 is strongly expressed and polycomb repressive complex PRC1.4 dominates over PRC1.2

    Lamia Abd Al Kader, Takashi Oka, Katsuyoshi Takata, Xu Sun, Hiaki Sato, Ichiro Murakami, Tomohiro Toji, Akihiro Manabe, Hiroshi Kimura, Tadashi Yoshino

    VIRCHOWS ARCHIV   463 ( 5 )   697 - 711   2013.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:SPRINGER  

    Polycomb group (PcG) proteins are important for the regulation of hematopoiesis by regulating chromatin compaction and silencing genes related to differentiation and cell cycle. Overexpression of enhancer of zeste homologue 2 (Ezh2) and Bmi-1/PCGF4 has been implicated in solid organ cancers, while Mel-18/PCGF2 has been reported as a tumor suppressor. Detailed expression profiles of PcG proteins and their diagnostic significance in malignant lymphomas are still unknown. In this study, we analyzed the expression levels of Ezh2, Bmi-1, Mel-18, and Ki67 in 197 Hodgkin's and non-Hodgkin's lymphoma patient samples and in lymphoma cell lines using immunohistochemistry, fluorescent immunocytochemistry, and Western blotting. Immunohistochemical staining showed that Ezh2 expression was significantly increased in aggressive compared to indolent subtypes of B cell neoplasms (P = 0.000-0.030), while no significant differences in Bmi-1 expression were found between these subtypes. Compared to the normal counterpart, T cell lymphomas showed significant overexpression of Bmi-1 (P = 0.011) and Ezh2 (P = 0.000). The Ki67 labeling index showed a positive correlation with Ezh2 expression in B cell lymphomas (correlation coefficient (Co) = 0.983, P = 0.000) and T/NK cell lymphomas (Co = 0.629, P = 0.000). Fluorescent immunohistochemical staining showed coexpression of Ezh2 and Ki67 in the same tumor cells, indicating that Ezh2 expression correlates with cell proliferation. Both B and T/NK cell neoplasms showed low expression of Mel-18 and high expression of both Bmi-1 and Ezh2. In conclusion, in aggressive lymphoma variants, Ezh2 is strongly expressed and polycomb repressive complex PRC1.4 dominates over PRC1.2. Coexpression of Bmi-1 and Ezh2 is a characteristic of aggressive lymphomas. Ezh2 correlates with the proliferation and aggressive nature of non-Hodgkin's lymphomas.

    DOI: 10.1007/s00428-013-1428-y

    Web of Science

    researchmap

  • Pathogenic mechanisms of influenza A(H1N1)pdm09 infection elucidated on gene expression profiling

    Nobuko Yamashita, Hirokazu Tsukahara, Mitsuru Tsuge, Yoshiharu Nagaoka, Masato Yashiro, Yukie Saito, Yosuke Fujii, Takashi Oka, Tsuneo Morishima

    Pediatrics International   55 ( 5 )   572 - 577   2013.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Background: The pathogenic mechanisms underlying influenza A(H1N1)pdm09-associated central nervous system (CNS) manifestations and pneumonia remain unclear. This study examined A(H1N1)pdm09 host responses using gene expression profiles of patients' peripheral blood. Methods: Sixteen A(H1N1)pdm09-infected children in three groups were examined: a CNS group, with convulsion and altered consciousness (n = 6)
    a pneumonia (Pneu) group (n = 5)
    and a group of infected control patients (n = 5). The signal ratios of the acute to recovery phases in CNS or Pneu were analyzed versus those of the control. Results: The CNS (619 transcripts) and Pneu (656 transcripts) groups had significantly increased signal ratios compared to the control group. Regarding the increased ratios of transcripts shown by multiple probes, contactin-associated protein-like 3 transcripts, oleoyl-ACP hydrolase transcripts, and interleukin 1 type 1 receptor were observed in CNS and Pneu. Increased ratios of prostaglandin-endoperoxide synthase 2 and α-synuclein were characteristic of CNS. Alkaline phosphatase and the Fc fragment of IgA receptor were characteristic of Pneu. Regarding enriched gene ontology terms, 'response to lipopolysaccharide', 'innate immune response', and 'intrinsic to membrane' were observed commonly in CNS and Pneu. Enriched gene ontology terms related to 'hemoglobin' and 'hemostasis' were, respectively, characteristic of CNS and Pneu. Conclusion: These symptom-associated transcripts might be some clues to the pathogenesis of the A(H1N1)pdm09 infection. © 2013 Japan Pediatric Society.

    DOI: 10.1111/ped.12139

    Scopus

    PubMed

    researchmap

  • Duodenal follicular lymphoma lacks AID but expresses BACH2 and has memory B cell characteristics

    125 ( 2 )   103 - 107   2013.8

  • Duodenal follicular lymphoma lacks AID but expresses BACH2 and has memory B-cell characteristics (vol 26, pg 22, 2013)

    Katsuyoshi Takata, Yasuharu Sato, Naoya Nakamura, Mami Tokunaka, Yukari Miki, Yara Yukie Kikuti, Kazuhiko Igarashi, Etsuro Ito, Hideo Harigae, Seiichi Kato, Eiko Hayashi, Takashi Oka, Yoshinobu Hoshii, Akira Tari, Hiroyuki Okada, Lamia Abd Al-Kader, Yoshinobu Maeda, Mitsune Tanimoto, Tomohiro Kinoshita, Tadashi Yoshino

    MODERN PATHOLOGY   26 ( 8 )   1152 - 1152   2013.8

     More details

    Language:English   Publisher:NATURE PUBLISHING GROUP  

    DOI: 10.1038/modpathol.2013.118

    Web of Science

    researchmap

  • 網羅的遺伝子発現解析、メルケル細胞ポリオーマウイルス解析に依るランゲルハンス細胞組織球症の疾患モデル

    村上 一郎, 松下 倫子, 岩崎 健, 桑本 聡史, 加藤 雅子, 堀江 靖, 林 一彦, 岡 剛史, 吉野 正

    日本病理学会会誌   102 ( 1 )   306 - 306   2013.4

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    researchmap

  • IL-17A receptor expression differs between subclasses of Langerhans cell histiocytosis, which might settle the IL-17A controversy

    Ichiro Murakami, Akira Morimoto, Takashi Oka, Satoshi Kuwamoto, Masako Kato, Yasushi Horie, Kazuhiko Hayashi, Jean Gogusev, Francis Jaubert, Shinsaku Imashuku, Lamia Abd Al-Kadar, Katsuyoshi Takata, Tadashi Yoshino

    VIRCHOWS ARCHIV   462 ( 2 )   219 - 228   2013.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:SPRINGER  

    Langerhans cell histiocytosis (LCH) is a lymphoproliferative disorder consisting of abnormal Langerhans cell-like cells and other lymphoid cells. LCH presents as either a multisystem LCH (LCH-MS) or a single-system LCH (LCH-SS). Currently, neither the pathogeneses nor the factors that define these disease subclasses have been elucidated. The interleukin (IL)-17A autocrine LCH model and IL-17A-targeted therapies have been proposed and have engendered much controversy. Those authors showed high serum IL-17A levels in LCH and argued that serum IL-17A-dependent fusion activities in vitro, rather than serum IL-17A levels, correlated with LCH severity (i.e. the IL-17A paradox). In contrast, others could not confirm the IL-17A autocrine model. So began the controversy on IL-17A, which still continues. We approached the IL-17A controversy and the IL-17A paradox from a new perspective in considering the expression levels of IL-17A receptor (IL-17RA). We detected higher levels of IL-17RA protein expression in LCH-MS (n = 10) as compared to LCH-SS (n = 9) (P = 0.041) by immunofluorescence. We reconfirmed these data by re-analyzing GSE16395 mRNA data. We found that serum levels of IL-17A were higher in LCH (n = 38) as compared to controls (n = 20) (P = 0.005) with no significant difference between LCH subclasses. We propose an IL-17A endocrine model and stress that changes in IL-17RA expression levels are important for defining LCH subclasses. We hypothesize that these IL-17RA data could clarify the IL-17A controversy and the IL-17A paradox. As a potential treatment of LCH-MS, we indicate the possibility of an IL-17RA-targeted therapy.

    DOI: 10.1007/s00428-012-1360-6

    Web of Science

    researchmap

  • Dynamic changes of epigenetic abnormalities during initiation and progression of adult T-cell leukemia/lymphoma (ATLL)

    Takashi Oka, Lamia Abd Al-Kader, Hiaki Sato, Kana Washio, Yoko Shinnou, Katsuyoshi Takata, Ichiro Murakami, Atae Utsunomiya, Tadashi Yoshino

    CANCER RESEARCH   72   2012.4

     More details

    Language:English   Publisher:AMER ASSOC CANCER RESEARCH  

    DOI: 10.1158/1538-7445.AM2012-3132

    Web of Science

    researchmap

  • 成人T細胞白血病・リンパ腫(ATLL)の発症・進展におけるエピジェネテイックス異常の動態解析

    岡 剛史, Abd Al-Kader Lamia, 佐藤 妃映, 神農 陽子, 鷲尾 佳奈, 高田 尚良, 村上 一郎, 大内田 守, 大島 孝一, 宇都宮 與, 吉野 正

    日本病理学会会誌   101 ( 1 )   291 - 291   2012.3

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    researchmap

  • Duodenal follicular lymphoma lacks AID but expresses BACH2 and has memory B-cell characteristics.

    Takata K, Sato Y, Nakamura N, Tokunaka M, Miki Y, Yukie Kikuti Y, Igarashi K, Ito E, Harigae H, Kato S, Hayashi E, Oka T, Hoshii Y, Tari A, Okada H, Mohamad AA, Maeda Y, Tanimoto M, Kinoshita T, Yoshino T

    Mod Pathol   26 ( 1 )   22 - 31   2012

  • Effect of Risedronate on Osteoblast Differentiation, Expression of Receptor Activator of NF-kappa B Ligand and Apoptosis in Mesenchymal Stem Cells

    Hirofumi Fujita, Kazuko Kurokawa, Tetsuya Ogino, Mio Ono, Masanao Yamamoto, Takashi Oka, Tohru Nakanishi, Naoya Kobayashi, Noriaki Tanaka, Tomohiro Ogawa, Etsuko Suzaki, Kozo Utsumi, Junzo Sasaki

    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY   109 ( 2 )   78 - 84   2011.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:WILEY-BLACKWELL  

    Nitrogen-containing bisphosphonates (BPs) are antiresorptive drugs used for the treatment of metabolic bone diseases. Bone marrow stromal cells such as mesenchymal stem cells (MSCs) and MSC-derived osteoblasts that originate from MSCs are known to regulate osteoclast differentiation and activation via the expression of receptor activator of NF-kappa B ligand (RANKL). Although the effects of nitrogen-containing BPs on osteoclasts and osteoblasts have been well investigated, their effects in MSCs have not been clarified. In this study, we investigated the effects of risedronate (RIS), a nitrogen-containing BP, on osteoblast differentiation, RANKL expression and apoptosis in human and rat MSCs. RIS suppressed the formation of mineralized nodules and mRNA expression of differentiation marker genes such as bone sialoprotein and osteocalcin in MSC-derived osteoblasts. The RANKL expression induced by 1,25-(OH)(2) vitamin D(3) was not affected by RIS in human MSC-derived osteoblasts. In addition, treatment with high-concentration RIS induced chromatin condensation, an apoptosis feature, in MSCs. RIS-induced chromatin condensation was suppressed by a pan-caspase inhibitor zVAD-FMK and a cell-permeable isoprenoid analogue geranylgeraniol. These results indicate that RIS suppressed osteoblast differentiation and induced caspase-and isoprenoid depletion-dependent apoptosis and suggest that the antiresorptive effect of RIS is not mediated by a decrease in the RANKL expression in MSC-derived osteoblasts.

    DOI: 10.1111/j.1742-7843.2011.00685.x

    Web of Science

    researchmap

  • Tyrosine phosphatase SHP-1 is expressed higher in multisystem than in single-system Langerhans cell histiocytosis by immunohistochemistry

    Ichiro Murakami, Takashi Oka, Satoshi Kuwamoto, Masako Kato, Kazuhiko Hayashi, Jean Gogusev, Toshihiko Imamura, Akira Morimoto, Shinsaku Imashuku, Tadashi Yoshino

    VIRCHOWS ARCHIV   459 ( 2 )   227 - 234   2011.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:SPRINGER  

    Langerhans cell histiocytosis (LCH) is a proliferative disorder of Langerhans cell (LC)-like CD1a-positive cell (LCH cell) with unknown causes. LCH consists of two subtypes: single-system LCH (LCH-SS) with favorable prognosis and multisystem LCH (LCH-MS) with poor prognosis. LCH has been indicated as a neoplastic disorder from monoclonal characteristics of LCH cells. This study aimed to investigate an expression of tyrosine phosphatase SHP-1 in LCH, since its expression levels were variously reported in many tumors, overexpression in ovarian cancers (a candidate oncoprotein), and downregulation by methylation in gastric cancers, prostate cancers, malignant lymphomas, and leukemias (a putative tumor suppressor). By immunohistochemistry (IHC), the SHP-1 expression in LCs and LCH cells was compared in LCH (two subtypes: LCH-SS = 21, LCH-MS = 12), dermatopathic lymphadenopathy (DLA) (n = 9) and normal epidermal LCs (n = 3) near LCH lesion. IHC results were analyzed semiquantitatively using a Photoshop software. The mean intensity score (IS) of DLA, LCH-SS, LCH-MS, and LCs were 47, 100, 139, and 167 (in arbitrary unit), respectively. The IS had significant differences among LCH-SS, LCH-MS, and DLA (p < 0.01). SHP-1 is expressed significantly higher in LCH-MS than in LCH-SS. SHP-1 can be a progression marker of LCH. SHP-1 is also useful for differential diagnosis between LCH in lymph nodes and DLA.

    DOI: 10.1007/s00428-011-1090-1

    Web of Science

    researchmap

  • 成人T細胞白血病・リンパ腫(ATLL)の発症・進展におけるエピジェネティックス異常

    岡 剛史, 佐藤 妃映, Lamia Abd. Al-Kader, 神農 陽子, 鷲尾 佳奈, 高田 尚良, 田村 麻衣子, 村上 一郎, 大内田 守, 大島 孝一, 宇都宮 與, 吉野 正

    日本リンパ網内系学会会誌   51   118 - 118   2011.6

     More details

    Language:Japanese   Publisher:(一社)日本リンパ網内系学会  

    researchmap

  • Cumulative epigenetic abnormalities in host genes with viral and microbial infection during initiation and progression of malignant lymphoma/leukemia

    Takashi Oka, Hiaki Sato, Mamoru Ouchida, Atae Utsunomiya, Tadashi Yoshino

    Cancers   3 ( 1 )   568 - 581   2011.3

     More details

    Language:English  

    Although cancers have been thought to be predominantly driven by acquired genetic changes, it is becoming clear that microenvironment-mediated epigenetic alterations play important roles. Aberrant promoter hypermethylation is a prevalent phenomenon in human cancers as well as malignant lymphoma/leukemia. Tumor suppressor genes become frequent targets of aberrant hypermethylation in the course of gene-silencing due to the increased and deregulated DNA methyltransferases (DNMTs). The purpose of this article is to review the current status of knowledge about the contribution of cumulative epigenetic abnormalities of the host genes after microbial and virus infection to the crisis and progression of malignant lymphoma/leukemia. In addition, the relevance of this knowledge to malignant lymphoma/leukemia assessment, prevention and early detection will be discussed. © 2011 by the authors
    licensee MDPI, Basel, Switzerland.

    DOI: 10.3390/cancers3010568

    Scopus

    researchmap

  • Downregulation of the B-cell receptor signaling component CD79b in plasma cell myeloma: A possible post transcriptional regulation

    Xingang Huang, Katsuyoshi Takata, Yasuharu Sato, Takehiro Tanaka, Kouichi Ichimura, Maiko Tamura, Takashi Oka, Tadashi Yoshino

    PATHOLOGY INTERNATIONAL   61 ( 3 )   122 - 129   2011.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:WILEY-BLACKWELL  

    The CD79 molecule, encoded by the CD79a and CD79b genes, is a signaling unit of the B-cell receptor complex, which transmits signals of B-cell activation, growth, and differentiation. They are B-cell-specific and expressed at most stages of B-cell development. Although plasma cells have been believed to lack these gene products, the regulation of CD79 expression in plasma cells is still controversial. In particular, the regulation of CD79b expression remains unclear. We sought to examine CD79b expression in normal and neoplastic plasma cells by immunohistochemical analysis. Out of the 23 clinical samples and 11 cell lines of plasma cell myeloma (PCM), none of the clinical samples and only 1 of 11 cell lines expressed CD79b immunohistologically, whereas non-neoplastic plasma cells in reactive hyperplastic lymph nodes exhibited loss of CD79b protein expression. This finding is quite different from our previous report on CD79a. Not only immunocytochemistry, but also RT-PCR and Western blot analysis of PCM cell lines gave identical results. Interestingly, we detected mRNA transcripts of CD79b in PCM cell lines, although protein translation was lacking. These findings suggest that expression of CD79b is downregulated in both plasma cells and plasma cell myeloma, and this process is possibly under post transcriptional regulation.

    DOI: 10.1111/j.1440-1827.2010.02634.x

    Web of Science

    researchmap

  • HTLV-1キャリアにおけるDNAメチル化の解析

    佐藤 妃映, 岡 剛史, Abd.Al-Kader Lamia, 神農 陽子, 鷲尾 佳奈, 高田 尚良, 田村 麻衣子, 村上 一郎, 大内田 守, 大島 孝一, 宇都宮 與, 高橋 聖之, 吉野 正

    日本病理学会会誌   100 ( 1 )   416 - 416   2011.3

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    researchmap

  • Multi-Step Aberrant CpG Island Hyper-Methylation Is Associated with the Progression of Adult T-Cell Leukemia/Lymphoma

    Hiaki Sato, Takashi Oka, Yoko Shinnou, Takami Kondo, Kana Washio, Masayuki Takano, Katsuyoshi Takata, Toshiaki Morito, Xingang Huang, Maiko Tamura, Yuta Kitamura, Nobuya Ohara, Mamoru Ouchida, Koichi Ohshima, Kenji Shimizu, Mitsune Tanimoto, Kiyoshi Takahashi, Masao Matsuoka, Atae Utsunomiya, Tadashi Yoshino

    AMERICAN JOURNAL OF PATHOLOGY   176 ( 1 )   402 - 415   2010.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER SOC INVESTIGATIVE PATHOLOGY, INC  

    Aberrant CpG island methylation contributes to the pathogenesis of various malignancies. However, little is known about the association of epigenetic abnormalities with multistep tumorigenic events in adult T cell leukemia/lymphoma (ATLL). To determine whether epigenetic abnormalities induce the progression of ATLL, we analyzed the methylation profiles of the SHP1, p15, p16, p73, HCAD, DAPK, hMLH-1, and MGMT genes by methylation specific PCR assay in 65 cases with ATLL patients. The number of CpG island methylated genes increased with disease progression and aberrant hypermethylation in specific genes was detected even in HTLV-1 carriers and correlated with progression to ATLL. The CpG island methylator phenotype (CIMP) was observed most frequently in lymphoma type ATLL and was also closely associated with the progression and crisis of ATLL. The high number of methylated genes and increase of CIMP incidence were shown to be unfavorable prognostic factors and correlated with a shorter overall survival by Kaplan-Meyer analysis. The present findings strongly suggest that the multistep accumulation of aberrant CpG methylation in specific target genes and the presence of CIMP are deeply involved in the crisis, progression, and prognosis of ATLL, as well as indicate the value of CpG methylation and CIMP for new diagnostic and prognostic biomarkers. (Am J Pathol 2010, 176:402-415; DOI: 10.2353/ajpath.2010.090236)

    DOI: 10.2353/ajpath.2010.090236

    Web of Science

    researchmap

  • Methylation of the Thyrosine Phosphatase SHP1 Gene and Loss of its Protein in Thyroid B-cell Lymphoma

    Saito Nobuaki, Nakatani Yohko, Oka Takashi, Ohshima Koichi, Takeshita Morishige, Iwasaki Hiroshi, Ikeda Seiyo

    Medical bulletin of Fukuoka University   37 ( 1 )   31 - 37   2010

     More details

    Language:Japanese   Publisher:Fukuoka University  

    CiNii Article

    CiNii Books

    researchmap

    Other Link: http://id.nii.ac.jp/1316/00002095/

  • IMMUNOHISTOCHEMICAL ANALYSES OF PTPN6 (SHP1) IN LANGERHANS CELL HISTIOCYTOSIS Reviewed

    Ichiro Murakami, Takashi Oka, Hiaki Sato, Toshiaki Morito, Katsuyoshi Takata, Yoko Shinno, Masayuki Takano, Kana Washio, Shingo Ko, Maiko Tamura, Naoko Ohnishi, Koichi Ichimura, Yasuharu Sato, Hiroyuki Yanai, Nobuya Ohara, Eisaku Kondo, Kiyoshi Takahashi, Takehiro Tanaka, Jean Gogusev, Francis Jaubert, Akira Morimoto, Shinsaku Imashuku, Tadaatsu Akagi, Tadashi Yoshino

    PEDIATRIC BLOOD & CANCER   53 ( 4 )   691 - 691   2009.10

     More details

    Language:English   Publisher:WILEY-LISS  

    Web of Science

    researchmap

  • Lipopolysaccharide-Induced Epithelial Monoamine Oxidase Mediates Alveolar Bone Loss in a Rat Chronic Wound Model

    Daisuke Ekuni, James D. Firth, Tarun Nayer, Takaaki Tomofuji, Toshihiro Sanbe, Koichiro Irie, Tatsuo Yamamoto, Takashi Oka, Zhenzi Liu, Juergen Vielkind, Edward E. Putnins

    AMERICAN JOURNAL OF PATHOLOGY   175 ( 4 )   1398 - 1409   2009.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER SOC INVESTIGATIVE PATHOLOGY, INC  

    Reactive oxygen species (ROS) production is an antimicrobial response to pathogenic challenge that may, in the case of persistent infection, have deleterious effects on the tissue of origin. A rat periodontal disease model was used to study ROS-induced chronic epithelial inflammation and bone loss. Lipopolysaccharide (LPS) was applied for 8 weeks into the gingival sulcus, and histological analysis confirmed the onset of chronic disease. junctional epithelium was collected from healthy and diseased animals using laser-capture microdissection, and expression microarray analysis was performed. Of 19,730 genes changed in disease, 42 were up-regulated >= 4-fold. Three of the top 10 LPS-induced genes, monoamine oxidase B (MAO/B) and flavin-containing monooxygenase 1 and 2, are implicated in ROS signaling. LPS-associated induction of the ROS mediator H(2)O(2) as well as MAO/B and tumor necrosis factor (TNF)-alpha levels were validated in the rat histological sections and a porcine junctional epithelial cell culture model. Topical MAO inhibitors significantly counteracted LPS-associated elevation of H(2)O(2) production and TNF-alpha expression in vivo and in vitro, inhibited disease-associated apical migration and proliferation of junctional epithelium and inhibited induced systemic H(2)O(2) levels and alveolar bone loss in vivo. These results suggest that LPS induces chronic wounds via elevated MAO/B-mediated increases in H(2)O(2) and TNF-alpha activity by epithelial cells and is further associated with more distant effects on systemic oxidative stress and alveolar bone loss. (Am J Pathol 2009,175:1398-1409; DOI: 10.2353/ajpath.2009.090108)

    DOI: 10.2353/ajpath.2009.090108

    Web of Science

    researchmap

  • Accumulation of aberrant CpG hypermethylation by Helicobacter pylori infection promotes development and progression of gastric MALT lymphoma

    Takami Kondo, Takashi Oka, Hiaki Sato, Yoko Shinnou, Kana Washio, Masayuki Takano, Toshiaki Morito, Katsuyoshi Takata, Nobuya Ohara, Mamoru Ouchida, Kenji Shimizu, Tadashi Yoshino

    INTERNATIONAL JOURNAL OF ONCOLOGY   35 ( 3 )   547 - 557   2009.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:SPANDIDOS PUBL LTD  

    Aberrant DNA hypermethylation is an important mechanism for the inactivation of tumor-related genes in human tumors. Gastric mucosa-associated lymphoid tissue (MALT) lymphomas arise from Helicobacter pylori-associated chronic gastritis: most patients are H. pylori-positive and eradication therapy is highly effective. In the present study, we used methylation-specific PCR to analyze the DNA methylation status of 11 tumor-related genes (Kip2, p16, hMLH-1, p15, p73, MGMT, DAPK, MINT1, MINT2, MINT31 and HCAD) in 21 specimens of MALT lymphoma, 5 specimens of MALT lymphoma with large cell component (high-grade MALT lymphoma), 15 specimens of diffuse large B-cell lymphoma (DLBCL), 8 specimens of complete remission of MALT lymphoma after eradication therapy, 5 specimens with no evidence of malignancy and PBMCs from 10 healthy donors. The average number of methylated genes was significantly greater in gastric lymphomas as compared to normal controls (P<0.001). The CpG island methylator phenotype (CIMP) was observed in 93.3% (14/15) of DLBCLs, 100% (5/5) of high-grade MALT lymphomas and 61.9% (13/21) of MALT lymphomas; in contrast, CIMP was not found in the control group (0%). The average number of methylated genes and the CIMP incidence significantly increased with H. pylori infection. Furthermore, aberrant CpG methylation of specific genes, such as p16, MGMT and MINT31, was consistently associated with H. pylori infection. These findings strongly suggest that H. pylori infection causes the aberrant DNA hypermethylation of specific genes and induces CIMP, which is an important epigenetic mechanism for the development and progression of gastric MALT lymphoma; additionally, our findings provide new epigenetic markers.

    DOI: 10.3892/ijo_00000366

    Web of Science

    researchmap

  • Duodenal and nodal follicular lymphomas are distinct: the former lacks activation-induced cytidine deaminase and follicular dendritic cells despite ongoing somatic hypermutations. International journal

    Katsuyoshi Takata, Yasuharu Sato, Naoya Nakamura, Yara Yukie Kikuti, Koichi Ichimura, Takehiro Tanaka, Toshiaki Morito, Maiko Tamura, Takashi Oka, Eisaku Kondo, Hiroyuki Okada, Akira Tari, Tadashi Yoshino

    Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc   22 ( 7 )   940 - 9   2009.7

     More details

    Language:English  

    Although most follicular lymphomas are believed to be of nodal origin, they sometimes originate from the duodenum. We have reported that the latter differ from nodal follicular lymphomas in having lower clinical stages and uniformly low histological grades, along with variable region of immunoglobulin heavy chain gene (VH) usage that is more similar to mucosa-associated lymphoid tissue (MALT) lymphomas. Little is known, however, about whether they possess other characteristics of nodal follicular lymphomas, particularly ongoing mutations with follicular dendritic cells. We examined 17 cases for which PCR identified the monoclonal bands of the immunoglobulin gene. The duodenal cases showed ongoing mutations, but they lacked activation-induced cytidine deaminase (AID) expression, a statistically significant difference from the nodal cases (P<0.001), and their follicular dendritic cell networks were disrupted. Moreover, not only were VH deviations observed but also they used very restricted VH genes. Although the mechanisms of ongoing mutation without AID and follicular dendritic cell were not clarified, restricted VH usage strongly suggested that antigen stimulation was involved, and that was similar to MALT lymphomas. In conclusion, duodenal follicular lymphomas were shown to be unique, in that they had ongoing hypermutations such as nodal cases, but the mechanisms involved in the hypermutation were quite different; furthermore, restricted VH usage suggested a strong similarity to the antigen-dependent origin of MALT lymphomas.

    DOI: 10.1038/modpathol.2009.51

    PubMed

    researchmap

  • 成人T細胞白血病/リンパ腫(ATLL)における特異的DNAメチル化と病態との関連

    佐藤 妃映, 岡 剛史, 神農 陽子, 鷲尾 佳奈, 高田 尚良, 守都 敏晃, 田村 麻衣子, 黄 新剛, 北村 雄太, 大原 信哉, 村上 一郎, 大内田 守, 谷本 光音, 大島 孝一, 宇都宮 與, 高橋 聖之, 吉野 正

    日本リンパ網内系学会会誌   49   114 - 114   2009.6

     More details

    Language:Japanese   Publisher:(一社)日本リンパ網内系学会  

    researchmap

  • 成人T細胞白血病/リンパ腫(ATLL)における特異的DNAメチル化と病態との相関

    佐藤 妃映, 岡 剛史, 神農 陽子, 鷲尾 佳奈, 高田 尚良, 守都 敏晃, 田村 麻衣子, 黄 新剛, 北村 雄太, 村上 一郎, 大内田 守, 大原 信哉, 大島 孝一, 宇都宮 與, 高橋 聖之, 吉野 正

    日本病理学会会誌   98 ( 1 )   275 - 275   2009.3

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    researchmap

  • Immunohistochemical Discrimination of Plasmacytoid Dendritic Cells from Myeloid Dendritic Cells in Human Pathological Tissues

    NISHIKAWA Yuriko, SATO Hiaki, OKA Takashi, YOSHINO Tadashi, TAKAHASHI Kiyoshi

    The journal of the Japanese Society of Lymphoreticular Tissue research   49 ( 1 )   23 - 31   2009

     More details

    Language:English   Publisher:The Japanese Society for Lymphoreticular Tissue Research  

    Until now, no method has been available to discriminate mature plasmacytoid DC (pDC) from myeloid DC (mDC) immunohistochemically. In this study, we report that these DC-subsets can be distinguished in routine pathological sections. Immature and mature monocyte-derived DCs (MoDCs) were S100 calcium binding protein B (S100B)+, while pDCs generated from pDC-precursors were S100B-. In contrast, both mature MoDC and pDC were fascin+. Epidermal Langerhans cells (LCs) were S100B+/fascin-. Although the majority of DCs were S100B+/fascin+ in the dermis with nonspecific inflammation, dermal DCs were mostly S100B-/fascin+ in psoriasis vulgaris, in which type I interferon secreted by pDC-precursors is thought to play a major role. S100B+/fascin+ DCs were accumulated in the superficial lymph node (LN), while they were scarce in the deep LN. In the superficial LN with dermatopathic lymphadenitis, a large number of S100B+/fascin+ DCs were accumulated in the T-zones, where numerous LC-derived DCs are accumulated. In contrast, almost all DCs were S100B-/fascin+ in the superficial LN with Kikuchi's lymphadenitis, in which numerous pDC-precursors are known to be present. In contrast to the superficial LN, the deep LN contained numerous S100B-/fascin+ DCs and a few S100B+ DCs. Thus, the distributions of S100B+ DC or S100B-/fascin+ DC correspond to the putative distribution of mDC or mature pDC, respectively. [J Clin Exp Hematopathol 49(1) : 23-31, 2009]

    DOI: 10.3960/jslrt.49.23

    CiNii Article

    CiNii Books

    researchmap

    Other Link: http://search.jamas.or.jp/link/ui/2009344727

  • 成人T細胞白血病/リンパ腫(ATLL)における特異的DNAメチル化と病態との関連

    佐藤 妃映, 岡 剛史, 神農 陽子, 鷲尾 佳奈, 高田 尚良, 守都 敏晃, 大原 信哉, 大内田 守, 大島 孝一, 谷本 光音, 宇都宮 與, 高橋 聖之, 吉野 正

    日本リンパ網内系学会会誌   48   85 - 85   2008.5

     More details

    Language:Japanese   Publisher:(一社)日本リンパ網内系学会  

    researchmap

  • Duodenal follicular lymphomas share common characteristics with mucosa-associated lymphoid tissue lymphomas

    Y. Sato, K. Ichimura, T. Tanaka, K. Takata, T. Morito, H. Sato, Y. Sato, E. Kondo, H. Yanai, N. Ohara, T. Oka, T. Yoshino

    JOURNAL OF CLINICAL PATHOLOGY   61 ( 3 )   377 - 381   2008.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:B M J PUBLISHING GROUP  

    Background: Follicular lymphomas occasionally arise in the extra-nodal organs and are frequently found in the duodenum. They are often localised tumours with multiple polyps around the ampulla of Vater.
    Aims: To examine a IgH/bcl-2 hybrid gene and VH gene to investigate the nature of the lymphoma cells and how they differ from nodal follicular lymphomas and MALT lymphomas.
    Methods: Of 40 patients reported previously, 35 with duodenal follicular lymphoma were studied in detail with respect to clinicopathological characteristics.
    Results: 37/40 patients were in clinical stage I (n= 30) or stage II (n= 7). Clonal immunoglobulin gene rearrangement was detected in 53.3% of examined cases, and rearrangement of IgH/bcl-2 gene at the major break point was detected in 27% of cases. Three of 8 examined cases were VH4 (38%); 2 out of them were VH4-34. As VH4 deviation is one of the common characteristics of MALT lymphomas and 2/3 were identical, duodenal follicular lymphomas have a similar aetiology to MALT lymphomas. Clinical course was also similar to that of MALT lymphomas.
    Conclusions: Results suggest that duodenal follicular lymphomas have intermediate characteristics of MALT lymphomas and nodal follicular lymphomas.

    DOI: 10.1136/jcp.2007.049825

    Web of Science

    researchmap

  • 成人T細胞白血病/リンパ腫(ATLL)における特異的DNAメチル化と予後との相関について

    佐藤 妃映, 岡 剛史, 神農 陽子, 鷲尾 佳奈, 高野 正幸, 高田 尚良, 守都 敏晃, 大原 信哉, 大内田 守, 大島 孝一, 宇都宮 與, 高橋 聖之, 吉野 正

    日本病理学会会誌   97 ( 1 )   358 - 358   2008.3

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    researchmap

  • リンパ系腫瘍におけるDNAメチル化異常.

    岡 剛史, 吉野正

    血液フロンテイア   18 ( 11 )   1 - 9   2008

     More details

  • Downregulation of drs mRNA expression is associated with the progression of adult T-cell leukemia/lymphoma

    Misuzu Shimakage, Nobumasa Inoue, Kohichi Ohshima, Kunimitsu Kawahara, Naoki Yamamoto, Takashi Oka, Yukihiro Tambe, Kazuta Yasui, Kayoko Matsumoto, Masuo Yutsudo, Hirokazu Inoue

    INTERNATIONAL JOURNAL OF ONCOLOGY   30 ( 6 )   1343 - 1348   2007.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:PROFESSOR D A SPANDIDOS  

    Although adult T-cell leukemia/lymphoma (ATLL) is initiated by infection with human T-cell leukemia virus (HTLV-1), many other factors are thought to be required for the progression from indolent ATL to aggressive ATLL. The drs gene was onginally isolated as a novel suppressor gene of v-src transformation and was shown to induce apoptosis in human cancer cells. To investigate the involvement of drs downregulation in the progression of ATLL, we examined the expression of drs in smoldering, chronic and aggressive ATLL, and found that drs expression was markedly reduced in clinically aggressive ATLL. In aggressive ATLL cell lines, expression of drs mRNA was not detected, although expression of drs mRNA was detected in T-cell lines infected with HTLV-1. A correlation between drs downregulation and expression of the Tax gene was not observed in these T-cell lines. Furthermore, introduction of drs into an ATL cell line, HUT102, by retrovirus vector suppressed the colony formation of the cells in soft agar and enhanced apoptotic cell death of the cells under low serum culture conditions. These results indicate that downregulation of drs is closely linked to the progression of ATLL, independently of Tax expression, suggesting that drs may suppress the progression of ATLL via enhancing apoptosis.

    Web of Science

    researchmap

  • Epigenetically distinct malignant cell population forms lymphoma-involving lesions in acute type adult T cell Leukemia/Lymphoma (ATLL)

    Takashi Oka, Hiaki Sato, Yoko Nakatani, Takami Kondo, Kana Washio, Masayuki Takano, Ichiro Murakami, Nobuya Ohara, Mamoru Ouchida, Koichi Ohshima, Kenji Shimizu, Mitsune Tanimoto, Kiyoshi Takahashi, Atae Utsunomiya, Tadashi Yoshino

    AIDS RESEARCH AND HUMAN RETROVIRUSES   23 ( 4 )   627 - 628   2007.4

     More details

    Language:English   Publisher:MARY ANN LIEBERT INC  

    Web of Science

    researchmap

  • Immunoelectron-microscopic study of CD4- and CD8- positive lymphocytes from healthy donors seropositive for human T-lymphotropic virus typeⅠ.

    Ohtsuki Y, Oka T, Manabe Y, Takeuchi T, Lee GH, Furihata M, Yoshino T, Taguchi H, Miyoshi I

    Biomedical Research   18 ( 2 )   83 - 88   2007

     More details

  • High Frequent Gene Silencing of Hemetopoietic Cell Specific Protein Tyrosinephosphatase SHP1 in Hemetopoietic Cell Malignancies.

    Oka T, Ouchida M, Tanimoto M, Shimizu K, Yoshino T

    International Journal of Medical and Biological Frontiers   11 ( 1 )   11 - 42   2007

     More details

  • Deviated VH4 immunoglobulin gene usage is found among thyroid mucosa-associated lymphoid tissue lymphomas, similar to the usage at other sites, but is not found in thyroid diffuse large B-cell lymphomas. International journal

    Yumiko Sato, Naoya Nakamura, Satoko Nakamura, Sumie Sakugawa, Koichi Ichimura, Takehiro Tanaka, Nobuya Ohara, Takeshi Oka, Eisaku Kondo, Tadashi Yoshino

    Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc   19 ( 12 )   1578 - 84   2006.12

     More details

    Language:English  

    It remains unclear whether or not diffuse large B-cell lymphomas of extranodal sites arise from mucosa-associated lymphoid tissue (MALT) lymphomas. We studied the clinicopathological features of MALT lymphoma and diffuse large B-cell lymphoma in the thyroid gland, with special reference to VH usage of immunoglobulin gene rearrangement, to clarify the relationships between these two types of lymphomas. In addition, t(11; 18) (q21; q21) translocation was examined by multiplex reverse transcription-polymerase chain reaction. We examined 58 patients with primary thyroid lymphoma: 31 (male seven and female 24) with MALT lymphoma and 27 (male three and female 24) with diffuse large B-cell lymphoma. Interestingly, the sequence of VH genes revealed that the two subtypes differed significantly in their use of the VH4 family (P < 0.05). Of the seven MALT lymphomas, three used the VH4 family and the other four used the VH3 family, whereas eight out of nine diffuse large B-cell lymphoma used the VH3 family, one used the VH1 family, and none used the VH4 family. It was also interesting that, in one diffuse large B-cell lymphoma patient with MALT lymphoma, the diffuse large B-cell lymphoma component used the VH3 family and the MALT lymphoma component used the VH4 family. These data imply that, in a subset of cases, these two subtypes do not share a common origin and that at least some diffuse large B-cell lymphomas have a de novo origin. No t(11; 18) (q21; q21) was detected in thyroid lymphomas, which are different from MALT lymphoma of the stomach, lungs, large intestine and ocular adnexa. This strongly indicated that the presence of t(11; 18) (q21; q21) in MALT lymphoma is organ-specific.

    DOI: 10.1038/modpathol.3800692

    PubMed

    researchmap

  • Down-regulation of ASY/Nogo transcription associated with progression of adult T-cell leukemia/lymphoma

    Misuzu Shimakage, Nobumasa Inoue, Kohichi Ohshima, Kunimitsu Kawahara, Takashi Oka, Kazuta Yasui, Kayoko Matsumoto, Hirokazu Inoue, Akihiro Watari, Shinji Higashiyama, Masuo Yutsudo

    INTERNATIONAL JOURNAL OF CANCER   119 ( 7 )   1648 - 1653   2006.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:WILEY-LISS  

    Adult T-cell leukemia/lymphoma (ATLL) is an aggressive form of human leukemia/lymphoma. Although this disease is initiated by infection with human T-lymphotropic virus type 1 (HTLV-1), many HTLV-1 carriers survive for a long period without aggressive illness, suggesting that other factors may play roles in the progression of ATLL to an aggressive state. However, the mechanism involved in this progression still remains unclear. Previously, we have reported that ASY/Nogo mRNA was markedly down-regulated in human small-cell lung carcinomas, whereas it was expressed in normal tissues and other lung carcinomas, such as adenocarcinoma and squamous cell carcinoma. To understand whether or not ASY/Nogo gene is involved in the progression of ATLL, we examined the expression of ASY/Nogo mRNA in smoldering, chronic and aggressive ATLL, and found that the expression level of ASY/Nogo mRNA was markedly reduced in clinically aggressive ATLL. HTLV-1 Tax expression was not affected by the down-regulation of ASY/Nogo mRNA. These results indicate that the ASY/Nogo gene may act as a suppressor against ATLL progression, independent of Tax expression. (c) 2006 Wiley-Liss, Inc.

    DOI: 10.1002/ijc.22011

    Web of Science

    researchmap

  • Dendritic cells interacting mainly with B cells in the lymphoepithelial symbiosis of the human palatine tonsil

    K Takahashi, Y Nishikawa, H Sato, T Oka, T Yoshino, K Miyatani

    VIRCHOWS ARCHIV   448 ( 5 )   623 - 629   2006.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:SPRINGER  

    The lymphoepithelial symbiosis (LES) of the human palatine tonsil is composed of spindle- or starshaped epithelial cells forming a loose meshwork, containing numerous lymphocytes and dendritic cells (DCs). In the present study, we immunohistochemically characterized DCs in the LES (LES-DCs). LES-DCs were phenotypically immature DCs that were S100 beta+, fascin-, HLA-DR+, CD1a-, CD80-, CD83-, CD86-, and CD123-. The most characteristic feature of LES-DCs was that they contacted many B cells, which were mostly IgM+ IgD+ resting naive B cells. Langerhans cells (LCs) located in the nonsymbiotic squamous epithelium were immature DCs that were S100 beta+, fascin-, and CD1a+ and did not contact lymphocytes. In contrast to LES-DCs, interdigitating dendritic cells (IDCs) in the T zone were mature DCs that were HLA-DR+, CD1a-, fascin+, CD80+, CD83+, and CD86+ and contacted numerous CD4+ T cells. Two subsets of IDC, S100 beta+ fascin+ IDC (IDC-1) and S100 beta- fascin+ IDC (IDC-2), were identified, and the majority of IDCs are IDC-2. In contrast to IDCs, which were distributed in the T-cell area in groups, LES-DCs were distributed along the crypt as if forming a barrier. These findings suggest that LES-DCs are a novel type of DC playing an important role in the induction of humoral immune response against incoming air- or food-borne pathogenic antigens.

    DOI: 10.1007/s00428-005-0085-1

    Web of Science

    researchmap

  • Abberant DNA methylation in the progression of adult T cell leukemia/lymphoma (ATLL)

    Hiaki Sato, Takashi Oka, Yoko Nakatani, Takami Kondo, Masayuki Takano, Nobuya Ohara, Mamoru Ouchida, Kouichi Oshima, Kenji Shimizu, Mitsune Tanimoto, Kiyoshi Tkahashi, Yoshino Tadashi

    CANCER RESEARCH   66 ( 8 )   2006.4

     More details

    Language:English   Publisher:AMER ASSOC CANCER RESEARCH  

    Web of Science

    researchmap

  • Molecular pathological analysis of the protein tyrosine phosphatase: SHP1 gene in the pathogenesis of lymphoma and leukemias

    Takashi Oka, Yoko Nakatani, Takami Kondo, Hiaki Sato, Kana Washio, Masayuki Takano, Ichirou Murakami, Yuriko Nishikawa, Mamoru Ouchida, Nobuya Ohara, Kiyoshi Takahashi, Kazuhiko Hayashi, Mitsune Tanimoto, Kenji Shimizu, Tadashi Yoshino

    CANCER RESEARCH   66 ( 8 )   2006.4

     More details

    Language:English   Publisher:AMER ASSOC CANCER RESEARCH  

    Web of Science

    researchmap

  • p27(Kip1) is detected on most gastric MALT lymphomas, but not large cell lymphomas.

    Hiaki Sato, Yumiko Sato, Koichi Ichimura, Takashi Oka, Eisaku Kondo, Takehiro Tanaka, Takami Kondo, Nobuya Ohara, Kiyoshi Takahashi, Tadashi Yoshino

    Journal of clinical and experimental hematopathology : JCEH   46 ( 1 )   25 - 30   2006.3

     More details

    Language:English  

    We investigated the relationship of gastric mucosa-associated lymphoid tissue (MALT) lymphoma tumorigenesis to Helicobacter pylori infection, the t (11;18) translocation, and alterations in cell cycle regulators. We sought to assess the implications of altered expression of p27(Kip1), a cyclin-dependent kinase inhibitor, on high-grade transformation and responsiveness to eradication therapy. We used immunohistochemistry to examine p27(Kip1), p53, and Ki-67 expression in 23 MALT lymphomas, five diffuse large B-cell lymphomas (DLBCLs), and four DLBCLs with associated MALT lymphoma. All of the MALT lymphomas were positive for p27(Kip1) expression and negative for p53 with a low Ki-67 index, regardless of the sensitivity of these cells to eradication. All DLBCLs were negative for p27(Kip1) and positive for p53, exhibiting a high Ki-67 index. In DLBCLs with MALT lymphoma, p27(Kip1) expression was absent from both the MALT and large cells components. In all of these lymphomas, the MALT components were negative for p53 and displayed a low Ki-67 index, while the large cell components were positive for p53 with a high Ki-67 index. The expression patterns of the DLBCLs differed significantly from those of the MALT lymphomas. p27(Kip1) was not detected in either component of DLBCL with MALT lymphoma, suggesting that decreased expression of p27(Kip1) in the MALT component may be related to high-grade transformation. Thus, p27(Kip1) expression in morphological MALT lymphomas could be useful tool to predict high-grade transformation to DLBCL.

    DOI: 10.3960/jslrt.46.25

    PubMed

    researchmap

  • Expression of phosphorylated Ser70 of Bcl-2 correlates with malignancy in human colorectal neoplasms. International journal

    Eisaku Kondo, Takayoshi Miyake, Masao Shibata, Toshikazu Kimura, Hiromi Iwagaki, Shin-Ichi Nakamura, Takehiro Tanaka, Nobuya Ohara, Koichi Ichimura, Takashi Oka, Hiroyuki Yanai, Futoshi Shibasaki, Tadashi Yoshino

    Clinical cancer research : an official journal of the American Association for Cancer Research   11 ( 20 )   7255 - 63   2005.10

     More details

    Language:English  

    PURPOSE: Bcl-2 is a model apoptosis suppressor postulated to promote tumorigenesis. Recently, it has been reported that Bcl-2 undergoes phosphoregulation of its Ser70 to substantially alter its molecular function. Previous studies further suggest that such phospho-Bcl-2 regulation may influence tumor progression in colorectal and other cancers; however, phosphorylation status of the Ser70 of Bcl-2 (pSer70) in vivo in tumors remains obscure. To elucidate this question that may suggest the biological role, we molecularly screened a panel of human colorectal adenomas and adenocarcinomas for endogenous expression of pSer70 Bcl-2. EXPERIMENTAL DESIGN: An antibody specific against pSer70 Bcl-2 was generated for thorough immunohistochemical examination of paraffin-embedded tumor specimens, allowing detection of the endogenously expressed antigen among a range of Bcl-2-positive colorectal neoplasms, including 75 tubular adenomas, 114 adenocarcinomas, and 15 cases of cancer in adenomas. RESULTS: Loss of pSer70 Bcl-2 expression was observed in adenocarcinomas in a differentiation-dependent manner (positivities: well differentiated 63%, moderately differentiated 52%, and poorly differentiated 12%), whereas tubular adenomas maintained their expression (positivity 88%). Interestingly, an inverse correlation was found between expression of pSer70 Bcl-2 and Ki-67 antigen in those cases of cancer in adenoma (P < 0.01). It was further observed that loss of pSer70 Bcl-2 expression was associated with significantly shorter survival (P < 0.05) and correlated with clinical stages and lymph node metastasis (P < 0.05 and P < 0.05, respectively). CONCLUSIONS: Loss of pSer70 Bcl-2 expression is closely linked to biological aggressiveness in colorectal tumors and represents a statistically significant molecular index for prognosis of patients with these tumors.

    DOI: 10.1158/1078-0432.CCR-05-0274

    PubMed

    researchmap

  • Analysis of genomic homology of murine gammaherpesvirus (MHV)-72 to MHV-68 and impact of MHV-72 on the survival and tumorigenesis in the MHV-72-infected CB17 scid/scid and CB17+/+ mice

    W Oda, J Mistrikova, M Stancekova, BM Dutia, AA Nash, H Takahata, ZS Jin, T Oka, K Hayashi

    PATHOLOGY INTERNATIONAL   55 ( 9 )   558 - 568   2005.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:BLACKWELL PUBLISHING  

    Murine gammaherpesvirus (MHV)-68-infected mice are well-known as models for Epstein-Barr virus (EBV)-related lymphoproliferative diseases. MHV-72 may be a relative of MHV-68, but any genetic comparison between the two (except for the M7 gene) has never been reported. The genetic compositions of MHV-72 and MHV-68 were compared and the pathology of MHV-72 infection studied in CB-17 severe combined immunodeficiency (scid/scid; SCID) and CB17 wild-type (CB17+/+) mice. The MHV-72 DNA sequence was almost identical to MHV-68 except for approximately 7000 bp corresponding to the MHV-68 M1-M3 genes. Twenty-seven of 30 MHV-72-infected SCID mice (90%) died from generalized infection with intranuclear viral inclusions for approximately 1 month, while MHV-72-infected CB17+/+ mice recovered from acute infection. Long observation and pathological study of 68 MHV-72-infected mice for up to 24 months revealed that the survival rate (29.4%) and survival time (21.3 months) of MHV-72-infected CB17+/+ mice were significantly lower (P = 0.0127) and shorter (P = 0.0065) than those of the controls (61.1% and 22.9 months), respectively. The malignancy development rate (60.3%) of the infected CB17+/+ mice was also significantly higher (P = 0.004) than those of the controls (22.2%). However, no MHV-72 DNA was detected in the tumors of infected mice. MHV-72 may have some tumor-promoting effects but the tumorigenesis in infected CB17+/+ mice is different from EBV-associated tumors.

    DOI: 10.1111/j.1440-1827.2005.01869.x

    Web of Science

    researchmap

  • Thymic myoid cells as a myasthenogenic antigen and antigen-presenting cells

    MY Matsumoto, H Matsuo, T Oka, T Fukudome, K Hayashi, H Shiraishi, M Motomura, N Shibuya, H Ayabe

    JOURNAL OF NEUROIMMUNOLOGY   150 ( 1-2 )   80 - 87   2004.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:ELSEVIER SCIENCE BV  

    We investigated immune property of a myoid cell line, established from Fisher rat thymus. Immunization of syngeneic rats with the myoid cells induced anti-rat acetylcholine receptor (AChR). Implantation of them into the thymus failed to induce typical thymic pathology of human myasthenia gravis (MG) or anti-AChR responses. We also demonstrated that the myoid cells were able to present exogenous antigens to T cells and induce antigen-specific T cell proliferation. These results suggest that myoid cells have the potential antigenicity to induce anti-AChR and the functions of antigen-presenting cells, but their expansion in the thymus may not directly cause MG. (C) 2004 Elsevier B.V. All rights reserved.

    DOI: 10.1016/j.jneuroim.2004.01.022

    Web of Science

    researchmap

  • Induction and prevention of virus-associated malignant lymphoma by serial transmission of EBV-related virus from cynomolgus by blood transfusion in rabbits

    TR Koirala, K Hayashi, ZS Jin, S Onoda, T Tanaka, W Oda, K Ichimura, N Ohara, T Oka, M Yamada, T Yoshino

    ACTA MEDICA OKAYAMA   58 ( 2 )   67 - 74   2004.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:OKAYAMA UNIV MED SCHOOL  

    Epstein-Barr virus (EBV)-related herpesvirus (Si-IIA-EBV) was serially transmitted for 3 passages from rabbit to rabbit of the opposite sex by blood transfusion, which subsequently induced virus-associated rabbit lymphomas. The virus could be transmitted by transfusion with 15-20 ml of whole blood (7/7) or irradiated blood (1/6) from the EBV-related virus-infected rabbits, but there was no transmission with transfusion of cell-free plasma (0/6) from the infected rabbits. Passive anti-EBV-VCA IgG (x 20 similar to x 10) titers decreased during the first 1 - 2 weeks in the transfused rabbits. The virus-transmitted rabbits showed a gradual increase in antibody titers ranging from peak titers of X 640 to x 2560 after 3 weeks of transfusion. The recipient origin of malignant lymphoma that developed in the first rabbit transfused by infected blood was confirmed by chromosomal analysis. This rabbit model thus shows that EBV-related herpesvirus is serially transmissible by blood transfusion and that transmission can not be completely prevented by irradiation of blood, but removal of blood cells is the best way to prevent transmission of EBV-related virus. Therefore, this animal model provides a convenient in vivo system for studies of the prevention and therapy of transfusion -related transmission of EBV and EBV-associated lymphoproliferative diseases in immunocompromised human beings.

    DOI: 10.18926/AMO/32097

    Web of Science

    researchmap

  • CD40 ligand stimulation inhibits the proliferation of mantle cell lymphoma lines

    ZH Jin, N Teramoto, K Hayashi, YX Liu, GS Jin, T Oka, K Takahashi, T Yoshino, T Akagi

    ANTICANCER RESEARCH   24 ( 2B )   691 - 697   2004.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:INT INST ANTICANCER RESEARCH  

    Mantle cell lymphoma (MCL) is a CD5(+) nonHodgkin's B-cell lymphoma characterized by the infiltration of intermediate sized B-cells into the mantle zones. Interaction between CD40L and CD40 is important for B cell proliferation and differentiation. CD40L stimulation can induce both growth arrest and proliferation of B cell lines according to their differentiation state. Previous reports examining the effect of stimulation via the CD40 cascade on ex vivo MCL cells have provided conflicting results. In this study, two MCL lines, SP49 and SP53, were examined for response to CD40L and/or IL-10. Co-cultivation with CD40L-erpressing mouse L cells reduced the BrdU incorporation of SP49 and SP53 cells by half to one-third while BrdU incorporation of control cell lines, including Ramos, BJAB and BALL-1, was not affected or increased. Anti-CD40L antibody blocked the CD40L inhibition of SP49 cell proliferation in a dose-dependent manner in the range from 0 to 20 ng/ml. IL-10 did not affect AICL cell proliferation in the presence or absence of CD40L-expressing cells, while Ramos proliferation was promoted by CD40L and IL-10. These results suggested the possibility that CD40L may also inhibit MCL proliferation in vivo.

    Web of Science

    researchmap

  • Activated proliferation of B-cell lymphomas/leukemias with the SHP1 gene silencing by aberrant CpG methylation

    M Koyama, T Oka, M Ouchida, Y Nakatani, R Nishiuchi, T Yoshino, K Hayashi, T Akagi, Y Seino

    LABORATORY INVESTIGATION   83 ( 12 )   1849 - 1858   2003.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:LIPPINCOTT WILLIAMS & WILKINS  

    Previously we showed reduced protein and mRNA expression of the SHP1 gene in lymphoma/leukemia cell lines and patient specimens by Northern blot, RT-PCR, Western blot, and immunohistochemical analyses. In this study, aberrant methylation in the SHP1 gene promoter was detected in many B-cell leukemia/lymphoma cell lines as well as in patient specimens, including diffuse large B-cell lymphoma (methylation frequency 93%), MALT lymphoma (82%), mantle cell lymphoma (75%), plasmacytoma (100%) and follicular lymphoma (96%) by methylation-specific PCR, bisulfite sequencing, and restriction enzyme-mediated PCR analyses. The methylation frequency was significantly higher in high-grade MALT lymphoma cases (100%) than in low-grade MALT lymphoma cases (70%), which correlated well with the frequency of no expression of SHP1 protein in high-grade (80%) and low-grade MALT lymphoma (54%). It suggests that the SHP1 gene silencing with aberrant CpG methylation relates to the lymphoma progression. SHP1 protein expression was recovered in B-cell lines after the treatment of the demethylating reagent: 5-aza-2'-deoxycytidine. Transfection of the intact SHP1 gene to the hematopoietic cultured cells, which show no expression of the SHP1 gene, induced growth inhibition, indicating that gene silencing of the SHP1 gene by aberrant methylation plays an important role to get the growth advantage of the malignant lymphoma/leukemia cells. The extraordinarily high frequency (75 to 100%) of CpG methylation of the SHP1 gene in B-cell lymphoma/leukemia patient specimens indicates that the SHP1 gene silencing is one of the critical events to the onset of malignant lymphomas/leukemias as well as important implications for the diagnostic or prognostic markers and the target of gene therapy. These data support the possibility that the SHP1 gene is one of the tumor suppressor genes.

    DOI: 10.1097/01.LAB.0000106503.65258.2B

    Web of Science

    researchmap

  • [Recent progress in the protein-tyrosine phosphatase SHP1 gene: the significant correlation of the SHP1 gene silencing with the onset of lymphomas/leukemias].

    Takashi Oka, Mamoru Ouchida

    Nihon rinsho. Japanese journal of clinical medicine   61 ( 11 )   2025 - 32   2003.11

     More details

    Language:Japanese   Publishing type:Research paper (scientific journal)  

    Using cDNA expression array and tissue microarray, we comprehensively and systematically analyzed the expression profile to investigate the lymphomagenesis. We detected the significant decrease of hematopoietic cell specific protein-tyrosine phosphatase SHP1 gene expression in various malignant lymphomas and leukemias. High-frequent silencing of the SHP1 gene by promoter methylation was detected in various kinds of leukemias and lymphomas as well as in many hematopoietic cell lines. The promoter methylation of the SHP1 gene was significantly correlated with the clinical stage. Loss of heterozygosity with microsatellite markers around the SHP1 gene was detected in 79% of informative ALL cases. These results suggest that loss of functional SHP1 is closely associated with the pathogenesis of leukemias/lymphomas.

    PubMed

    researchmap

  • 現代医学の焦点(254)広範な悪性リンパ腫・白血病発症に関連するSHP1遺伝子に関する最新知見

    岡 剛史, 大内田 守

    日本臨床   61 ( 11 )   2025 - 2032   2003.11

     More details

    Language:Japanese   Publisher:日本臨床社  

    CiNii Article

    CiNii Books

    researchmap

    Other Link: http://search.jamas.or.jp/link/ui/2004059364

  • Therapeutic trials for a rabbit model of EBV-associated Hemophagocytic Syndrome (HPS): Effects of vidarabine or CHOP, and development of Herpesvirus papio (HVP)-negative lymphomas surrounded by HVP-infected lymphoproliferative disease

    K Hayashi, H Joko, TR Koirala, S Onoda, ZS Jin, M Munemasa, N Ohara, W Oda, T Tanaka, T Oka, E Kondo, T Yoshino, K Takahashi, M Yamada, T Akagi

    HISTOLOGY AND HISTOPATHOLOGY   18 ( 4 )   1155 - 1168   2003.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:F HERNANDEZ  

    Epstein-Barr virus-associated hemophagocytic syndrome (EBV-AHS), which is often associated with fatal infectious mononucleosis or T-cell lymphoproliferative diseases (LPD), is a distinct disease characterized by high mortality. Treatment of patients with EBV-AHS has proved challenging. To develop some therapeutic interventions for EBV-AHS, we examined the effectiveness of an antiviral agent (vidarabine) or chemotherapy (CHOP), using a rabbit model for EBV-AHS.
    Fourteen untreated rabbits were inoculated intravenously with cell-free virions of the EBV-Iike virus Herpesvirus papio (HVP). All of the rabbits died of HVP-associated (LPD) and hemophagocytic syndrome (HPS) between 21 and 31 days after inoculation. Furthermore, three HVP-infected rabbits treated with vidarabine died between days 23 and 28 after inoculation, and their clinicopathological features were no different from those of untreated rabbits, indicating that this drug is not effective at all to treat HVP-induced rabbit LPD and HPS.
    Three of the infected rabbits that were treated with one course, with an incomplete set of three courses, or with three full courses of CHOP treatment died of HVP-induced LPD and HPS with a bleeding tendency and/or with opportunistic infections. They died on the 26th, 62nd and 105th day after virus inoculation, respectively. CHOP treatment transiently suppressed the HVP-induced LPD and contributed to the prolonged survival time of two infected rabbits. However, it did not remove all of the HVP-infected cells from the infected rabbits, and residual HVP-infected lymphocytes caused recurrences of rabbit LPD and HPS. The most interesting finding of this experiment was observed in the infected rabbit with the longest survival time of 105 days: HVP-negative lymphomas surrounded by HVP-induced LPD developed in the larynx and ileum of this rabbit, causing an obstruction of the lumen. We concluded that these were not secondary lymphomas caused by CHOP treatment, because no suspicious lesions were detected in three uninfected rabbits that were treated with three courses of CHOP for 120 days. It is therefore necessary to clarify the mechanism by which HVP-negative lymphomas associated with HVP-induced LPD can develop.
    Our data from therapeutic trials using EBV-AHS animal models indicate that vidarabine is not effective as an agent to treat HVP-infected rabbits, and even the cytotoxic chemotherapy of CHOP is not sufficient to cure the HVP-infected rabbits or to prolong the survival time of infected rabbits. Further studies will therefore be required to develop better therapies to treat EBV-AHS.

    Web of Science

    researchmap

  • Rabbit model for human EBV-associated hemophagocytic syndrome (HPS) - Sequential autopsy analysis and characterization of IL-2 dependent cell lines established from herpesvirus papio-induced fatal rabbit lymphoproliferative diseases with HPS

    K Hayashi, ZS Jin, S Onoda, H Joko, N Teramoto, N Ohara, W Oda, T Tanaka, YX Liu, TR Koirala, T Oka, E Kondo, T Yoshino, K Takahashi, T Akagi

    AMERICAN JOURNAL OF PATHOLOGY   162 ( 5 )   1721 - 1736   2003.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER SOC INVESTIGATIVE PATHOLOGY, INC  

    Epstein-Barr virus-associated hemophagocytic syndrome (EBV-AHS) is often associated with fatal infectious mononucleosis or T-cell lymphoproliferative diseases (LPD). To elucidate the true nature of fatal LPD observed in Herpesvirus papio (HVP)-induced rabbit hemophagocytosis, reactive or neoplastic, we analyzed sequential development of HVP-induced rabbit LPD and their cell lines. All of the seven Japanese White rabbits inoculated intravenously with HVP died of fatal LPD 18 to 27 days after inoculation. LPD was also accompanied by hemophagocytic syndrome (HPS) in five of these seven rabbits. Sequential autopsy revealed splenomegaly and swollen lymph nodes, often accompanied by bleeding, which developed in the last week. Atypical lymphoid cells infiltrated many organs with a "starry sky" pattern, frequently involving the spleen, lymph nodes, and liver. HVP-small RNA-1 expression in these lymphoid cells was clearly demonstrated by a newly developed in situ hybridization (ISH) system. HVP-ISH of immunomagnetically purified lymphoid cells from spleen or lymph nodes revealed HVP-EBER1+ cells in each CD4+, CD8+, or CD79a+ fraction. Hemophagocytic histiocytosis was observed in the lymph nodes, spleen, bone marrow, and thymus. HVP-DNA was detected in the tissues and peripheral blood from the infected rabbits by PCR or Southern blot analysis. Clonality analysis of HVP-induced LPD by Southern blotting with TCR gene probe revealed polyclonal bands, suggesting polyclonal proliferation. Six IL-2-dependent rabbit T-cell lines were established from transplanted scid mouse tumors from LPD. These showed latency type I/II HVP infection and had normal karyotypes except for one line, and three of them showed tumorigenicity in nude mice. These data suggest that HVP-induced fatal LPD in rabbits is reactive polyclonally in nature.

    Web of Science

    researchmap

  • Characterization of rabbit model for EBV-associated hemophagocytic syndrome (HPS)

    K Hayashi, ZS Jin, S Onoda, N Teramoto, N Ohara, W Oda, T Tanaka, TR Koirala, T Oka, T Yoshino, K Takahashi, T Akagi

    MODERN PATHOLOGY   16 ( 1 )   235A - 235A   2003.1

     More details

    Language:English   Publisher:LIPPINCOTT WILLIAMS & WILKINS  

    Web of Science

    researchmap

  • 難治性リンパ腫発症関連遺伝子SHP1に関する最新知見

    岡 剛史, 大内田守

    日本臨床   61(11): 2025-2032   2003

     More details

  • Gene silencing of the tyrosine phosphatase SHP1 gene by aberrant methylation in leukemias/lymphomas. International journal

    Takashi Oka, Mamoru Ouchida, Maho Koyama, Yoichiro Ogama, Shinichi Takada, Yoko Nakatani, Takehiro Tanaka, Tadashi Yoshino, Kazuhiko Hayashi, Nobuya Ohara, Eisaku Kondo, Kiyoshi Takahashi, Junjiro Tsuchiyama, Mitsune Tanimoto, Kenji Shimizu, Tadaatsu Akagi

    Cancer research   62 ( 22 )   6390 - 4   2002.11

     More details

    Language:English  

    High-frequent silencing of hematopoietic cell-specific protein-tyrosine phosphatase SHP1 gene by promoter methylation was detected in various kinds of leukemias and lymphomas, as well as in many hematopoietic cell lines, which is supported by our previous observation of strong decrease of SHP1 mRNA and protein. The promoter methylation of the SHP1 gene was clearly correlated with the clinical stage. Loss of heterozygosity with microsatellite markers near the SHP1 gene was shown in 79% of informative acute lymphoblastic leukemia cases. These results suggest that functional loss of SHP1 is associated with the pathogenesis of leukemias/lymphomas.

    PubMed

    researchmap

  • Expression of Heat Shock Protein 60 in Normal and Neoplastic Human Lymphoid Tissues

    JIN Hua Shu, YOSHINO Tadashi, JIN Zaishun, OKA Takashi, KOBAYASHI Keita, YAMASAKI Rie, LIU Yi Xuan, YOKOTA Kenji, OGUMA Keiji, AKAGI Tadaatsu

    The journal of the Japanese Society of Lymphoreticular Tissue research   42 ( 1 )   25 - 32   2002

     More details

    Language:English   Publisher:The Japanese Society for Lymphoreticular Tissue Research  

    A molecular chaperonin in mammals, heat shock protein 60 (HSP60) is constitutively expressed in the mitochondria at a low level and is rapidly up-regulated under stress. However, the role of HSP60 in the lymphoid tissues has not been well clarified. In the present study, expression of HSP60 was examined by flow cytometry and immunohistochemistry in normal peripheral blood mononuclear cells, reactive lymphoid tissues, and malignant lymphomas. HSP60 was found to be present constitutively at low levels in a fraction of resting T cells and most monocytes. The blastic change upon mitogen stimulation induced HSP60 at much higher levels in more T, B and NK cells. In normal lymphoid tissues, HSP60 was expressed preferentially in the cytoplasm of large-sized lymphoid cells and macrophages in the germinal centers and the interfollicular area.<br>In non-Hodgkin lymphomas strong expression of HSP60 was detected in most cases of diffuse large B-cell lymphoma, follicular lymphoma, and grade 3 and NK/T cell lymphoma. No immunostaining was observed in low grade B-cell lymphomas, including follicular lymphoma, grade 1 and B-lymphoblastic lymphomas. HSP60 immunoreactivity was variable in T-cell lymphomas. Intense expression of HSP60 was observed in Reed-Sternberg cells in all cases of Hodgkin lymphoma.

    DOI: 10.3960/jslrt.42.25

    CiNii Article

    CiNii Books

    researchmap

  • 悪性リンパ腫・白血病におけるプロテイン チロシンフォスファターゼSHP1遺伝子の発現異常.

    岡 剛史, 吉野 正, 林 一彦, 赤木忠厚

    癌の臨床   48,10,561-568   2002

     More details

  • Recent advances in DNA microarrays

    T Nakanishi, T Oka, T Akagi

    ACTA MEDICA OKAYAMA   55 ( 6 )   319 - 328   2001.12

     More details

    Language:English   Publisher:OKAYAMA UNIV MED SCHOOL  

    The structure of the human genome is almost completely elucidated and the life sciences will now aim for a general and integrated study of gene expressions and the functional elucidation of proteins. In such a study, various new techniques have been developed, and DNA microarray technology is the most representative one. As for the DNA microarray techniques, several thousands to tens of thousands of gene segments are immobilized on a glass slide at high density, and cDNA probes prepared from specific cells or tissues are hybridized on the slides from which gene expression profiles are obtained at one sweep in a short time. The present development of this technique and its possible application to medicine-related fields are described.

    DOI: 10.18926/AMO/32002

    Web of Science

    researchmap

  • Reduction of hematopoietic cell-specific tyrosine phosphatase SHP-1 gene expression in natural killer cell lymphoma and various types of lymphomas/leukemias: Combination analysis with cDNA expression array and tissue microarray

    T Oka, T Yoshino, K Hayashi, N Ohara, T Nakanishi, Y Yamaai, A Hiraki, CA Sogawa, E Kondo, N Teramoto, K Takahashi, J Tsuchiyama, T Akagi

    AMERICAN JOURNAL OF PATHOLOGY   159 ( 4 )   1495 - 1505   2001.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER SOC INVESTIGATIVE PATHOLOGY, INC  

    To investigate the lymphomagenesis of NK/T lymphoma, we comprehensively and systematically analyzed the expression pattern of the human NK/T cell line (NK-YS) genome by cDNA expression array and tissue microarray. We detected significant changes in the gene expression of NK-YS cell line: an increase in 18 and a decrease in 20 genes compared to normal NK cells or peripheral blood mononuclear cells. Among these genes, we found a strong decrease in hematopoietic cell specific protein-tyrosine-phosphatase SHPTP1 (SHP1) mRNA by cDNA expression array and reverse transcriptase-polymerase chain reaction. Further analysis with standard immunohistochemistry and tissue microarray, which used 207 paraffin-embedded specimens of various kinds of malignant lymphomas, showed that 100% of NK/T lymphoma specimens and more than 95% of various types of malignant lymphoma. were negative for SHP1 protein expression. On the other hand, SHP1 protein was strongly expressed in the mantle zone and interfollicular zone lymphocytes in reactive lymphoid hyperplasia specimens. In addition, various kinds of hematopoietic cell lines, particularly the highly aggressive lymphoma/leukemia lines, lacked SHP1 expression in vitro, suggesting that loss of SHP1 expression may be related to not only malignant transformation, but also tumor cell aggressiveness. SHP1 expression could not be induced in either of two NK/T cell fines by phorbol ester, suggesting that genetic impairment or modification with methylation of SHP1 DNA could be one of the critical events in the pathogenesis of NK/T lymphoma. This evidence strongly suggests that loss of SHP1 gene expression plays an important role in multistep tumorigenesis, possibly as an anti-oncogene in the wide range of lymphomas/leukemias as well as NK/T lymphomas.

    Web of Science

    researchmap

  • Loss of expression of alpha 4 beta 7 integrin and L-selectin is associated with high-grade progression of low-grade MALT lymphoma

    YX Liu, T Yoshino, N Ohara, T Oka, ZS Jin, K Hayashi, T Akagi

    MODERN PATHOLOGY   14 ( 8 )   798 - 805   2001.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:LIPPINCOTT WILLIAMS & WILKINS  

    Expression of adhesion molecule in low-grade B-cell mucosa-associated lymphoid tissue (MALT) lymphoma of the gastrointestinal tract has been reported in recent years, but these reports have primarily focused on low-grade gastrointestinal MALT lymphoma. In this study, we examined the lymphocytic homing receptor alpha4 beta7 integrin, L-selectin, and VLA-4 and mucosal addressin cell adhesion molecule-1 (MAdCAM-1) in low-grade lymphoma of the gastrointestinal tract and other organs such as the ocular adnexa and thyroid. We also observed changes in the expression pattern associated with high-grade transformation. Neoplastic cells in the gastrointestinal low-grade lymphoma and the low-grade component of high-grade MALT lymphoma were found to be alpha4 beta7 integrin(+), L-selectin(+), whereas the gastrointestinal high-grade component and diffuse large B-cell lymphoma were found to be alpha4 beta7 integrin(-), L-selectin(-). High endothelial venules in the gastric MALT lymphomas expressed MAdCAM-1. In the ocular adnexa. low-grade MALT lymphoma, most cases were alpha4 beta7 integrin(-), L-selectin(+); and in the thyroid, most cases of both low- and high-grade MALT lymphoma were alpha4 beta7 integrin-, L-selectin(-). These findings show that alpha4 beta7 integrin and L-selectin may play an important role in the lymphocyte homing of gastrointestinal low-grade MALT lymphoma and in the loss of alpha4 beta7 integrin expression throughout the course of high-grade progression.

    DOI: 10.1038/modpathol.3880393

    Web of Science

    researchmap

  • Morphological interactions of interdigitating dendritic cells with B and T cells in human mesenteric lymph nodes

    K Takahashi, A Kenji, T Norihiro, K Eisaku, O Takashi, H Kazuhiko, Y Tadashi, A Tadaatsu

    AMERICAN JOURNAL OF PATHOLOGY   159 ( 1 )   131 - 138   2001.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER SOC INVESTIGATIVE PATHOLOGY, INC  

    Interdigitating dendritic cells (IDC) of the human mesenteric lymph nodes (LN) were examined by two-color immunofluorescent microscopy and flow cytometry to clarify their exact localization, immunophenotype, and relationships with T and B cells. IDC were identified as HLA-DRbright large dendriform cells of the T cell areas co-expressing CD40, CD54 (ICAM-1), CD80 (B7/B7-1), CD83, and CD86 (B70/B7-2). The majority of IDC directly attached to a few IgD+ naive B cells as well as to numerous CD4+ T cells. When LN cells were singly suspended and briefly incubated in vitro, IDC formed clusters with IgD+ IgM+ naive B cells, but not with IgA+ or IgG+ B cells. When suspended LN cells were cultured, clustered B cells disappeared within 7 days, and on prolonged culture, some IDC developed into extensively dendriform cells forming stable complexes with several or sometimes numerous CD4+ IL-2R+ CD40L+ activated T cells. These findings indicate that resting naive B cells actually interact with IDC directly in T cell areas of human secondary lymphoid tissues. IDC have a non-antigen (Ag)-specific, strong affinity for resting naive B cells, but this affinity is transient and IDC cannot form stable complexes with B cells, although they can form stable complexes with activated T cells. It is suggested that the stable IDC/Ag-activated T cell complexes make it possible to capture and to stimulate rare Ag-specific resting naive B cells with high efficiency.

    Web of Science

    researchmap

  • An animal model for human EBV-associated hemophagocytic syndrome - Herpesvirus papio frequently induces fatal lymphoproliferative disorders with hemophagocytic syndrome in rabbits

    K Hayashi, N Ohara, N Teramoto, S Onoda, HL Chen, T Oka, E Kondo, T Yoshino, K Takahashi, J Yates, T Akagi

    AMERICAN JOURNAL OF PATHOLOGY   158 ( 4 )   1533 - 1542   2001.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER SOC INVESTIGATIVE PATHOLOGY, INC  

    Epstein-Barr virus-associated hemophagocytic syndrome (EBV-AHS) Is often associated with fatal infectious mononucleosis. However, the animal model for EBV-AHS has not been developed. We reported the first animal model for EBV-AHS using rabbits infected with EBV-related herpesvirus of baboon (HVP), Eleven of 13 (85%) rabbits inoculated intravenously with HVP-producing cells developed fatal lymphoproliferative disorders (LPD) between 22 and 105 days after Inoculation. LPD was also accompanied by hemophagocytic syndrome (HPS) in nine of these 11 rabbits, The peroral spray of cell-free HVP induced the virus infection with increased anti-EBV-viral capsid antigen-IgG titers in three of five rabbits, and two of these three infected rabbits died of LPD with HPS, Autopsy revealed hepatosplenomegaly and swollen lymph nodes. Atypical lymphoid T cells expressing EBV-encoded small RNA-I infiltrated diffusely in many organs, frequently involving the lymph nodes, spleen, and liver. Hemophagocytic histiocytosis was observed in the lymph nodes, spleen, bone marrow, and thymus, HVP-DNA was detected in the tissues and peripheral blood from the infected rabbits by polymerase chain reaction or Southern blot analysis. Re-verse transcriptase-polymerase chain reaction revealed both HVP-EBNA1 and HVP-EBNA2 transcripts, suggesting latency type Ri infection. These data indicate that the high rate of rabbit LPD with HPS induction is caused by HVP, This system is useful for studying the pathogenesis, prevention, and treatment of human EBV-AHS.

    Web of Science

    researchmap

  • An animal model for human EBV-associated hemophgocytic syndrome.

    Hayashi K, Ohara N, Teramoto N, Onoda S, Chen H-L, Oka T, Kondo E, Yoshino T, Takahashi K, Yates J, Akagi T

    Am J Pathol   2001

     More details

  • Myasthenogenisity of thymic myoid cell.

    Yoshinaga M, Matsuo H, Oka T, Motomura M, Shibuya N, Ayabe H

    J. Neuroimmunol   2001

     More details

  • Differentiation of rat thymic myoid progenitor cell line established by coculture with human T-lymphotropic virus type-I-producing human T cells

    T Oka, K Hayashi, Y Nakaoka, Y Ohtsuki, T Akagi

    CELL AND TISSUE RESEARCH   300 ( 1 )   119 - 127   2000.4

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:SPRINGER VERLAG  

    A thymus-derived myoid precursor cell line (STI), which differentiates to myoid cells in the growth arrest condition, was established by the cocultivation of F344 rat thymic cells with human T-lymphotropic virus type-I (HTLV-I)-producing human lymphoid cells. No integration of HTLV-I was detected in ST1 cells by Southern blot hybridization. III a differentiation culture condition such as confluent culture or serum starvation, STI cells began to fuse, creating multinuclear giant cells, with the induced expression of MyoD1 and various muscle-specific antigens, including a-sarcomeric actin, skeletal muscle myosin, myoglobin, desmin, and acetylcholine receptor. Ultrastructural investigation revealed that differentiated ST1B cells created aggregates of thick and thin filaments with Z-band-like composition, then formed sarcomeric structures and tubular honeycomb arrays. Finally, these cells spontaneously contracted with a frequency of 0.5-2.0 Hz and synchronized with adjoining cells. Transplantation of ST1B cells into nude mice produced a small tumor nodule, showing clear differentiation to skeletal muscle cells. ST1B cells did not indicate any colony-forming activities in soft agar, demonstrating that ST1B cells retain some of the physiologically normal phenotypes. This rare cell line is promising for use in various physiological and pathological investigations including functional research of thymic myoid cells and the pathological role in autoimmune diseases, as well as animal model experiments of cell therapy related to muscular degenerative disorders or regeneration of injured muscles.

    DOI: 10.1007/s004410050053

    Web of Science

    researchmap

  • Sequence analysis and variation of EBNA-1 in Epstein-Barr virus-related herpesvirus of cynomolgus monkey

    N Ohara, K Hayashi, N Teramoto, T Oka, K Fujimoto, Y Yoshikawa, E Castanos-Velez, P Biberfeld, T Akagi

    INTERVIROLOGY   43 ( 2 )   102 - 106   2000.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:KARGER  

    Objectives:The Epstein-Barr virus (EBV) nuclear antigen 1 (EBNA-1) is an important protein for immortalization and tumorigenesis of infected cells. EBNA-1 gene variants may play a role in tumorigenesis. We determined the nucleotide and amino acid (aa) sequences of EBNA-1 in EBV-related herpesviruses from cynomolgus monkeys (cynomolgus-EBV) which induced malignant lymphomas in its natural host and in rabbits, and compared them with sequences of EBV and other lymphocryptoviruses (LCVs). Methods: Polymerase chain reaction and direct sequencing methods were performed using extracted DNA from cynomolgus-EBV-infected cell lines. Results: The amino acid sequences of cynomolgus-EBV EBNA-1 from two cell lines (SI-IIA: 588 aa; Ts-BG: 619 aa) which are antigenically cross-reactive to human EBV EBNA-1 showed homology with human EBV (SI-IIA: 53%; Ts-BG: 58%) and other LCVs from baboons (54 and 52%) and rhesus monkeys (60 and 58%), especially in the C-terminal unique domain. Homology of the EBNA-1 sequence between SI-IIA and Ts-BG was 92%. The sequence difference between EBV and the related LCVs was manifested mainly in the length of the internal repeat 3-corresponding region, which contains serine in the glycine/alanine repeat region of nonhuman LCVs. Conclusion: Sequence variation of cynomolgus-EBV EBNA-1 from different cell lines was observed. However, their sequences show a relatively high homology with human EBV and share the common features of EBNA-1 of EBV and other LCVs. Copyright (C) 2000 S. Karger AG, Basel.

    DOI: 10.1159/000025031

    Web of Science

    researchmap

  • Epstein-Barr virus(EBV)-negative nasopharyngeal carcinoma cell line TW03 enhances its tumorigenicity Reviewed

    Teramoto N, Maeda A, Kobayashi K, Hayashi K, Oka T, Takahashi K, Takada K, Klein G, Akagi T

    Labo.Investigation   80   303 - 312   2000

     More details

  • Epstein-Barr virus infection to Epstein-Barr virus-negative nasopharyngeal carcinoma cell line TW03 enhances its tumorigenicity Reviewed

    Norihiro Teramoto, Akihiko Maeda, Keita Kobayashi, Kazuhiko Hayashi, Takashi Oka, Kiyoshi Takahashi, Kenzo Takada, Georg Klein, Tadaatsu Akagi

    Laboratory Investigation   80 ( 3 )   303 - 312   2000

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Lippincott Williams and Wilkins  

    Almost all nasopharyngeal carcinomas (NPCs) are infected by Epstein-Barr virus (EBV), but most ex vivo NPC cells lose EBV genomes during passages. In this study, an EBV-negative NPC cell line, TW03, established from EBV- carrying NPC was reinfected with EBV by cocultivation with irradiated Akata cells carrying recombinant EBV containing a neomycin-resistant gene. The reinfected EBV (+) TW03 cells expressed EBERs and EBNA1, but not EBNA2, lytic proteins (ZEBRA and EA-D), or LMP1. They had an epithelial appearance similar to that of EBV (-) TW03 cells. The doubling times of EBV (+) and EBV () TW03 cells were almost identical. However, the EBV (+) TW03 cells formed larger colonies with ragged contours in anchorage-independent cultures. An in vitro invasion assay showed that EBV (+) TW03 cells had a higher invasive activity than EBV () TW03 cells (p &lt
    0.01). Both EBV () and EBV (+) TW03 cells formed poorly differentiated squamous cell carcinomas in SCID and nude mice. EBV (+) TW03 cells showed a higher tumorigenicity to nude mice (12 of 13) than EBV (- ) TW03 cells (1 of 9) (p &lt
    0.001). In the severe combined immunodeficiency (SCID) tumors of EBV (+) TW03 cells, not all of the tumor cells were EBER-1 positive. EBER-1 was more frequently detected in the peripheral regions and daughter nodules of the tumors than in the central areas. The microdissection polymerase chain reaction showed that the EBER-1 -negative TW03 cells in the EBV (+) TW03 SCID tumors lost EBV genomes. EBER-1-negative cells showed as high a rate of Ki-67 positivity as EBER-1-positive cells, indicating that the former were proliferating rather than dead or dying. In horny pearls, keratinizing cells were ZEBRA-positive and EBER-negative. Loss of EBV genomes was not associated with squamous differentiation. These data indicated that reinfection of EBV promotes the tumorigenicity of EBV (-) TW03 cells by enhancing the invading activity.

    DOI: 10.1038/labinvest.3780035

    Scopus

    PubMed

    researchmap

  • Cyno-EBV (EBV-related herpesvirus from cynomolgus macaques) induces rabbit malignant lymphomas and their tumor cell lines frequently show specific chromosomal abnormalities

    K Hayashi, HL Chen, H Yanai, TR Koirala, N Ohara, N Teramoto, T Oka, T Yoshino, K Takahashi, K Miyamoto, K Fujimoto, Y Yoshikawa, T Akagi

    LABORATORY INVESTIGATION   79 ( 7 )   823 - 835   1999.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:LIPPINCOTT WILLIAMS & WILKINS  

    Malignant lymphoma (ML) induction in rabbits by Epstein-Barr virus (EBV)-related herpesvirus of cynomolgus (Cyno-EBV) is reported. Twenty-seven of 30 (90%) rabbits inoculated intravenously with Cyno-EBV-producing simian (cynomolgus) lymphocyte cell line (Ts-B6) cells developed ML between 45 and 115 days after inoculation. The peroral inoculation of Ts-B6 cells induced ML in only 2 of 10 (20%) rabbits (75 to 85 days). Five of 6 (83%) rabbits injected with cell-free pellets from Ts-B6 cultures also developed ML (27 to 122 days). Antibody response to the viral capsid antigen of EBV was also detected in sera from rabbits inoculated with Ts-B6. ML of the large cell or mixed type infiltrated diffusely in many organs, frequently involving the spleen, liver, kidneys, heart, and less frequently the lungs, lymph nodes, brain, eyes, gastrointestinal tract, thymus, and bone marrow. A chromosomal analysis of five lymphoma cell lines established from tumor-bearing rabbits revealed the rabbit karyotype. Three of these cell lines showed the chromosomal abnormalities with 12q- or t (7p+:12q-). EBV-encoded small RNA-1 and EBV-associated nuclear antigen 1 were expressed in Ts-B6 cells, the tumor tissues, and all rabbit cell lines by in situ hybridization and by immunofluorescence tests, respectively. EBV DNA was also detected in Ts-B6 cells and rabbit lymphoma cell lines by polymerase chain reaction and Southern blot analysis. The Southern blots of EBV termini revealed oligoclonal bands in the Cyno-EBV-induced rabbit lymphomas. No lymphoma was induced by the inoculation of B95-8 (EBV-producing cells) or peripheral leukocytes from normal cynomolgus (controls). These data suggest that the high rate of lymphoma induction in rabbits may be caused not by human EBV (B95-8) but by Cyno-EBV from Ts-B6 cells. A sequence analysis of the IR1 (BamHIW) region of Cyno-EBV revealed that this region is quite similar to that of herpesvirus Macaca fascicularis 1,which is a causative agent for a monkey model of AIDS-retated lymphomas. The present rabbit model of lymphoma with specific chromosomal abnormalities is very useful to clarify the role of EBV in human EBV-associated lymphoma and provides a means for studying prophylactic and therapeutic regimens.

    Web of Science

    researchmap

  • Myoid cell differentiation of rat thymus-derived progenitor cell Line established by co-culture with HTLV-1-producing human T-cells

    Oka T, Hayashi K, Nakaoka Y, Ohtsuki Y, Akagi T

    20   A50   1999

     More details

    Authorship:Lead author  

    researchmap

  • P53 protein expression in Non-HodgKins lymphomas is infrequently related to p53 gene mutation

    Oka T, Sarker A.B, Teramoto N, Yoshino T, Akagi T

    48   15 - 21   1998

     More details

    Authorship:Lead author  

    researchmap

  • Characterization of a novel human natural Killer-cell line (NK-YS)established from natural killer cell lymphoma/leukemia associated with Epstein-Barr virus infection Reviewed

    Tsuchiyama J, Yoshino T, Mori M, Kondo E, Oka T, Akagi T, Hiraki A, Nakayama H, Shibuya A, Ma Y, Kawabata T, Okada S, Harada M

    92 ( 4 )   1374 - 1383   1998

     More details

  • Evidence for specific immune response against P210 BCR-ABL in long-term remission CML patients treated with interferon

    T. Oka, K. J. Sastry, P. Nehete, S. J. Schapiro, J. Q. Guo, M. Talpaz, R. B. Arlinghaus

    Leukemia   12 ( 2 )   155 - 163   1998

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Nature Publishing Group  

    Interferon-alpha treatment induces complete cytogenetic remission in 25% of Philadelphia chromosome (Ph)-positive chronic myelogenous leukemia (CML) patients. These remissions are durable unlike remissions induced with other therapies and yet residual leukemia is detectable in most of these patients. Total peripheral blood mononuclear cells (PBMCs) from CML patients in long-term remission following interferon treatment exhibited significantly higher proliferative responses (four- to 15-fold over background) than normals directed against P210 BCR-ABL in extracts of transfected monkey fibroblast cells. Surprisingly, similar enhanced levels of specific proliferative responses were observed with extracts from cells expressing Bcr and/or Abl proteins. In contrast, extracts from vector only or v-Mos-expressing cells had background level responses. Control monkey fibroblast cells lacking BCR-ABL expression failed to induce proliferation over background levels. Normal individuals had no significant responses to Bcr/Abl extracts. On the other hand, peripheral blood mononuclear cells from allogeneic bone marrow transplant CML patients had proliferative responses to cell extracts independent of Bcr-Abl. These data indicate that patients in remission due to alpha-interferon treatment have significantly higher levels of specific cellular immunoreactivity against Bcr/Abl sequences than normal controls, which could play a role in maintaining cytogenetic remission in Ph-positive CML patients.

    DOI: 10.1038/sj.leu.2400919

    Scopus

    PubMed

    researchmap

  • Analysis of the genome of an Epstein-Barr-virus(EBV)-related herpesvirus in a cynomolgus monkey cell line (Si-IIA) Reviewed

    Ino H, Hayashi K, Yanai H, Teramoto N, Koirala T.R, Chen H.L, Oka T, Yoshino T, Takahashi K, Akagi T

    51 ( 4 )   207 - 212   1997

     More details

  • Metastatic potential of lymphoma/leukemia cell lines in SCID mice is closely related to expression of CD44

    Nobuhiro Kawasaki, Yoshinobu Matsuo, Tadashi Yoshino, Hiroyuki Yanai, Takashi Oka, Norihiro Teramoto, Cao Liu, Eisaku Kondo, Jun Minowada, Tadaatsu Akagi

    Japanese Journal of Cancer Research   87 ( 10 )   1070 - 1077   1996

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:Japanese Cancer Association  

    To investigate whether the lymphocyte homing receptors, adhesion molecules regulating normal lymphocyte traffic, influence the dissemination of lymphoma cells, 24 lymphoma/leukemia cell lines were inoculated into SCID mice subcutaneously, and the correlation between the expression of the adhesion molecules and the metastatic potential of the cell lines was examined. Among the six adhesion molecules examined (LFA-1, ICAM-1, CLA, VLA-4, L-selectin and CD44), L-selectin increased the incidence of lymph node metastasis, and CD44 expression was related to both lymph node and organ (hematogenous) metastasis. A monoclonal antibody to the standard form of CD44 (CD44s), Hermes-3, inhibited the local growth and remote metastasis of CD44+ cell lines. Thus, it is concluded that at least CD44s expression is important in both lymphatic and hematogenous metastasis.

    DOI: 10.1111/j.1349-7006.1996.tb03112.x

    Scopus

    PubMed

    researchmap

  • Aberrant expression of the p53 tumor suppresser gene in sdult T-cell leukemia and HTLV-1-infected cells Reviewed

    Yamato,K, Oka,T, Hiroi,M, Iwahara,Y, Sugito,S, Miyoshi,I

    Jpn. J. Cancer Research   84   4 - 8   1993

     More details

  • Molphological characterization of a new human epithelioid sarcoma cell line, ESO20488, in vitro and in vivo. Reviewed

    Sonobe,H, Furihata, M, Iwata, J, Oka, T, Ohtsuki, T, Hamasato, S, Fujimoto, S

    63   219 - 225   1993

     More details

  • Phenotypical progression of a rat lymphoid cell line immortalized by HTLV-1 to induced lymphoma/leukemia-like disease in rats. Reviewed

    Oka,T, Sonobe,H, Iwata,J, Kubonishi,I, Satoh,H, Takata,M, Tanaka,Y, Tateno,M, Tozawa,H, Mori,S, Yoshiki,T, Ohtsuki,Y

    66   6686 - 6694   1992

     More details

    Authorship:Lead author  

    researchmap

  • Establishment and characterization of a new human synovial sarcoma cell line, HS-SY-II Reviewed

    Sonobe H, Manabe Y, Furihata M, Iwata J, Oka, T, Ohtsuki Y, Mizobuchi H, Yamamoto H, Kumano O, d Abe

    67   498 - 505   1992

     More details

  • Similarity, in molecular structure and function, between the plant toxin purothionin and the mammalian pore-forming proteins

    T. Oka, Y. Murata, T. Nakanishi, H. Yoshizumi, H. Hayashida, Y. Ohtsuki, K. Toyoshima, A. Hakura

    Molecular Biology and Evolution   9 ( 4 )   707 - 715   1992

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Many proteins containing domains of a cysteine-rich repeated motif, such as epidermal growth factor (EGF), have been reported. Here we report strong similarity between the amino acid sequence of a plant toxin-i.e., purothionin and its homologues-and with those of a domain found in mammalian pore-forming cytoplasmic proteins: components of complement and perforin of cytotoxic T- lymphocytes or natural killer-like cytotoxic cells. These similar sequences were found to be identical to the so-called EGF-like cysteine-rich repeated motif itself. Electronmicroscopic observations indicated that, like complement and perforin, purothionin forms pores in the cytoplasmic membrane of target cells, resulting in their death within a few hours. On the basis of these sequence comparisons and physiological functions, we propose a scheme for the evolution of proteins containing modules of the cysteine-rich repeat motif.

    Scopus

    PubMed

    researchmap

  • Inhibitory effects of human interferons on the immortalization of HUMAN, but not rabbit, T lymphocytes by human T‐lymphotropic virus type‐I (HTLV‐I)

    Takashi Oka, Jun Iwata, Mutsuo Furihata, Hiroshi Sonobe, Isao Miyoshi, Yuji Ohtsuki

    International Journal of Cancer   51 ( 6 )   915 - 920   1992

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    The effects of human interferon (IFN)‐α, ‐β, and ‐γ on the immortalization of human and rabbit lymphocytes by human T‐lymphotropic virus type‐l (HTLV‐I) have been investigated. The immortalization of human peripheral‐blood lymphocytes co‐cultured with lethally X‐ray‐irradiated HTLV‐l‐producer cells, MT‐2, was blocked in the presence of more than 40 u/ml human recombinant IFN‐α or more than 200 u/ml human natural type IFN‐fi. However, rhlFN‐γ did not block immortalization by HTLV‐I even at higher doses. On the other hand, the presence of high doses of hlFN‐α, ‐β, or ‐γ did not exhibit any biological effect on the immortalization of rabbit peripheral‐blood lymphocytes co‐cultured with lethally X‐ray‐irradiated MT‐2 cells. Integration of the full length of HTLV‐I genome was detected in every transformant by Southern blot analysis. All cell lines established were CD4+/CD8÷ T‐lymphocytes, except for one cell line of CD4+/CD8+. Morphologically intact HTLV‐I production was observed by electron microscopy in these cells. Our results indicate that HTLV‐I released under the strongly suppressed condition in the presence of IFNs remains active and able to immortalize T lymphocytes. It is also suggested that immortalization of human T lymphocytes by HTLV‐I can be inhibited by the antiviral state induced by the treatment with low doses of hlFN‐α and ‐β, whereas immortalization of rabbit T lymphocytes is not inhibited because of the species specificity of hlFNs. Copyright © 1992 Wiley‐Liss, Inc., A Wiley Company

    DOI: 10.1002/ijc.2910510614

    Scopus

    PubMed

    researchmap

  • Plant defence and molecular evolution.

    Oka,T., Hayashida,H., and Nakanishi,T.

    The Heredity,   46   51 - 57   1992

     More details

  • Single cilium in human leukemic cells heterotransplanted into hamsters

    Y. Ohtsuki, I. Kubonishi, H. Sonobe, J. Iwata, T. Oka, I. Miyoshi

    Acta Anatomica   141 ( 1 )   42 - 45   1991

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Single cilium formation was studied in two human hematopoietic cell lines, KCL-22 and MT-2. KCL-22 established from a patient with chronic myelogenous leukemia in blastic crisis, and MT-2, a human cord T cell line carrying human T-lymphotropic virus type I, were transplanted into hamsters. Ciliogenesis was observed in both cell lines, only after transplantation into hamsters.

    Scopus

    PubMed

    researchmap

  • MORPHOLOGICAL CHARACTERIZATION OF A NEWLY ESTABLISHED HUMAN OSTEOSARCOMA CELL-LINE, HS-OS-1, REVEALING ITS DISTINCT OSTEOBLASTIC NATURE

    H SONOBE, H MIZOBUCHI, Y MANABE, M FURIHATA, J IWATA, T HIKITA, T OKA, Y OHTSUKI, T GOTO

    VIRCHOWS ARCHIV B-CELL PATHOLOGY INCLUDING MOLECULAR PATHOLOGY   60 ( 3 )   181 - 187   1991

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:SPRINGER VERLAG  

    A newly established human osteosarcoma cell line, HS-Os-1, from an osteoblastic tumor arising in the left humerus of an 11-year-old girl was morphologically characterized in vitro and in vivo. HS-Os-1 cells in a monolayer have been maintained for more than 2 years since the initial cultivation, and were round or polygonal in shape with marked pleomorphism. Their cytoplasm was strongly positive for specific markers of osteoblasts, such as alkaline phosphatase and osteocalcin. Tumors induced in nude mice by HS-Os-1 cell inoculation at passage 12 or 23 revealed typical histological features of osteoblastic osteosarcoma, similar to those observed in the original tumor, producing prominent osteoid matrix with calcification. Ultrastructurally, HS-Os-1 cells in vitro and tumor cells in vivo showed similar well-developed, markedly dilated rough endoplasmic reticulum, polysomes and microfilaments in their cytoplasm. Additionally, many collagen fibers associated with deposition of electron-dense material were detected in the stroma featuring osteoid matrix. Thus, the HS-Os-1 cell line was shown to exhibit its osteoblastic nature in vitro and in vivo, and therefore might become an extremely useful tool for various pathomorphological investigations on human osteosarcomas.

    Web of Science

    researchmap

  • Characterization of two human lymphoid cell lines producing human T-lymphotropic virus type-(]G0001[) (HTLV-(]G0001[)) isolated from patients with HTLV-(]G0001[) associated myelopathy or encephalopathy.

    Iwata,J, Oka,T, Furihata,M, Sonobe,H, Matsubayashi,K, Uemura,Y, Miyoshi,I, Ohtsuki,Y

    118   101 - 112   1991

     More details

  • Single cilium in human leukemic cells heterotransplanted into hamsters. Reviewed

    Ohtsuki,Y, Kubonishi,I, Sonobe,H, Iwata,J, Oka,T, Miyoshi,I

    141   42 - 45   1991

     More details

  • Adult T-cell leukemia/lymphoma with skin lesions similar to mycosis fungoides. Reviewed

    Ookawa,K, Wada,M, Kitagawa,N, Kodama,H, Kanzaki,T, Fujishita,H, Taguchi,H, Oka,T, Takiwaki,H

    45   17 - 21   1991

     More details

  • Establishment and characterization of a human cell line, HS-MM, derived from a case of clear sarcoma. Reviewed

    Sonobe,H, Manabe,Y, Furihata,M, Iwata,J, Hikita,T, Tanimoto,T, Kiuna,O, Oka,T, Ohtsuki,Y, Mizobuchi,H, Kawashimo,T, Kimano,O

    3   352 - 356   1990

     More details

  • Ultrastructural and immunoelectron microscopic observation of human T-lymphotropic virus type-1 (HTLV-1) with high voltage electron microscope. Reviewed

    Ohtsuki,Y, Iwata,J, Furihata,M, Hikita,T, Mizobuchi,H, Manabe,Y, Oka,T, Ido,E, Sonobe,H, Miyoshi,I

    23   373 - 381   1990

     More details

  • Characterization of flat revertants isolated from cells transformed by Abelson murine leukemia virus (Ab‐MuLV)

    Takashi Oka, Masuo Yutsudo, Hirokazu Inoue, Fujito Higuchi, Akira Hakura

    Journal of Cellular Physiology   145 ( 3 )   428 - 433   1990

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Transformed Fisher rat fibroblast cell lines by Abelson murine leukemia virus frequently revert to the normal phenotype in usual culture conditions. Molecular Biological analysis of thre revertant clones isolated from the transformants showed that their morphological reversions were due to inactivation of the v‐abl oncogene at multiple steps including transcription, translation or v‐abl protein kinase activity itself without any change in structural gene expression of helper virus. These findings suggest the existence of a specific mechanism(s) for elimination of the v‐abl oncogene by segregation, mutation, or gene rearrangement in these cells. Copyright © 1990 Wiley‐Liss, Inc.

    DOI: 10.1002/jcp.1041450306

    Scopus

    PubMed

    researchmap

  • Establishment and characterization of a cell line, Hs-Os-1, derived from an osteoblastic type of human osteosarcoma. Reviewed

    Sonobe,H, Mizobuchi,H, Manabe,Y, Furihata,M, Iwata,J, Hikita,T, Kiuna,O, Tanimoto,T, Oka,T, Ohtsuki,Y

    3   148 - 151   1990

     More details

  • Suppressive effects of interferons on the production and release of human T-lymphotropic virus type-1. Reviewed

    Oka,T, Ohtsuki,Y, Sonobe,H, Furihata,M, Miyoshi,I

    115   63 - 73   1990

     More details

    Authorship:Lead author  

    researchmap

  • Immortalization of rat spleen and thymus T-cells by human T-cell leukemia virus type-(]G0001[)(共著)

    Akagi Tadaatsu, Takata Hiroshi, Yoshino Tadashi, Teramoto Norihiro, Yano Shoki, Oka Takashi

    Acta Med. Okayama   43 ( 3 )   143 - 151   1989.6

     More details

    Language:English   Publisher:Okayama University Medical School  

    DOI: 10.18926/AMO/30886

    CiNii Article

    CiNii Books

    researchmap

  • Electron microscopic study of suppressive effects on the production of human T-lymphotropic virus type-1 with human interferons. Reviewed

    Ohtsuki,Y, Oka,T, Furihata,M, Takahashi,K, Hayashi,K, Iwata,J, Hikita,T, Sonobe,H, Miyoshi,I

    22   205 - 213   1989

     More details

  • Thymic malignant lymphoma (lymphoblastic type) with SVC syndrome resulting in rapid death-Report of an autopsy case-. Reviewed

    Sonobe, H, Manabe,Y, Furihata,M, Iwata,J, Kiuna,O, Hikita,T, Hayashi,K, Oka,T, Ohtsuki,Y, Yamashiro,T, Tamiya,T, Fujieda,M, Kurashige,T

    26   21 - 26   1989

     More details

  • Inactivation and Activation of Inward Current During Adaptation to Potassium Ions in Paramecium Caudatum

    Takashi Oka, Yasuo Nakaoka

    Cell Structure and Function   14 ( 2 )   209 - 216   1989

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Paramecium cells adapted to 2 mM K+ were voltage clamped and transient inward currents induced by step-depolarizations were studied. When the external K+ concentration was increased to 8 mM, the inward current was largely suppressed. Similar suppression of the inward current was induced by positive shifts of the holding potential above the resting level. The suppression of inward current is, therefore, primarily caused by depolarizing changes in the membrane potential. During adaptation to 8 mM K+, the inward current recovered to about 70% of that in the cells adapted to 2 mM K+, the resting membrane repolarized, and the steady state inactivation of the inward current was shifted to a more positive level than the cells adapted to 2 mM K+. When mutant cells which lack depolarization-sensitive Ca-current were adapted to 8 mM K+, a step-depolarization induced a fast activation of outward current, which would subtract from the inward current in the wild-type cells, suggesting that the transient inward current of cells adapted to 8 mM K+ is partially reduced by the fast activation of outward current. © 1989, Japan Society for Cell Biology. All rights reserved.

    DOI: 10.1247/csf.14.209

    Scopus

    researchmap

  • IImmunocytochemical and ultrastructural characterization of human T-lymphotropic virus type I (HTLV-I)-producing rabbit lymphoid cell lines. Reviewed

    Y. Ohtsuki, I. Miyoshi, T. Oka, K. Hayashi, K. Takahashi, M. Furihata, J. Iwata, T. Takeuchi, H. Sonobe

    100   245 - 254   1988

     More details

  • Isolation of virus producing transformants from human gastric cancer cell line HGC-27, infected with human T-cell leukemia virus type-1 Reviewed

    Akagi,T, Yoshino,T, Motoi,M, Takata,H, Yano,S, Miyoshi,I, Oka,T, Ohtsuki,Y

    79   836 - 942   1988

     More details

  • Inhibitory effects of interferons on the assembly and relase of human T-lymphotropic virus type-1 (HTLV-1) Reviewed

    Oka,T, Ohtsuki,Y, Sonobe,H, Furihata,M, Miyoshi,I

    25   11 - 17   1988

     More details

    Authorship:Lead author  

    researchmap

  • Ultrastructural study of human T-lymphotropic virus type-1 (HTLV-1) in rabbit lymphoid cell lin Reviewed

    Ohtsuki,Y., Oka,T., Furihata,M., and Miyoshi,I.,

    14   68 - 73   1988

     More details

  • Changes in membrane potential during adaptation to external potassium ions. Reviewed

    Oka,T, Nakaoka,Y, Oosawa,F

    126   111 - 117   1986

     More details

    Authorship:Lead author  

    researchmap

  • Transformation of hamster spleen lymphocytes by human T‐cell leukemia virus type I

    T. Akagi, H. Takata, Y. Ohtsuki, K. Takahashi, T. Oka, S. Yano, I. Miyoshi

    International Journal of Cancer   37 ( 5 )   775 - 779   1986

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Co‐cultivation of spleen cells of Syrian golden hamsters with lethally irradiated MT‐2 cells harboring human T‐cell leukemia virus type I (HTLV‐I) resulted in the establishment of lymphoid cell lines, HCT‐1 and HCT‐2, which exhibited the normal karyotype of golden hamsters. Cells of both the HCT‐1 and HCT‐2 lines lacked surface immunoglobulins and reacted with a monoclonal antibody (MAb) specific for hamster T cells. Some were positive for OKIal. None of them expressed HTLV structural antigens (p19 and p24) or virus particles, but they contained HTLV‐1 proviral DNA monoclonally. By immunochemical analysis of the labelled cell antigens, sera from adult T‐cell leukemia (ATL) patients reacted with the two polypeptides, p37 and p40, which may not be viral structural proteins and still remain to be characterized. HCT‐1 and HCT‐2 cells were transplantable into newborn hamsters, pre‐treated with anti‐hamster thymocyte serum and non‐treated, respectively, producing diffuse malignant lymphoma. These findings indicated that HTLV‐1 not only immortalized but also transformed hamster T cells non‐productively. Copyright © 1986 Wiley‐Liss, Inc., A Wiley Company

    DOI: 10.1002/ijc.2910370520

    Scopus

    PubMed

    researchmap

  • Changes in membrane potential during adaptation to external potassium ions. Reviewed

    Oka,T, Nakaoka,Y, Oosawa,F

    J. Exp. Biol.   126   111 - 117   1986

     More details

    Authorship:Lead author  

    researchmap

  • Immortalization of human lymphocytes by co-cultivation with lethally irradiated T Cell leukemia virus type-1 Reviewed

    Akagi,T, Ohtsuki,Y, Takahashi,K, Takeda,I, Oka,T, Miyoshi,I

    J. Cancer Res. Clin. Oncol.   110   86 - 94   1985

     More details

  • Experimental infection of rabbits with human T cell leukemia virus type-1 Reviewed

    Akagi,T, Takeda,I, Oka,T, Ohtsuki,Y, Yano,S, Miyoshi,I

    76   86 - 94   1985

  • Experimental infection of rabbits with human T cell leukemia virus type-1 Reviewed

    Akagi,T, Takeda,I, Oka,T, Ohtsuki,Y, Yano,S, Miyoshi,I

    Jpn. J. Cancer Res.   76   86 - 94   1985

  • Immortalization of human lymphocytes by co-cultivation with lethally irradiated T Cell leukemia virus type-1 Reviewed

    Akagi,T, Ohtsuki,Y, Takahashi,K, Takeda,I, Oka,T, Miyoshi,I

    110   86 - 94   1985

     More details

  • T cell growth factors from adult T cell leukemia virus-transformed cell lines

    Yasuji Okai, Takashi Oka, Tadaatsu Akagi, Sayuri Kurata, Nobuo Fujiyoshi

    FEBS Letters   177 ( 2 )   200 - 204   1984.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Some characteristics of T cell growth factors derived from adult T cell leukemia virus (ATLV)-transformed cell lines, MT 1 and MT 2 were analyzed. MT 1 cells release significant interleukin 2 (IL 2) activity into the culture medium, which showed the same elution pattern of gel filtration and isoelectric focusing of IL 2 from lectin-stimulated normal human lymphocytes. This activity was also detected in the cell extract of MT 1. In contrast, MT 2 cell line did not produce IL 2 activity, but non-IL 2 type growth factor was observed. The significance of these factors from MT cell lines is discussed from the viewpoint of 'autokine' in ATLV-transformed cells. ALTV-transformed cell T cell growth factor. © 1984.

    DOI: 10.1016/0014-5793(84)81283-1

    Scopus

    PubMed

    researchmap

  • ACCELERATION OF PARAMECIUM SWIMMING VELOCITY IS EFFECTED BY VARIOUS CATIONS

    Y NAKAOKA, T OKA, K SERIZAWA, H TOYOTAMA, F OOSAWA

    CELL STRUCTURE AND FUNCTION   8 ( 1 )   77 - 84   1983

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:JAPAN SOC CELL BIOLOGY  

    DOI: 10.1247/csf.8.77

    Web of Science

    researchmap

  • Effects of magnetic fields on the growth of tumor cells. Reviewed

    Ogawa,K, Motoi,M, Oka,T, Yamada,O

    111 - 120   1979

     More details

▼display all

Books

  • 成人T細胞白血病・リンパ腫におけるエピジェネテイック異常と発症・進展機構の解析

    2014 

     More details

  • Accumulation of Specific Epigenetic Abnormalities during Development and Progression of T cell Leukemia/Lymphoma.

    INTECH Open Access Publisher  2011 

     More details

  • jointly worked

    2011 

     More details

  • Gene silencing:New research

    Nova Science Publishers,Inc,New Yoek  2006 

     More details

  • Immunoelectron microscopic study of the expression of T-cell receptor(TCR) /CD3 complex in human T-Cymphotropic Virus(HTLV) - producing cells (共著)

    in "Cells and Diseases" Hematolymphoreticular Study Group, Seoul, Korea  1997 

     More details

  • Immunoelectron microscopic study of the expression of T-cell receptor(TCR) CD3 complex in human T-Cymphotropic Virus(HTLV) - producing cells "jointly worked"

    in "Cells and Diseases" Hematolymphoreticular Study Group, Seoul, Korea  1997 

     More details

  • Ultrastructural and immunoelectron microscopic comparisons of human T-lymphotropic virus type-(]G0001[) Japanese monkey derived type-C virus particles.(共著)

    in Approaches to cancer therapy research in France & Japan. Fukutani, R., et al., edited, Pergamon Press,  1987 

     More details

  • Ultrastructural and immunoelectron microscopic comparisons of human T-lymphotropic virus type-(]G0001[) Japanese monkey derived type-C virus particles."jointly worked"

    in Approaches to cancer therapy research in France & Japan. Fukutani, R., et al., edited, Pergamon Press,  1987 

     More details

  • Effects of magnetic fields on the growth of Ehrlich''s ascites tumor cells.(共著)

    in Symposium on Biomagnetics. edited by Nakagawa K., Sun Enterprise Press, Tokyo,  1980 

     More details

  • Effects of magnetic fields on the growth of cultured cells.

    in Symposium on Biomagnetics., edited by Nakagawa, K., Sun Enterprise Press, Tokyo,  1980 

     More details

  • Effects of homogeneous magnetic fields on the growth of tumor cells."jointly worked"

    in Symposium on Biomagnetics., edited by Nakagawa K., Sun Enterprise Press, Tokyo,  1980 

     More details

  • Effects of magnetic fields on the growth of Ehrlich''s ascites tumor cells."jointly worked"

    in Symposium on Biomagnetics. edited by Nakagawa K., Sun Enterprise Press, Tokyo,  1980 

     More details

  • Effects of magnetic fields on the growth of cultured cells.

    in Symposium on Biomagnetics., edited by Nakagawa, K., Sun Enterprise Press, Tokyo,  1980 

     More details

  • Effects of homogeneous magnetic fields on the growth of tumor cells.(共著)

    in Symposium on Biomagnetics., edited by Nakagawa K., Sun Enterprise Press, Tokyo,  1980 

     More details

▼display all

MISC

  • 成人T細胞白血病/リンパ腫(ATL)を発症したHTLV-1キャリアにおける異常DNAメチル化の解析

    佐藤 妃映, 岡 剛史, 神農 陽子, 鷲尾 佳奈, 村上 一郎, 大内田 守, 宇都宮 與, 吉野 正

    日本リンパ網内系学会会誌   57   88 - 88   2017.5

     More details

    Language:Japanese   Publisher:(一社)日本リンパ網内系学会  

    researchmap

  • 成人T細胞白血病/リンパ腫(ATL)におけるDNA異常メチル化と病態の変動との関連

    佐藤 妃映, 岡 剛史, 神農 陽子, 村上 一郎, 大内田 守, 宇都宮 與, 吉野 正

    日本病理学会会誌   106 ( 1 )   355 - 355   2017.3

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    researchmap

  • Gene expression analysis of hypersensitivity to mosquito bite, chronic active EBV infection and NK/T-lymphoma/leukemia

    Kana Washio, Takashi Oka, Lamia Abdalkader, Michiko Muraoka, Akira Shimada, Megumi Oda, Hiaki Sato, Katsuyoshi Takata, Yoshitoyo Kagami, Norio Shimizu, Seiichi Kato, Hiroshi Kimura, Kazunori Nishizaki, Tadashi Yoshino, Hirokazu Tsukahara

    LEUKEMIA & LYMPHOMA   58 ( 11 )   2683 - 2694   2017

     More details

    Language:English   Publisher:TAYLOR & FRANCIS LTD  

    The human herpes virus, Epstein-Barr virus (EBV), is a known oncogenic virus and plays important roles in life-threatening T/NK-cell lymphoproliferative disorders (T/NK-cell LPD) such as hypersensitivity to mosquito bite (HMB), chronic active EBV infection (CAEBV), and NK/T-cell lymphoma/leukemia. During the clinical courses of HMB and CAEBV, patients frequently develop malignant lymphomas and the diseases passively progress sequentially. In the present study, gene expression of CD16((-))CD56((+))-, EBV(+) HMB, CAEBV, NK-lymphoma, and NK-leukemia cell lines, which were established from patients, was analyzed using oligonucleotide microarrays and compared to that of CD56(bright)CD16(dim/-) NK cells from healthy donors. Principal components analysis showed that CAEBV and NK-lymphoma cells were relatively closely located, indicating that they had similar expression profiles. Unsupervised hierarchal clustering analyses of microarray data and gene ontology analysis revealed specific gene clusters and identified several candidate genes responsible for disease that can be used to discriminate each category of NK-LPD and NK-cell lymphoma/leukemia.

    DOI: 10.1080/10428194.2017.1304762

    Web of Science

    researchmap

  • 成人T細胞白血病/リンパ腫(ATL)におけるDNA異常メチル化と予後との関連について

    佐藤妃映, 岡剛史, 神農陽子, 鷲尾佳奈, 村上一郎, 大内田守, 宇都宮與, 吉野正

    日本HTLV-1学会学術集会   3rd   2016

  • 成人T細胞白血病リンパ腫に於けるHTLV-1Tax遺伝子発現によるDNAメチル化の一細胞変動 Reviewed

    岡 剛史, 大内田 守, 岡田 康志, 山縣 一夫, 吉野 正

    日本癌学会総会記事   74回   E - 1154   2015.10

     More details

    Language:English   Publisher:日本癌学会  

    researchmap

  • 成人T細胞白血病/リンパ腫(ATL)におけるDNA異常メチル化と病態との関連

    佐藤 妃映, 岡 剛史, 神農 陽子, 鷲尾 佳奈, 村上 一郎, 大内田 守, 大島 孝一, 宇都宮 與, 吉野 正

    日本リンパ網内系学会会誌   55   117 - 117   2015.6

     More details

    Language:Japanese   Publisher:(一社)日本リンパ網内系学会  

    researchmap

  • 成人T細胞白血病リンパ腫に於ける 細胞DNAメチル化の変動解析 Reviewed

    岡 剛史, 大内田 守, 岡田 康志, 上田 潤, 山縣 一夫, 吉野 正

    日本病理学会会誌   104 ( 1 )   494 - 494   2015.3

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    researchmap

  • 成人T細胞白血病リンパ腫に於けるDNAメチル化の動的変動(Dynamic changes of DNA methylation in adult T cell leukemia/lymphoma (ATL)) Reviewed

    岡 剛史, 大内田 守, 岡田 康志, 上田 潤, 山縣 一夫, 吉野 正

    日本癌学会総会記事   73回   E - 1032   2014.9

     More details

    Language:English   Publisher:日本癌学会  

    researchmap

  • 成人T細胞白血病/リンパ腫(ATL)関連細胞株における特異的DNAメチル化の解析

    佐藤妃映, 岡剛史, 神農陽子, 鷲尾佳奈, 村上一郎, 大内田守, 宇都宮與, 高橋聖之, 吉野正

    日本病理学会会誌   103 ( 1 )   2014

  • 成人T細胞白血病/リンパ腫(ATL)関連細胞株におけるDNA異常メチル化の解析

    佐藤妃映, 岡剛史, 神農陽子, 鷲尾佳奈, 村上一郎, 大内田守, 宇都宮與, 高橋聖之, 吉野正

    日本HTLV-1学会学術集会   1st   2014

  • 成人T細胞白血病/リンパ腫(ATL)関連細胞株における特異的DNAメチル化の解析

    佐藤妃映, 岡剛史, 神農陽子, 鷲尾佳奈, 村上一郎, 大内田守, 宇都宮與, 高橋聖之, 吉野正

    日本リンパ網内系学会会誌   54   2014

  • 成人T細胞白血病/リンパ腫(ATL)における特異的DNAメチル化と予後との相関

    佐藤妃映, 岡剛史, AL-KADER Lamia Abd, 神農陽子, 鷲尾佳奈, 村上一郎, 大内田守, 宇都宮與, 高橋聖之, 吉野正

    ATLシンポジウム/HTLV-1国際シンポジウム/HTLV-1研究会プログラム・抄録集   2nd-3rd-6th   2013

  • 成人T細胞白血病/リンパ腫(ATLL)における特異的DNAメチル化と予後との相関

    佐藤妃映, 岡剛史, LAMIA Abd Alkader, 神農陽子, 鷲尾佳奈, 村上一郎, 大内田守, 大島孝一, 宇都宮與, 高橋聖之, 吉野正

    日本病理学会会誌   102 ( 1 )   2013

  • Upregulation of Ezh2 expression correlates with higher tumor proliferation and grade in non-Hodgkin's Band T-cell lymphoma

    Lamia Abd Al-Kader, Takashi Oka, Katsuyoshi Takata, Xu Sun, Hiaki Sato, Ichiro Murakami, Hiroshi Kimura, Arie P. Otte, Tadashi Yoshino

    CANCER RESEARCH   72   1034 - 1034   2012.4

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:AMER ASSOC CANCER RESEARCH  

    DOI: 10.1158/1538-7445.AM2012-1034

    Web of Science

    researchmap

  • 成人T細胞白血病・リンパ腫(ATL)の発症・進展におけるエピジェネテイックス異常のダイナミックス

    岡剛史, ABD AL-Kader Lamia, 佐藤妃映, 神農陽子, 鷲尾佳奈, 村上一郎, 村上一郎, 大内田守, 宇都宮與, 吉野正

    ATLシンポジウム/HTLV-1国際シンポジウム/HTLV-1研究会プログラム・抄録集   1st-2nd-5th   2012

  • 成人T細胞白血病/リンパ腫(ATLL)におけるDNAメチル化と病態との関連

    平岩 千尋, 岡 剛史, 佐藤 妃映, Abd. Al-Kader Lamia, 神農 陽子, 鷲尾 佳奈, 佐藤 康晴, 高田 尚良, 田村 麻衣子, 村上 一郎, 大内田 守, 大島 孝一, 宇都宮 與, 吉野 正

    日本病理学会会誌   100 ( 1 )   496 - 496   2011.3

     More details

    Language:Japanese   Publisher:(一社)日本病理学会  

    researchmap

  • Cumulative kinetics of epigenetic abnormalities during initiation and progression of Adult T-cell Leukemia/Lymphoma (ATLL).

    Oka T, Sato H, A Al-Kader L, Shinnou Y, Washio K, Takata K, Murakami I, Utsunomiya A, Ouchida M, Takahashi K, Yoshino T

    Retrovirology   8 ( Suppl 1 )   195 - 195   2011

     More details

  • Identification of novel direct targets of miR-19a in MCF-7 breast cancer cells

    Hirotaka Kanzaki, Mamoru Ouchida, Sachio Ito, Seiji Tamaru, Hiroko Hanafusa, Yoshimi Jitsumori, Takashi Oka, Kenji Shimizu

    CANCER RESEARCH   70   2010.4

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:AMER ASSOC CANCER RESEARCH  

    DOI: 10.1158/1538-7445.AM10-LB-246

    Web of Science

    researchmap

  • Multi-step accumulation of aberrant CpG island hypermethylation in specific genes promotes development and progression of lymphomas/leukemias

    Takashi Oka, Hiaki Sato, Takami Kondo, Yoko Shinnou, Kana Washio, Ichiro Murakami, A. B. D. Al-Kader Lamia, Xu Sun, Katsuyoshi Takata, Mamoru Ouchida, Koichi Ohshima, Mitsune Tanimoto, Atae Utsunomiya, Kiyoshi Takahashi, Tadashi Yoshino

    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE   26 ( Sup1 )   S44 - S44   2010

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:SPANDIDOS PUBL LTD  

    Web of Science

    researchmap

  • Helicobacter pylori infection induce accumulation of aberrant CpG hypermethylation to promote development and progression of gastric MALT lymphoma

    Takashi Oka, Takami Kondo, Hiaki Sat, Yoko Shinnou, Kana Washio, Toshiaki Morit, Katsuyoshi Takat, Nobuya Ohara, Mamoru Ouchida, Kenji Shimizu, Tadashi Yoshin

    Proceedings of The 3rd International Symposium for Future Technology Creating Better Human Health and Society Comprehensive Approach to Cancer and Infectious Diseases   1 ( 1 )   105 - 105   2010

     More details

  • IMMUNOHISTOCHEMICAL ANALYSES OF PTPN6 (SHP1) ON LANGERHANS CELL HISTIOCYTOSIS

    Ichiro Murakami, Takashi Oka, Hiaki Sato, Yuta Kitamura, Toshiaki Morito, Katsuyoshi Takata, Yoko Shinno, Masayuki Takano, Kana Washio, Xingang Huang, Maiko Tamura, Naoko Ohnishi, Koichi Ichimura, Yasuharu Sato, Hiroyuki Yanai, Nobuya Ohara, Eisaku Kondo, Kiyoshi Takahashi, Takehiro Tanaka, Jean Gogusev, Francis Jaubert, Akira Morimoto, Shinsaku Imashuku, Tadaatsu Akagi, Tadashi Yoshino

    Proceedings of XXIV Annual Meeting of the Histiocyte Society   2008

     More details

  • 胃原発悪性リンパ腫におけるmethylator phenotypeとH.pylori感染に関する検討

    近藤孝美, 岡剛史, 中谷陽子, 佐藤妃映, 佐藤妃映, 鷲尾佳奈, 高野正幸, 大原信哉, 大内田守, 吉野正

    日本病理学会会誌   96 ( 1 )   2007

  • SHP1遺伝子発現抑制と悪性リンパ腫・白血病発症機構の解析

    岡剛史, 大内田守, 中谷陽子, 近藤孝美, 佐藤妃映, 佐藤妃映, 鷲尾佳奈, 高野正幸, 村上一郎, 大原信哉, 高橋聖之, 吉野正

    日本病理学会会誌   95 ( 1 )   2006

  • 異常メチル化によるSHP1 gene silencingと悪性リンパ腫・白血病発症機構

    岡剛史, 中谷陽子, 近藤孝美, 佐藤妃映, 佐藤妃映, 高野正幸, 鷲尾佳奈, 大内田守, 大原信哉, 清水憲二, 谷本光音, 高橋聖之, 吉野正

    日本癌学会学術総会記事   65th   2006

  • T細胞性リンパ腫における,SHP1発現とSTAT sの活性化プロファイルとの関連

    中谷陽子, 岡剛史, 佐藤妃映, 佐藤妃映, 近藤孝美, 高野正幸, 鷲尾佳奈, 鷲尾佳奈, 村上一郎, 大原信哉, 大内田守, 吉野正

    日本病理学会会誌   95 ( 1 )   2006

  • Characterization of Epstein-Barr virus-infected mantle cell lymphoma lines

    ZS Jin, N Teramoto, T Yoshino, K Takada, T Oka, K Hayashi, T Akagi

    ACTA MEDICA OKAYAMA   54 ( 5 )   193 - 200   2000.10

     More details

    Language:English   Publisher:OKAYAMA UNIV MED SCHOOL  

    It has been reported that Epstein-Barr virus (EBV) resides in resting B cells in vivo. However, an ideal in vitro system for studying EBV latent infection in vivo has not yet been established. In this study, a mantle cell lymphoma line, SP53, was successfully infected with a recombinant EBV containing a neomycin-resistant gene. The EBV-carrying SP53 cells were obtained by selection using G418. They expressed EBER-1, EBNAs, and LMP1; this expression pattern of the EBV genes was similar to that in a lymphoblastoid cell line (LCL). However, proliferation assay showed that the EBV-carrying SP53 cells have a doubling time of 73 h, compared with 57 h of SP53 cells. Transplantation of 10(8) SP53 cells to nude mice formed tumors in 4 of 10 mice inoculated, but the EBV-carring SP53 cells did not. Unexpectedly, EBV infection reduced the proliferation and tumorigenicity of SP53 cells. However, the EBV-carrying SP53 cells showed higher resistance to apoptosis induced by serum starvation than did the SP53 cells. The inhibition of proliferation and the resistance to apoptosis induced in SP53 cells by EBV infection indicate that this cell line might to some extent provide a model of in vivo EBV reservoir cells.

    DOI: 10.18926/AMO/32293

    Web of Science

    researchmap

▼display all

Presentations

  • HTLV-1キャリアにおける異常DNAメチル化と成人T細胞白血病/リンパ腫(ATL)発症との関連について

    第4回日本HTLV-1学会学術集会  2017 

     More details

  • Sensitive detection of dynamic changes of metabolic abnormalities during onset and progression of adult T-cell leukemia/lymphoma (ATL) and induction of specific leukemic cell death by photodynamic action

    The18th International Conference on Human Retrovirology: HTLV and Related Viruses HTLV  2017 

     More details

  • Aberrant DNA methylation is associated with the clinical course in the same patients with ATL

    The18th International Conference on Human Retrovirology: HTLV and Related Viruses HTLV  2017 

     More details

  • Proteomic analysis on Langerhans cell histiocytosis patients and a new triple-risk factor model

    2017 

     More details

  • Sensitive detection of dynamic changes of metabolic abnormalities during onset and progression of adult T-cell leukemia/lymphoma (ATL) and induction of specific leukemic cell death by photodynamic action

    The18th International Conference on Human Retrovirology: HTLV and Related Viruses HTLV  2017 

     More details

  • Aberrant DNA methylation is associated with the clinical course in the same patients with ATL

    The18th International Conference on Human Retrovirology: HTLV and Related Viruses HTLV  2017 

     More details

  • Proteomic analysis on Langerhans cell histiocytosis patients and a new triple-risk factor model

    第106回日本病理学会総会  2017 

     More details

  • 成人T細胞白血病/リンパ腫(ATL)におけるDNA異常メチル化と病態の変動との関連

    第106回日本病理学会総会  2017 

     More details

  • 成人T細胞白血病/リンパ腫(ATL)を発症したHTLV-1キャリアにおける異常DNAメチル化の解析

    H29第57回日本リンパ網内系学会  2017 

     More details

  • ECOLOGY OF MERKEL CELL POLYOMAVIRUS IN HEALTHY SKIN SHOWS A CLOSE AGREEMENT WITH INTERLEUKIN-1 LOOP MODEL IN LANGERHANS CELL HISTIOCYTOSIS

    32nd Annual Meeting of the Histiocyte Society  2016 

     More details

  • ECOLOGY OF MERKEL CELL POLYOMAVIRUS IN HEALTHY SKIN SHOWS A CLOSE AGREEMENT WITH INTERLEUKIN-1 LOOP MODEL IN LANGERHANS CELL HISTIOCYTOSIS

    32nd Annual Meeting of the Histiocyte Society  2016 

     More details

  • Single cell dynamics of DNA methylation induced by the Tax gene expression of HTLV-I in adult T-cell leukemia/lymphoma

    The 9th International Symposium for Future Technology Creating Better Human Health and Society.New Horizons in Interdisciplinary Cancer Research  2016 

     More details

  • Single cell dynamics of DNA methylation perturbated by Tax gene expression of HTLV-I in adult T cell leukemia/lymphoma (ATL)

    The 74rd Annual Meeting of the Japanese Cancer Association, 2015  2015 

     More details

  • 成人T細胞白血病/リンパ腫(ATL)における特異的DNAメチル化と病態との関連

    第104回日本病理学会  2015 

     More details

  • ランゲルハンス細胞組織球症患者血清の質量分析器による解析

    第104回日本病理学会  2015 

     More details

  • 成人T細胞白血病リンパ腫に於ける一細胞DNAメチル化の変動解析

    第104回日本病理学会  2015 

     More details

  • 成人T細胞白血病/リンパ腫(ATL)におけるDNA異常メチル化と病態との関連

    第55回リンパ網内系学会学術集会  2015 

     More details

  • 成人T細胞白血病/リンパ腫(ATL)発症・進展特異的な代謝異常に関するメタボローム解析

    第55回リンパ網内系学会学術集会  2015 

     More details

  • 成人T細胞白血病/リンパ腫(ATL)におけるDNA異常メチル化と病態との関連

    第2回日本HTLV-1学会学術集会  2015 

     More details

  • Dynamic changes of DNA methylation in adult T cell leukemia/lymphoma (ATL)

    The 73rd Annual Meeting of the Japanese Cancer Association  2014 

     More details

  • Aberrant expression of Polycomb complex1 (PRC1) from balanced to Bmi-1/PCGF4 dominant over Mel-18/PCGF2 in malignant lymphoma

    2014 

     More details

  • Dynamic changes of DNA methylation in adult T cell leukemia/lymphoma (ATL)

    The 73rd Annual Meeting of the Japanese Cancer Association  2014 

     More details

  • Sensitive detection and specific induction of cell death in adult T-cell leukemia/lymphoma cells by photodynamic reactions

    The 7th International Symposium for Future Technology Creating Better Human Health and Society  2014 

     More details

  • B細胞腫瘍及びT/NK腫瘍におけるポリコーム抑制性複合体2(PRC2)のEzh1 と Ezh2の特異的発現

    第103回日本病理学会  2014 

     More details

  • 成人T細胞白血病/リンパ腫(ATL)細胞株における特異的DNAメチル化の解析

    第103回日本病理学会  2014 

     More details

  • メルケル細胞ポリオーマウイルス解析に依るランゲルハンス細胞肉腫の疾患モデル

    第103回日本病理学会  2014 

     More details

  • 成人T細胞白血病/リンパ腫(ATL)関連細胞株における特異的DNAメチル化の解析

    第53回リンパ網内系学会  2014 

     More details

  • Aberrant expression of Polycomb complex1 (PRC1) from balanced to Bmi-1/PCGF4 dominant over Mel-18/PCGF2 in malignant lymphoma

    第53回リンパ網内系学会  2014 

     More details

  • 成人T細胞白血病・リンパ腫(ATL)発症・進展に於ける代謝異常に関するメタボローム解析

    第1回日本HTLV−1学会  2014 

     More details

  • 成人T細胞白血病/リンパ腫(ATL)関連細胞株におけるDNA異常メチル化の解析

    第1回日本HTLV−1学会  2014 

     More details

  • High expression of Ezh2, Eed and Suz-12 in the aggressive variants of non-Hodgkin lymphoma

    The 72st Annual Meeting of the Japanese Cancer Association,  2013 

     More details

  • Sensitive detection and apoptotic cell death induction of adult T-cell leukemia/lymphoma (ATL) cells with photodynamic actions

    The16th International Conference on Human Retrovirology: HTLV and Related Viruses HTLV 2013  2013 

     More details

  • 成人T細胞白血病・リンパ腫(ATL)細胞の光動力学的反応による特異的細胞死の誘導

    HTLV-I 研究会  2013 

     More details

  • 成人T細胞白血病/リンパ腫(ATLL)における特異的DNAメチル化と予後との相関

    HTLV-I 研究会  2013 

     More details

  • Sensitive detection and cell death induced by ALA-mediated photodynamic actions in adult T-cell leukemia/lymphoma cells

    The 72st Annual Meeting of the Japanese Cancer Association,  2013 

     More details

  • ポリコーム群(PcG)蛋白の異常発現とnon-Hodgkin lymphomaの増殖性と悪性度

    「抗感受性悪性腫瘍に対する標準治療確率のための他施設共同研究」班 (飛内班)の「難治性リンパ腫小班」(木下班)平成24年度班会議,  2012 

     More details

  • Identification and profiling of aberrantly expressed microRNAs during progression of adult T-cell leukemia/lymphoma (ATLL)

    The 5th International Symposium for Future Technology Creating Better Human Health and Society Comprehensive Approach to Cancer and Infectious Diseases,  2012 

     More details

  • Upregulation of Ezh2 expression Correlates with Higher Tumor Proliferation and Grade in Non Hodgkin B and T Cell Lymphoma,

    American Association of Cancer Research (AACR) Annual Meeting  2012 

     More details

  • Dynamic changes of epigenetic abnormalities during initiation and progression of adult T-cell leukemia/lymphoma (ATLL)

    American Association of Cancer Research (AACR) Annual Meeting  2012 

     More details

  • 成人T細胞白血病・リンパ腫(ATTL)の発症・進展におけるエビジェネティックス異常の動態解析

    第101回日本病理学会  2012 

     More details

  • ランゲルハンス細胞組織球症(LCH)におけるIL-17Rの検討

    第101回日本病理学会  2012 

     More details

  • Upregulation of Ezh2 expression Correlates with Grade in Non Hodgkin Lymphoma

    第101回日本病理学会  2012 

     More details

  • 十二指腸濾胞性リンパ腫の発症機構とエビジェネティクス解析

    第101回日本病理学会  2012 

     More details

  • Aberrant expression of Ezh2 correlates with tumor proliferation and signals a more aggressive nature in non Hodgkin lymphoma

    リンパ網内系学会2012  2012 

     More details

  • Aberrant expression of hsa-miR34a in leukemic cells of adult T-cell leukemia/lymphoma (ATL)

    リンパ網内系学会2012  2012 

     More details

  • 成人T細胞白血病・リンパ腫(ATLL)の発症・進展におけるエピジェネテイックス異常のダイナミックス

    HTLV-1研究会2012  2012 

     More details

  • Tumor proliferation index Ki67 correlates with PcG2 protein Ezh2 expression in non-Hodgkin lymphoma,

    第71回日本癌学会学術総会  2012 

     More details

  • 十二指腸濾胞性リンパ腫のメチル化解析と発症機構の解析,

    第71回日本癌学会学術総会  2012 

     More details

  • ANALYSES OF PTPN6 (SHP-1) TRANSFECTANT BY EXPRESSION ARRAY - COMPARED WITH OPEN DATA OF LCH SUBTYPE (GSE16395)-

    27th Annual Meeting of the Histiocyte Society  2011 

     More details

  • "Cumulative aberrant methylation in specific genes during progression of Adult T-cell Leukemia/Lymphoma (ATLL) "

    "The 4th International Symposium for Future Technology Creating Better Human Health and Society Comprehensive Approach to Cancer and Infectious Diseases "  2011 

     More details

  • HTLV-1キャリアにおけるDNA メチル化の解析

    日本病理学会2011  2011 

     More details

  • PTPN6(SHP-1)遺伝子導入Langerhans cell 様細胞株(ELD-1)に関する検討

    日本病理学会2011  2011 

     More details

  • EZH2 is up-regulated in aggressive subtypes of non Hodgkin B and T cell lymphoma

    日本病理学会2011  2011 

     More details

  • 消化管follicular lymphomaの病理組織学的検索(十二指腸下行脚での特異性)

    日本病理学会2011  2011 

     More details

  • 成人T細胞白血病/リンパ腫(ATLL)におけるDNAメチル化と病態との関連

    日本病理学会2011  2011 

     More details

  • Cumulative kinetics of epigenetic abnormalities during initiation and progression of Adult T-cell Leukemia/Lymphoma (ATLL)

    15th International Conference on Human Retrovirology: HTLV and Related Retroviruses  2011 

     More details

  • Multi-step accumulation of aberrant CpG island hypermethylation in specific genes promotes development and progression of lymphomas/leukemias

    Invited Lecture at University of Amsterdam  2011 

     More details

  • 成人T細胞白血病・リンパ腫(ATLL)の発症・進展におけるエピジェネテイックス異常

    日本リンパ網内系学会  2011 

     More details

  • Clonal Epigenetic Changes in Specific Genes during Progression of Adult T-cell Leukemia/Lymphoma (ATLL)

    XV International Congress of Virology,  2011 

     More details

  • Aberrant expression of PcG proteins in Non-Hodgkin B- and T-Cell Lymphoma: A relation to aggressive sub-types

    The XXV Symposium of the International Association for Comparative Research on Leukemia and Related Diseases  2011 

     More details

  • 成人T細胞白血病(ATLL)の進展に於けるエピジェネティック状態の動的変化

    第70回日本癌学会学術総会  2011 

     More details

  • 悪性リンパ腫に於けるEzh2の異常発現;aggressivenessとの関連

    第70回日本癌学会学術総会  2011 

     More details

  • B細胞リンパ腫におけるCD79b発現の検討

    第70回日本癌学会学術総会  2011 

     More details

  • 超微量検体による悪性リンパ腫・白血病の早期発見・診断・高感度病態モニタリング技術の開発

    Bio Japan 2011  2011 

     More details

  • 間葉系肝細胞の骨芽細胞分化に伴う石灰化における細胞死の関与

    第33回日本分子生物学会年会・第83回日本生化学会大会 合同大会  2010 

     More details

  • Helicobacter pylori infection induce accumulation of aberrant CpG hypermethylation to promote development and progression of gastric MALT lymphoma

    The 3rd International Symposium for Future Technology Creating Better Human Health and Society  2010 

     More details

  • Identification of novel direct target of miR-19a in MCF-7 breast cancer cell

    Annual Meeting of the American Association for Cancer Research  2010 

     More details

  • Langerhans cell histiocytosisにおける活性化型PTPN6(SHP-1)pY536の発現

    第99回日本病理学会総会  2010 

     More details

  • Development and progression of gastric MALT lymphoma are associated with accumulation of specific aberrant CpG hypermethylation by Helicobacter pylori infection

    Epigenetics研究会  2010 

     More details

  • HTLV-1キャリアにおけるDNA異常メチル化と病態との関連

    第3回HTLV研究会  2010 

     More details

  • 間葉系幹細胞の特異的分化に関与するエピジェネティック制御遺伝子の網羅的解析

    硬組織再生生物学会  2010 

     More details

  • Accumulation of aberrant CpG hypermethylation in specific genes induce development and progression of MALT lymphoma

    日本癌学会  2010 

     More details

  • Down -regulation of BCR signaling component CD79b in plasm cell myeloma: potential post-transcriptionl mechanism

    日本癌学会  2010 

     More details

  • Aberrant expression of Polycomb Group (PcG) gene:Bmi-1 in malignant lymphoma

    日本癌学会  2010 

     More details

  • Multi-step accumulation of aberrant CpG island hypermethylation during progression of lymphoma/leukemia

    13th International Symposium on Molecular Medicine,15th World Congress on Advances in Oncology  2010 

     More details

  • 成人T細胞白血病・リンパ腫(ATLL)の発症・進展におけるEpigenetics異常の解析

    第二回木下班会議  2010 

     More details

  • TNF−アルファによるは骨細胞分化に対するヒト間養鶏肝細胞とリセドロナートの影響

    第33回日本分子生物学会年会・第83回日本生化学会大会 合同大会  2010 

     More details

  • Association of specific DNA hypermethylation with the clinicopahthologic characteristics in Adult T cell leukemia/lymphoma

    日本癌学会  2009 

     More details

  • Association of specific DNA hypermethylation with the clinicopahthologic characteristics in Adult T cell leukemia/lymphoma

    2009 

     More details

  • 超微量検体による悪性リンパ腫・白血病の早期発見・診断・予後推定法の開発

    Innovation Japan 2009  2009 

     More details

  • Immunohistochemical analyses of PTPN6(SHP1) on Langerhnas cell histiocytosis

    H20癌学会  2008 

     More details

  • Association of aberrant DNA methylation with a poor prognosis in Adult T cell leukemia / lymphoma.

    H20癌学会  2008 

     More details

  • Identification of the specific genes regulated by epigenetic mechanism during osteoblastic/adipocytic differentiations in human mesenchymal stem cells

    第31回日本分子生物学会、第81回日本生化学会合同大会  2008 

     More details

  • Effect of nitrogen containing bisphosphonate on osteoblast differentiation of rat mesenchymal stem cell

    第31回日本分子生物学会、第81回日本生化学会合同大会  2008 

     More details

  • Immunohistochemical analysis of PTPN6 (SHP-1) on Langerhans cell histiocytosis

    第97回日本病理学会  2008 

     More details

  • 成人T細胞白血病/リンパ腫(ATLL)における特異的DNA メチル化と予後との相関について

    第97回日本病理学会  2008 

     More details

  • T cellリンパ腫におけるSHP1の発現低下と、脱メチル化処理による発現回復がSignal pathwayに及ぼす変化

    第97回日本病理学会  2008 

     More details

  • 樹状細胞と樹状マクロファージから視た胸腺腫のWHO 分類

    第97回日本病理学会  2008 

     More details

  • 成人T細胞白血病/リンパ腫(ATLL)における特異的DNAメチル化と病態との関連

    H20リンパ網内系学会  2008 

     More details

  • IMMUNOHISTOCHEMICAL ANALYSES OF PTPN6 (SHP1) ON LANGERHANS CELL HISTIOCYTOSIS

    International conference of LCH  2008 

     More details

  • 成人T細胞白血病/リンパ腫(ATLL)における特異的DNA メチル化と病態・予後との相関

    第1回HTLV1研究会  2008 

     More details

  • 悪性腫瘍とエピジェネティックス; 造血器腫瘍発症・進展におけるエピジェネティック異常

    臨床分子形態学会  2008 

     More details

  • Molecular Pathological examination on aberrant expression of cyclinD1 and CD79a in multiple myeloma cell lines

    66thAnnual meeeting of the Japanese Cancer association  2007 

     More details

  • 成人T細胞白血病/リンパ腫(ATLL)におけるCpG island methylater phenotype(CIMP)の解析

    第96回日本病理学会  2007 

     More details

  • " Langerhans cell histiocytosisにおけるPTPN6(SHP-1)の発現

    第96回日本病理学会  2007 

     More details

  • 胃原発悪性リンパ腫におけるmethylator phenotypeとH.pylori感染に関する検討

    第96回日本病理学会  2007 

     More details

  • 間葉系幹細胞の脂肪細胞/骨芽細胞分化におけるエビジェネティックな制御機構の解析

    第96回日本病理学会  2007 

     More details

  • 悪性リンパ腫・白血病におけるエピジェネティックな異常の解析

    第96回日本病理学会  2007 

     More details

  • 成人T細胞性白血病/リンパ腫・関連疾患のエピジェネティック

    第22回悪性リンパ腫治療研究会  2007 

     More details

  • Epigenetic abnormalities associated with Gene Silencing induce onset and progression of lymphomas/leukemias

    Annual Meeting of the American Association for Cancer Research, 2007,LA, USA  2007 

     More details

  • CPG ISLAND METHYLATOR PHENOTYPE (CIMP) PROMOTES THE PROGRESSION OF ADULT T-CELL LEUKEMIA/LYMPHOMA (ATLL).

    Annual Meeting of the American Association for Cancer Research, 2007,LA, USA  2007 

     More details

  • EPIGENETICALLY DISTINST MALIGNANT CELL POLULATION FORMS LYMPHOMA-INVOLVING LESION IN ACUTE TYPE ADULT T-CELL LEUKEMIA/LYMPHOMA (ATLL).

    13th International Conference on Human Retrovirology HTLV and Related Viruses  2007 

     More details

  • ABERRANT DNA METHYLATION IS ASSOCIATED WITH THE CLINICOPATHOLOGIC CHARACTERISTICS IN PATIENTS WITH ADULT T-CELL LEUKEMIA/LYMPHOMA (ATLL).

    13th International Conference on Human Retrovirology HTLV and Related Viruses  2007 

     More details

  • CPG ISLAND METHYLATOR PHENOTYPE (CIMP) PROMOTES THE PROGRESSION OF ADULT T-CELL LEUKEMIA/LYMPHOMA (ATLL).

    13th International Conference on Human Retrovirology HTLV and Related Viruses  2007 

     More details

  • 成人T細胞白血病/リンパ腫(ATLL)における特異的DNAメチル化と病態・臨床症状との相関

    第47回日本リンパ網内系学会総会  2007 

     More details

  • 胃原発悪性リンパ腫の発症・進展と特異的遺伝子のepigeneticな変化に関する検討

    第47回日本リンパ網内系学会総会  2007 

     More details

  • Immunohistochemical analyses of PTPN6(SHP1) on Langerhans cell histiocytosis.

    66thAnnual meeeting of the Japanese Cancer association  2007 

     More details

  • Genes specifically changing DNA methylation during osteoblastic/adipocytic differentiations in mesenchymal stem cells

    66thAnnual meeeting of the Japanese Cancer association  2007 

     More details

  • 胃原発悪性リンパ腫におけるHelicobacter pylori感染とmethylator phenotype

    第65回癌学会総会  2006 

     More details

  • MOLECULAR PATHOLOGICAL ANALYSIS OF THE PROTEIN TYROSINE PHOSPHATASE: SHP1 GENE IN THE PATHOGENESIS OF LYMPHOMAS AND LEUKEMIA

    97th Annual Meeting of American Association for Cancer Research 2006  2006 

     More details

  • Abberant DNA metylation in the progression of adult T cell leukemia/lymphoma (ATLL).

    97th Annual Meeting of American Association for Cancer Research 2006  2006 

     More details

  • 成人T細胞白血病/リンパ腫(ATLL)における病期の進行とDNAメチル化の関連

    第95回日本病理学会総会  2006 

     More details

  • SHP1遺伝子発現抑制と悪性リンパ腫・白血病発症機構の解析

    第95回日本病理学会総会  2006 

     More details

  • Langerhans cell histiocytosisにおけるkeratin及びVMAT2の発現

    第95回日本病理学会総会  2006 

     More details

  • T細胞性リンパ腫における、SHP1発現とSTATsの活性化プロファイルとの関連

    第95回日本病理学会総会  2006 

     More details

  • リンパ節胚中心におけるEpigeneticな遺伝子発現制御の解析

    第95回日本病理学会総会  2006 

     More details

  • Aberrant DNA methylation during the progression of adult T cell leukemia/lymphoma (ATLL).

    20th IUBMB International Congress of Biochemistry and Molecular Biology and FAOBMB Congress  2006 

     More details

  • Identification of the genes specifically changing DNA methylation status during osteoblastic/adipocytic differentiations in human mesenchymal stem cells

    20th IUBMB International Congress of Biochemistry and Molecular Biology and FAOBMB Congress  2006 

     More details

  • High sensitive and high fidelity detection of hematopoietic malignancies with CpG methylation

    20th IUBMB International Congress of Biochemistry and Molecular Biology and FAOBMB Congress  2006 

     More details

  • Helicobacter pylori infection induces the aberrant CpG island methylation in gastric MALT lymphoma

    20th IUBMB International Congress of Biochemistry and Molecular Biology and FAOBMB Congress  2006 

     More details

  • The Aberrant DNA Hypermethylation Induced by Helicobacter Pylori Infection Develops the Progression of Gastric MALT Lymphoma

    The 9th Korean-Japanese Hematolymphoreticular workshop,  2006 

     More details

  • CPG Island Methylator Phenotype (CIMP) Promotes the Progression of Adult T-Cell Leukemia/Lymphoma (ATLL)

    The 9th Korean-Japanese Hematolymphoreticular workshop,  2006 

     More details

  • Gene Silencing Associated with Epigenetic Abnormalities Induce Onset and Progression of Lymphomas/Leukemias

    The 9th Korean-Japanese Hematolymphoreticular workshop,  2006 

     More details

  • 異常メチル化によるSHP1 gene silencing と悪性リンパ腫・白血病発症機構

    第65回癌学会総会  2006 

     More details

  • 成人T細胞白血病/リンパ腫(ATLL)におけるCpG island methylater phenotype (CIMP)の解析

    第65回癌学会総会  2006 

     More details

  • 骨ランゲルハンス細胞組織球症病変から樹立された細胞株(PRU-1)の解析

    第64回日本癌学会学術総会  2005 

     More details

  • 悪性リンパ腫・白血病の発症機構に関する分子病理学的解析

    第6回癌と免疫セミナー  2005 

     More details

  • 造血器腫瘍の高感度・高精度検出技術の開発

    第94回日本病理学会総会  2005 

     More details

  • 胃MALTリンパ腫におけるp27Kip1,Ki67抗原,p53の発現

    第94回日本病理学会総会  2005 

     More details

  • 骨ランゲルハンス細胞組織球症病変から樹立された細胞株(PRU-1)の解析

    第94回日本病理学会総会  2005 

     More details

  • 悪性リンパ腫/白血病の発症機構におけるSHP-1 gene silencingの果たす役割についての解析

    第94回日本病理学会総会  2005 

     More details

  • MHV-72とMHV-68の遺伝子比較並びにMHV-72感染マウスの病理と腫瘍発生への影響

    第94回日本病理学会総会  2005 

     More details

  • T細胞性悪性リンパ腫における、SHP1 gene silencingの解析

    第64回日本癌学会学術総会  2005 

     More details

  • 成人T細胞性白血病(ATL)におけるDNA異常メチル化の解析

    第64回日本癌学会学術総会  2005 

     More details

  • MHV-72とMHV-68の遺伝子比較並びにMHV-72感染マウスの病理と腫瘍発生への影響

    第64回日本癌学会学術総会  2005 

     More details

  • 悪性リンパ腫・白血病における異常メチル化によるSHP1 gene silencingの解析

    第64回日本癌学会学術総会  2005 

     More details

  • Molecular Pathological Analyses of the Genes Related to the Pathogenesis of Lymphomas/leukemias with Complementary DNA and Tissue Microarray

    AACR speial conference in cancer research,“Chromatin,Chromosomes and cancer Epigenetics  2004 

     More details

  • Hematopoitic cell specific thyrosine phosphatase: SHP1 as a Novel Biomarker of hematopoietic malignancies

    7th International Symposium on the molecular basis of predictive oncology & intervention strategies  2004 

     More details

  • Regulatory role of Epstein-Barr virus-infection and CD40 ligand stimulation on the proliferation of Mantle cell lymphoma lines

    7th International Symposium on the molecular basis of predictive oncology & intervention strategies  2004 

     More details

  • ヒト不死化間葉系幹細胞の全遺伝子発現プロファイル及びエピジェネテイック解析と再生医療への応用

    第3回日本再生医療学会総会  2004 

     More details

  • EBV関連血球貪食症候群の家兎モデルを用いた治療法の検討及びリンパ腫の発生

    第93回日本病理学会総会  2004 

     More details

  • High frequent inhibition of the SHP1 gene expression in T-cell lymphoma by CpG island methylation

    第93回日本病理学会総会  2004 

     More details

  • Murine gammaherpesvirus 72 (MHV72) 感染マウスの急性期変化並びに長期観察により発生する腫瘍病変の解析

    v第93回日本病理学会総会  2004 

     More details

  • 新規高感度・高精度悪性リンパ腫・白血病biomarker:チロシンフォスファターゼSHP1

    第1回日本病理学会カンファレンス、日本病理学会カンファレンス2004広島「ガンの発生と病態を巡るトピックス」  2004 

     More details

  • SHP1遺伝子CpG islandメチル化によるB細胞リンパ腫の異常増殖

    第63回日本癌学会学術総会  2004 

     More details

  • ヒト間葉系幹細胞の全遺伝子発現プロファイルとエピジェネテイック解析 - その再生医療への応用

    第26回日本分子生物学会年会  2003 

     More details

  • Regulatory role of Epstein-Barr virus-infection and CD40 ligand stimulation on the proliferation of Mantle cell lymphoma lines

    7th International Symposium on the molecular basis of predictive oncology & intervention strategies  2003 

     More details

  • cDNA microarray及び病理組織microarrayのNK/Tリンパ腫の発症機構の解析

    悪性リンパ腫治療研究会  2003 

     More details

  • Transdifferentiation of thymic myoid progenitor cells and possible role of thymic myoid cells in myasthenia gravis

    The 15th annual meeting of Japanese soxiety for neuroimmunology in conjunction with COE international symposium  2003 

     More details

  • Transdifferentiation of thymic myoid progenitor cells and possible role of thymic myoid cells in myasthenia gravis

    The 15th Annual Meeting of Japanese Society for Neuroimmunology in conjunction with COE International Symposium  2003 

     More details

  • EBV関連血球貪食症候群の家兎モデルを用いた治療法の検討

    第92回日本病理学会総会  2003 

     More details

  • B細胞系悪性リンパ腫におけるSHP1遺伝子の発現抑制とCpG islandのメチル化の解析

    第92回日本病理学会総会  2003 

     More details

  • Murine gammaherpesvirus 72 (MHV72) によるマウスの急性及び潜伏感染後の悪生リンパ腫誘発モデルの解析

    第92回日本病理学会総会  2003 

     More details

  • 悪性リンパ腫・白血病におけるSHP1遺伝子の発現抑制機構の解析

    第92回日本病理学会総会  2003 

     More details

  • リン酸化型Bcl-2の生体組織における発現ー大腸良・悪性腫瘍における解析

    第92回日本病理学会総会  2003 

     More details

  • EBV-like virus (HVP)によるEBV関連血球貪食症候群家兎モデルを用いた治療法の検討およびリンパ腫の発生

    第62回日本癌学会総会  2003 

     More details

  • EBV-like virus (HVP)の経口感染により誘発される血球貪食症候群とリンパ増殖性疾患を伴うウサギモデルの解析

    第62回日本癌学会総会  2003 

     More details

  • 胃MALTリンパ腫の臨床病理:除菌後判定、発症及び除菌有効性因子

    第62回日本癌学会総会  2003 

     More details

  • 悪性リンパ腫・白血病におけるチロシンフォスファターゼSHP1遺伝子発現抑制機構

    第62回日本癌学会総会  2003 

     More details

  • Molecular Pathological analysis of the genes related to the pathogenesis of lymphomas and leukemias with cDNA and tissue maicroarray methods

    8th World Congress on Advances in Oncology and 6th International Symposium on Molecular Medicine  2003 

     More details

  • Reduced expression of the SHP1 gene in B-cell lmalignancies detected by the aberrant methylation

    8th World Congress on Advances in Oncology and 6th International Symposium on Molecular Medicine  2003 

     More details

  • High frequent gene scilencing of the SHP1 gene in T-cell lymphomas and leukemias by abberant methylation

    8th World Congress on Advances in Oncology and 6th International Symposium on Molecular Medicine  2003 

     More details

  • cDNA microarray及び病理組織microarrayのNK/Tリンパ腫の発症機構の解析

    厚生省がん助成金「難治性リンパ腫様の分子生物学的特徴の解明と疾患特異的治療法の開発に関する研究」班会議  2002 

     More details

  • 悪性リンパ腫・白血病におけるチロシンフォスファターゼSHP1遺伝子発現抑制

    第91回日本病理学会総会  2002 

     More details

  • EBV関連血球貪食症候群の家兎モデル:EBV-like virusによる血球貪食症とリンパ球増殖異常由来細胞株の性状

    第91回日本病理学会総会  2002 

     More details

  • ヒト口蓋扁桃のinterdigitating DCとPlasmacytoid DCの組織分布、形態、フェノタイプの違いについて

    第91回日本病理学会総会  2002 

     More details

  • Murine gammaherpesvirus 72 (MHV-72)の感染によるマウスの急性感染及び潜伏感染後の悪性リンパ腫誘発モデルの解析

    第42回日本リンパ網内系学会  2002 

     More details

  • EBV関連血球貪食症候群の家兎モデル:Herpesvirus papioによる血球貪食症を伴う致死的ウサギリンパ球増殖異常症の病態解析

    2002 

     More details

  • cDNA microarray及び病理組織microarrayのNK/Tリンパ腫の分子病態解明への応用

    日本病理学会秋期特別総会  2002 

     More details

  • NK細胞腫瘍細胞株におけるgene expression profiling解析

    厚生省がん助成金「難治性リンパ腫様の分子生物学的特徴の解明と疾患特異的治療法の開発に関する研究」班会議  2001 

     More details

  • Molecular Pathological Analysis of the Genes Related to the Pathogenesis of Adult T-cell Leukemia/Lymphoma with cDNA Expression Array and Tissue Microarray

    10th International Conference on Human Retrovirology:HTLV and Related Viruses  2001 

     More details

  • Down reguration of Drs mRNA expression in lymphomas of adult T cell leukemia

    10th International Conference on Human Retrovirology:HTLV and Related Viruses  2001 

     More details

  • Animal model of EBV-related lymphomagenesis: EBV-related herpesviruses from cynomorgus frequently induced rabbit T-cell lymphomas

    21th International Cancer Symposium in Sapporo: EBV and human cancer  2001 

     More details

  • 悪性リンパ腫のgene expression profiling及び病理組織maisroarrayを用いた発症機構の解析

    厚生省がん助成金「難治性リンパ腫様の分子生物学的特徴の解明と疾患特異的治療法の開発に関する研究」班会議  2001 

     More details

  • Myasthenogenisity of thymic myoid cells

    6th International Congress, International Society of Neuroimmunology  2001 

     More details

  • 突然の精神症状にて発症し、脳生検にて生前診断しえたangiotropic lymphoma の一例

    日本病理学会  2000 

     More details

  • EBV陰性Nasopharyngeal carcinoma cell line:TW03へのEBV再感染は腫瘍形成能をたかめる

    日本病理学会  2000 

     More details

  • MALTリンパ腫における接着分子α4β7インテグリン、Lセレクチンの発現と高悪性度化に伴う発現減弱

    日本リンパ網内系学会  2000 

     More details

  • Depressed expression of hematopoietic cell specific tyrosine phosphatase SHP1 in NK/T lymphoma revealed by complementary DNA and tissue microarrays

    日本癌学会  2000 

     More details

  • Cyno-EBV(カニクイザル由来EBV関連ウイルス)のin vivo感染により不死化したウサギリンパ球株の性状解析

    日本癌学会  2000 

     More details

  • 自己T細胞による単球由来樹状細胞の指状咬合細胞への成熟

    日本癌学会  2000 

     More details

  • 胸腺由来前駆細胞より分化したthymic myoid cellsのCD4+/8+胸腺細胞との特異的接着とアポトーシスCD4+/8+胸腺細胞の捕捉

    日本組織培養学会  2000 

     More details

  • EBV-related herpesviruses from cynomolgus induce a high rate of rabbit T-cell lymphoma

    89th Annual meeting of US & Canadian Acad. of Pathol.  2000 

     More details

  • Molecular Pathological analysis of the genes related to the pathogenesis of NK/T-lymphoma with complementary DNA and tissue maicroarray methods

    23th International Congress of the International Academy of Pathology  2000 

     More details

  • Molecular analysis of ocular adenexal lymphoproliferative interdigitating cells

    23th International Congress of the International Academy of Pathology  2000 

     More details

  • Loss of expression of α4β7 integrin and L-selectin is associated with high-grade progression of MALT lymphoma

    23th International Congress of the International Academy of Pathology  2000 

     More details

  • Antigen-nonspecific T-cells mediate the maturation of immature monocyte-derived dendritic cells into interdigitating cells

    23th International Congress of the International Academy of Pathology  2000 

     More details

  • 病理組織micro-array法によるNK/Tリンパ腫発症に関与する遺伝子群の分子病理学的解析

    日本病理学会  2000 

     More details

  • Mantle cell lymphoma line(SP53)へのEBVの感染

    日本病理学会  2000 

     More details

  • カニクイザル由来EBV関連ウイルスによるウサギ悪性リンパ腫誘発モデル:ウイルス亜系(3種類の細胞株)によるウサギモデルの比較

    日本病理学会  2000 

     More details

  • カニクイザル由来EBV関連ヘルペスウイルスのEBNA1遺伝子構造

    日本癌学会  1999 

     More details

  • サル由来EBV関連ヘルペスウイルス(Si-IIA-EBV)感染細胞におけるEBNA1の発現とEBNA1 遺伝子構造

    日本病理学会  1999 

     More details

  • HTLV-I産生細胞との混合培養により樹立された前駆細胞より分化したthymic myoid cells とCD4+/CD8+胸腺細胞との特異的接着

    日本病理学会  1999 

     More details

  • サルEBV関連ウイルスの輸血感染によるウサギ悪性リンパ腫発生とその予防

    日本病理学会  1999 

     More details

  • Myoid cell differentiation of rat thymus-derived progenitor cell line established by co-culture with HTLV-I-producing human T cells

    9th International Conference on Human Retrovirology  1999 

     More details

  • 病理組織micro-arrayの作成とlymphoma解析への応用

    日本癌学会  1999 

     More details

  • 眼窩リンパ増殖性疾患の単クローン性の検討

    日本癌学会  1999 

     More details

  • Apoptosis of CD4+/CD8+thymocytes by specific adhesionto thymic myoid cells differenciated from a rat thymus-derived myoid precursor cell line

    日本免疫学会  1999 

     More details

  • 成熟樹状細胞に分化しうるヒト白血球のサブセットについて

    日本癌学会  1999 

     More details

  • サルEBV関連ウイルスの輸血感染によるウサギ悪性リンパ腫発生とその予防

    日本癌学会  1999 

     More details

▼display all

Works

  • 第33回「バイオシーズ公開会」NPO法人 近畿バイオインダストリー振興会議主催

    2015

     More details

  • 「中央西日本メディカルイノベーション2015」

    2015

     More details

  • 岡山大学知恵の見本市2012

    2012

     More details

  • Bio Japan 2011

    2011

     More details

  • Innovation JAPAN2004

    2004

     More details

  • Innovation JAPAN2004

    2004

     More details

  • 第3回国際バイオEXPO JAPAN

    2004

     More details

▼display all

Awards

  • 日本白血病研究基金助成事業一般研究賞

    2012  

     More details

    Country:Japan

    researchmap

  • Best presentation Award,9th Korean-Japanese Lymphoretucular Workshop (KJLW 2006)

    2006  

     More details

  • Best presentation Award,9th Korean-Japanese Lymphoretucular Workshop (KJLW 2006)

    2006  

     More details

  • Award for an Outstanding Achievement,"8th World Congress on Advances in Oncology and 6th International Symposium on Molecular Medicine

    2003  

     More details

    Country:Japan

    researchmap

Research Projects

  • Single cell analysis of dynamic change of epigenetic abnormalities in adult T cell leukemia/lymphoma (ATL)

    Grant number:16K08667  2016.04 - 2021.03

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

    Oka Takashi

      More details

    Grant amount:\4810000 ( Direct expense: \3700000 、 Indirect expense:\1110000 )

    Adult T-cell leukemia/lymphoma (ATL), an aggressive type of T-cell malignancy, is induced by human T-cell leukemia virus type I (HTLV-1) infection. The outcomes, following therapeutic interventions for ATL, have not been satisfactory. In the present investigation, we established live-cell imaging method of DNA methylation using methylated DNA binding protein (MBD) fused with enhanced green fluorescent protein (EGFP); MBD-EGFP to detect dynamic changes of DNA methylation induced by endogenous and/or exogenous environmental perturbations in human leukemia cells. Comprehensive global DNA methylation and gene expression analyses revealed dynamic changes of target gene methylation and gene expression followed by HTLV1tax gene expression. In vitro live cell imaging of DNA methylation with HTLV-1tax-oncogene ON/OFF system is useful system to investigate epigenetic mechanism of ATL leukemogenesis/lymphomagenesis.

    researchmap

  • Regulatory molecular mechanism of calcification on osteoblastic differentiation of human mesenchymal stem cells in vitro

    Grant number:16K10915  2016.04 - 2019.03

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

    Sasaki Junzo

      More details

    Grant amount:\4810000 ( Direct expense: \3700000 、 Indirect expense:\1110000 )

    It is believed that osteoblasts induced bone mineralization via release of matrix vesicle. We reported that necrotic and apoptotic cells also serve as nuclei for calcification on osteoblastic differentiation of human mesenchymal stem cells (hMSC) in vitro. In this study, we investigated regulatory molecular mechanism of calcification on osteoblastic differentiation of hMSC in vitro. We identified various molecules binding to necrotic dead cells under calcification medium containing fetal bovine serum using mass spectrometry. The gene cloning of calcification related candidates was performed. Overexpression of one of the candidates promoted the calcification on osteoblastic differentiation of hMSC in vitro suggesting that the molecule in serum has a role on calcification by osteoblasts.

    researchmap

  • clarification of the mechanism of proteinuria related with tranport protein

    Grant number:26461611  2014.04 - 2018.03

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

    AYA KUNIHIKO

      More details

    Grant amount:\4940000 ( Direct expense: \3800000 、 Indirect expense:\1140000 )

    Though we induced proteinuria the podocyte-specific conditional knockout mice of this transport protein with LPS, we could not find strong tendency of the degree of albuminuria in knockout mice compared with control. We created the tamoxifen-inducible knockout mice of this transport protein. After tamoxifen administration, poor weight gain and atypical glands in intestine was found in these knockout mice.

    researchmap

  • Identification of new biomarkers about Langerhans cell histiocytosis using mass spectrometry

    Grant number:26460451  2014.04 - 2017.03

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

    MURAKAMI Ichiro, OKA Takashi

      More details

    Grant amount:\5070000 ( Direct expense: \3900000 、 Indirect expense:\1170000 )

    Plasma sample from 12 patients with LCH-RO (-) (5 MS-LCH and 7 SS-LCH) and 5 non-LCH patients were analyzed by peptidomics. Mass spectrometry (MS) spectra were acquired and peptides exhibiting quantitative differences between MS-LCH and SS-LCH patients were targeted.
    One new candidate biomarker, m/z 3145 was selected and identified after obtaining a MS/MS fragmentation pattern using liquid chromatography-MS/MS. This peak was identified as a proteolytic fragment derived from interalpha-trypsin inhibitor heavy chain 4 (ITIH4, [PDB: Q14624]).
    Peptidomics of LCH have revealed that the level of acute-phase ITIH4 distinguishes MS-LCH-RO (-) from SS-LCH-RO (-). Acute-phase proteins serve non-specific, physiological immune functions within the innate immune system. LCH may be a reactive disorder with both underlying neoplastic potential of antigen presenting cells harboring BRAF mutations and hyper-immunity of other inflammatory cells against MCPyV infection.

    researchmap

  • Epigenetic abnormalities during onset and progression of adult T-cell leukemia/lymphoma (ATL)

    Grant number:25460437  2013.04 - 2016.03

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

    Oka Takashi, ITO SACHIO, OUCHIDA MAMORU, YOSHINO TADASHI

      More details

    Grant amount:\5200000 ( Direct expense: \4000000 、 Indirect expense:\1200000 )

    We investigated the epigenetic mechanism of onset and progression of non-Hodgikin lymphoma as well as adult T-cell leukemia/lymphoma (ATL). We found that epigenetic abnormalities including unbalanced expression of Polycomb Repressive Complex (PRC) molecules, aberrant expression of miRNA and mRNA and also aberrant DNA methylation are playing the important role in the pathogenesis of ATL. Ezh2 was strongly expressed and polycomb repressive complex PRC1.4 dominates over PRC1.2 in aggressive lymphoma variants as well as ATL. Tax protein expression induced epigenetic heterogeneity with expanding the global DNA methylation profile to generate various epigenetic clones, suggesting that Tax-mediated epigenetic clonal heterogeneity and diversity may contribute to induce leukemic transformation and more aggressive clonal progression.

    researchmap

  • Direct target genes of miRNAs involved in lung cancer

    Grant number:24591905  2012.04 - 2016.03

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

    Ouchida Mamoru, OKA Takashi, ITO Sachio

      More details

    Grant amount:\5330000 ( Direct expense: \4100000 、 Indirect expense:\1230000 )

    Lately, miR-17-92, which is highly expressed in malignant lung cancer cells, is considered the key miRNA for tumorigenesis. However, its direct targets remain under reported. We identified the FOXP1, TP53INP1, TNFAIP3, and TUSC2 genes as miR-19a targets, using luciferase, pull-down, and western blot assays. The four miR-19a target cDNA expression vectors suppressed cell viability, colony formation, migration, and invasion of lung cancer cells.

    researchmap

  • Molecular and pathological analysis of transfromation of follicular lymphoma

    Grant number:23590398  2011 - 2013

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

    YOSHINO Tadashi, OKA Takashi

      More details

    Grant amount:\5330000 ( Direct expense: \4100000 、 Indirect expense:\1230000 )

    We focused on the follicular dendrici cell meshwork for examining the transformation of follicular lymphoma. Duodenal follicular lymphoma which is a subtype of rare transformation lacks dendritic cell meshwork, but nodal follicular lymphoma has dense meshwork. Furthermore, duodenal follicular lymphoma has memory B cell characteristics and it suggested that tumor cell origin is important for transformation (Mod Pathol 2013). From the comprehensive gene expression analysis, nodal follicular lymphoma had different characteristics from duodenal follicular lymphoma, and cytokine-related genes and adhesion molecule was important for tumorigenesis. (Cancer Sci 2014)

    researchmap

  • Search for new biomarkers about Langerhans cell histiocytosis using mass spectrometry

    Grant number:23590426  2011 - 2013

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

    MURAKAMI Ichiro, OKA Takashi

      More details

    Grant amount:\5200000 ( Direct expense: \4000000 、 Indirect expense:\1200000 )

    We proposed possibility that LCH has both neoplastic character and reactive character. As a trigger of the reactive origin we proposed the dermotropic Merkel cell polyomavirus (MCPyV) as a pathogenic agent. The lesional hyperreactivity may define the clinical courses of LCH. Though primary infection with MCPyV may play a significant pathogenic role in LCH, other mechanisms might also play important roles in LCH.
    As clues to understand these mechanisms, we think serum biomarkers are important. LCH consists of two subtypes: single-system LCH (SS-LCH) with favorable prognosis and multisystem LCH (MS-LCH) with poor prognosis. LCH is also classified as either LCH developed in at least one high-risk organ (RO (+)) or LCH developed in organ without high-risk organ (LCH-RO (-)). As a preliminary analysis we already delineated 2 candidate biomarkers in sera which differentiate the LCH from controls, MS-LCH from SS-LCH, or LCH-RO (+) from LCH-RO (-), respectively.

    researchmap

  • Comprehensive analyses of epigenetic abnormalities inadult T-cell leukemia/lymphoma (ATLL)

    Grant number:22590312  2010 - 2012

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

    OKA Takashi, YOSHINO Tasashi, OUCHIDA Mamoru

      More details

    Grant amount:\4550000 ( Direct expense: \3500000 、 Indirect expense:\1050000 )

    We investigated the epigenetic mechanism of onset and progression of non-Hodgikinlymphoma as well as adult T-cell leukemia/lymphoma (ATLL). We found that epigenetic abnormalities including unbalanced expression of Polycomb Repressive Complex (PRC) molecules, aberrant expression of miRNA and mRNA and also aberrant DNA methylation are playing the important role in the pathogenesis of ATLL.

    researchmap

  • Identification and functional analysis of esophageal cancer-related genes by pull-down method using biotin-labeled miRNA

    Grant number:22591433  2010 - 2012

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

    ITO Sachio, OKA Takashi, OUCHIDA Mamoru

      More details

    Grant amount:\4680000 ( Direct expense: \3600000 、 Indirect expense:\1080000 )

    In order to identify possible predictive markers, We performed the identification of miRNA related to the degree of differentiation-grade and malignancy by the profiling of esophageal cancer cell lines and esophageal cancer clinical specimens. In poorly differentiated cells, miR-29a and let-7b were overexpressed. We identified target genes of these miRNAs using in vitro pull-down method, and found some candidates of target genes related to tumor suppressor and apoptosis. Our results suggest that these miRNAs are involved in esophageal cancer progression.

    researchmap

  • Analyses of epigenetic mechanism of lymphomagenesis/leukemogenesis

    Grant number:19590349  2007 - 2008

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

    OKA Takashi, YOSHINO Tadashi, OUCHIDA Mamoru

      More details

    Grant amount:\4420000 ( Direct expense: \3400000 、 Indirect expense:\1020000 )

    悪性腫瘍の発症機構に関する研究は、これまで癌遺伝子、癌抑制遺伝子の構造異常などを伴うゼネテイックな変化に注目して研究が進められてきた。それに対し近年遺伝子の構造異常を伴わないエピジェネテイックな機構による発癌が注目されてきている。我々は造血器腫瘍の発症機構をとくにエピジェネテイックな機構に注目し解析を行い、HTLV-I, H.pyloriの感染によって異常なDNAメチル化が誘導・蓄積することが造血器腫瘍発症に重要であることを見いだした。これらの知見を元に造血器腫瘍を高感度に早期発見・早期診断することが可能になると期待される。

    researchmap

  • Analysis of stem-cell differentiation mechanism by using DNA microarray and novel bisulfite modification.

    Grant number:17590080  2005 - 2006

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

    NAKANISHI Tohru, HAYATSU Hikoya, MORI Hiroki, OKA Tsuyoshi

      More details

    Grant amount:\3500000 ( Direct expense: \3500000 )

    We performed DNA microarray analysis of immortalized human mesenchymal stem cell clones. Among them, clone no.12 showed highest ability of differentiation to osteoblasts, chondrocytes and adipocytes, and its profiling analysis showed characteristic patterns of gene expression. In order to know the relationship between stem cell differentiation and DNA methylation, we next performed global methylation analysis of stem cell clones under differentiation processes by using CpG methylation array system. As a result, we isolated 11 genes under osteoblastic differentiation process and four genes under adipocytic differentiation process as candidates of up-regulated or down-regulated genes of methylation status. Furthermore, we isolated 82 genes varying their methylation levels during stem cell differentiation by using novel bisulfite modification with which genome-wide identification of methylation sites may become possible. These genes were supposed to be important for regulation of stem cell differentiation and reconstruction of methylation status. These results may contribute to the progress of stem cell research and regeneration medicine up to date.

    researchmap

  • Early-detection, diagnosis and monitoring of malignant lymphoma/leukemia.

    Grant number:17590302  2005 - 2006

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

    OKA Takashi, YOSHINO Tadashi, OUCIDA Mamoru, SHINAGAWA Katsuzi

      More details

    Grant amount:\3700000 ( Direct expense: \3700000 )

    There are various kinds of hematopoietic malignancies including lymphoma and leukemia. There is wide range of spectrum in terms of prognosis. Some of them are very aggressive and hard to control. Others show slightly well prognosis. In many cases, relapse will occur after the regression of tumor cells with the treatments of chemotherapy, x-irradiation or immuno-therapy etc., if only a small number of tumor cells could survive. In order to prevent relapse and induce complete remission, development of highly sensitive, specific technology to detect tumor cells is urgently required.
    We found highly frequent gene silencing of specific genes with DNA hyper-methylation in hematopoietic malignancies. Especially, we found that some type of malignant lymphoma/leukemia show specific changes of methylation profiles and also CpG island methylator phenotype (CIMP) in accordance with the progression. In the basis of these findings, we developed a new highly sensitive, specific system to detect hematopoietic malignancies. It will be useful for the early-detection, diagnosis and monitoring of malignant lymphoma/leukemia.

    researchmap

  • Molecular pathologenesis of gastric MALT lymphomas and their response to eradiacation of H. pylori

    Grant number:16390106  2004 - 2006

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (B)

    YOSHINO Tadashi, OKA Takashi

      More details

    Grant amount:\15200000 ( Direct expense: \15200000 )

    Responsiveness of gastric MALT lymphomas to eradication of H. pylori was related to titers of serum anti-HSP 60 antibody. SHP-1 was positive in some resistant patients, whereas patients in complete remission was negative for SHP-1. Peripheral mononuclear cells taken from patients of gastric MALT lymhoma express high level of CD4OL and produced IL4 at the presence of HSP60 or H.pylori which was contrast to those from patients with chronic gastritis and ulcers and healthy donors that produce INF γ. Methylation of SHP1 was low level in MALT lymphomas, intermediate level in MALT lymphoma associated with diffuse large cell lymphoma, and high level in pure DLBCLs. Moreover, by the analysis of 10 tumor-suppressor genes, 86% of MALT lymphomas showed methylation in at least one supressor gene, whereas cases after eradiation showed 46% and remission cases showed only 14%. We also examined p27, p53, Ki67 antigen expressions, and all MALT lymphomas were positive for p27, negative for p53, and low MIB-1 index. DLBCLs were negative for p27, positive for p53 and high MIB-1 index. Interestingly, MALT-lymhoma component associated with DLBCL lacked p27. This findings suggested loss of p27 may be related to high-grade progression which is closely related to resistance of eradication.

    researchmap

  • Molecular Pathological analyses of aberrant expression of the proteintyrosine phosphatase SHP1 gene in terms of lymphomagenesis/leukemogenesis.

    Grant number:15590302  2003 - 2004

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

    OKA Takashi, YOSHINO Tadashi, HAYASHI Kazuhiko, OUCHIDA Mamoru

      More details

    Grant amount:\3700000 ( Direct expense: \3700000 )

    The studies of gene expression on a genomic scale with cDNA microarrays make it easy to measure the transcripts for every gene at once. Various types of lymphomas/leukemias have been analyzed with the cDNA microarray or macroarrays to investigate the molecular basis of lymphomagenesis/leukemogenesis. Recently, our group analyzed the expression pattern of the human NK/T cell line (NK-YS) genome by cDNA macroarray and tissue-microarray comprehensively and systematically followed by RT-PCR and Western blotting. The significant changes in the gene expression of NK-YS cell line were detected : increase in 18 and decrease in 20 genes compared to normal NK cells or peripheral blood mononuclear cells. Among these genes, we found a strong decrease in hematopoietic cell specific protein-tyrosine-phosphatase SHP1 mRNA by cDNA-macroarray and RT-PCR. Further analysis with standard immunohistochemistry and tissue-microarray, which utilized 207 paraffin-embedded specimens of various kinds of malignant lymphomas, showed that 100% of NK/T lymphoma specimens and more than 95% of various types of malignant lymphoma were negative for SHP1 protein expression. The promoter region of the SHP1 gene has been revealed to be highly methylated in patient samples of adult T cell leukemia (methylation frequency 90%), natural killer (NK)/T cell lymphoma (91%), diffuse large B-cell lymphoma (93%), MALT lymphoma (82%), mantle cell lymphoma (75%), plasmacytoma (100%) and follicular lymphoma (96%). The methylation frequency was significantly higher in high grade-MALT lymphoma cases (100%) than in low grade- MALT lymphoma cases (70%), correlating well with the frequency of no expression of SHP1 protein in high grade- (80%) and low grade-MALT lymphoma (54%). It suggests that the SHP1 gene silencing with aberrant CpG methylation relates to the lymphoma progression in addition to the malignant transformation. Furthermore, the promoter methylation of the SHP1 gene was clearly correlated with the clinical stage such as complete remission or relapse. Loss of heterozygosity with microsatellite markers near the SHP1 gene was showed in 79% of informative ALL cases. These evidences show that the SHP1 gene is a relevant novel biomarker of the wide range of hematopoietic malignancies. Additionally, the loss of SHP1 gene expression is suggested to play an important role in multistep lymphomagenesis/leukemogenesis.

    researchmap

  • Expression of SHP-1 and API2/MA LT 1 on MALT lymphomas

    Grant number:14570144  2002 - 2003

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

    YOSHINO Tadashi, OKA Takashi

      More details

    Grant amount:\3500000 ( Direct expense: \3500000 )

    We found out 13% of ocular adnexal lymphomas showed API2/MALTI. This abnormality was detected not only on MALT cases but a part of large-cell lymphoma. Moreover, API2IMALT 1 was found in 'a case which had no clonal expansion of immunoglobulin gene arrangement by PCR method. These findings are novel and were reported an article of Modern Pathology, 2003. In 2003, we analyzed MALT lymphomas of other organs. Forty-seven cases of colorectal MALT lymphomas were examined and revealed that 15% of them had this abnormality. Comparing between API2/MALTI positive and negative cases, there was no difference of the patients age, depth of lesions, multiplicity, macroscopic findings and IPI. But former ones were in higher clinicall staging and bigger in size, and male-doinance. Especially, positve cases were all in stage II or more, and this is statistically clearly higher than that of negative cases. This finding suggested that API2/MALTI is related to aggressive tumor growth, and it is important for selecting the rapeutic ways. This finding was also described in antother paper of Modern Pathology. We did not find this abnormality in thyroid or salivary gland MALT lymphomas. In these series, we incidentaly found that follicular lymphomas are often found in salivary cases. This point has been examined. About the SHPT expression, we analyzed methylation of this molecule and revealed 82% of MALT lymphomas, 93% DLBCL, 75% mantle cell lymphomas, 100% plasmacytoma, 96% follicular lymphomas. This is very intresting for histopathogenesis of lymphomas.

    researchmap

  • Research On MALT Lymphoma As a Model of Multistep Carcinogenesis

    Grant number:13470044  2001 - 2002

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (B)

    AKAGI Tadaatsu, KONDO Eisaku, OKA Takashi, YOSHINO Tadashi

      More details

    Grant amount:\12200000 ( Direct expense: \12200000 )

    1Eppression of adhesion molecules was investigated in MALT lymphomas of the G-I tract, ocular adnexa, and thyroid. α4s7 integrin and L-selectin were detected on low-grade MALT lymphoma cells and low-grade portions of high-grade MALT lymphoma, but not on high-grade portions of high-grade MALT lymphoma or diffuse large B-cell lymphomas. Most MALT lymphoma cases of the ocular adnexa were positive only for L-selectin. Neither was detected in the thyroid. MAdCAM-1, a ligand for α4s7 integrin, was expressed on the HEV in the inflammatory lesions and MALT lymphoma tissues of theG-I tract and thyroid, but not in the ocular adnexa or salivary gland.
    2.t(11;18)(API2/MALT1) in MALT lymphomas was investigated using FISH and RT-PCR. API2/MALT1 translocation was detected in a small portion of ocular adnexal and large intestinal MALT lymphomas and also rarely in diffuse large B-cell lymphomas and reactive lymphoreticular hyperplasia, but not in MALT lymphomas of the salivary gland and thyroid.
    3.Eradication of Helicobacter pylori induced complete remission in 88% of the patients with gastric MALT lymphoma, but not effective in the PI2/MALT1-positive cases.
    4.Clinicopathological and immunogenetic features of ocular adnexal lymphoproliferative disorders including MALT lymphomas were characterized.
    5. Clinicopathological features of multiple organ MALT lymphomas were characterized.
    6. Peripheral blood mononuclear cells in patients with MALT lymphoma showed increased expression of CD40 ligand and augmented production of IL4 by stimulation with cytokine or combined stimulation with HSP60. DNA microarray analysis indicated increased levels of HLA-DR and integrin mRNAs.

    researchmap

  • Molecular pathological analysis of the genes related to the onset of malignant lymphomas.

    Grant number:12670161  2000 - 2002

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

    OKA Takashi, YOSHINO Tadashi

      More details

    Grant amount:\1900000 ( Direct expense: \1900000 )

    Using cDNA expression array and tissue microarray, we comprehensively and systematically analyzed the expression profile to investigate the lymphomagenesis. We detected the significant decrease of hematopoietic cell specific protein-tyrosine phosphatase SHP1 gene expression in various malignant lymphomas and leukemias. High-frequent silencing of the SHP1 gene by promoter methylation was detected in various kinds of leukemias and lymphomas as well as in many hematopoietic cell lines. Tne promoter methylation of the SHP1 gene was significantly correlated with the clinical stage. Loss of heterozygosiry with microsatellite markers near the SHP1 gene was showed in 79% of informative ALL cases. These results suggest that functional loss of SHP1 is closely associated with the pathogenesis of leukemias/lymphomas

    researchmap

  • ANIMAL MODEL FOR HUMAN EB VIRUS-RELATED TUMOR: PATHOGENESIS OF RABBIT LYMPHOMA INDUCED BY SIMIAN EBV-RELATED VIRUS

    Grant number:11470058  1999 - 2001

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (B)

    HAYASHI Kazuhiko, OHARA Nobuya, OKA Takashi, KONDO Eisaku

      More details

    Grant amount:\9400000 ( Direct expense: \9400000 )

    Animal models of human EBV-associated diseases are essential to elucidate the pathogenesis of EBV-infection and EBV-associated diseases. Here we reported our two newly developed rabbit models of lymphoproliferative diseases (LPD) induced by simian EBV-like viruses. The first is Cynomolgus-EBV-induced T-cell lymphomas in rabbits inoculated intravenously (77-90%) and orally (82- 89%) about 2 -5 months later. EBV-DNA was detected in peripheral blood by PCR since 2 days after oral inoculation while anti-EBV-VCA IgG was raised 3 weeks later. Rabbit lymphomas and their cell lines contained EBV-DNA and expressed EBV-encoded RNA-1 (EBER-1). Rabbit lymphomas and their cell lines contained EBV-DNA and expressed EBV-encoded RNA-1 (EBER-1). Rabbit lymphoma cell lines, some of which have specific chromosomal abnormality, showed tumorigenicity in nude mice. The second is the first and unique animal model for EBV-infected T-cell LPD with virus-associated hemophagocytic syndrome (VAHS) using rabbits infected with the baboon EBV-like herpesvirus, Herpesvirus papio (HVP). Rabbits inoculated intravenously with HVP-producing cells showed increased anti-EBV-VCA-IgG titers, and most (85%) subsequently died of fatal LPD and VAHS, with bleeding and hepatosplenomegaly, within a relatively short time (22-105 days). Peroral spray of cell-free HVP induced viral infection with seroconversion in 3 out of 5 rabbits, with 2 of the 3 infected rabbits dying of LPD with VAHS. Atypical T lymphocytes containing HVP-DNA and expressing EBER-1 were observed in many organs. Hemophagocytic histiocytosis was observed in the lymph nodes, spleen, bone marrow, and thymus. These rabbit models are also useful and inexpensive alternative experimental model systems for studying the biology and pathogenesis of EBV, and prophylactic and therapeutic regimens, especially in relation to human fatal EBV-related LPD and VAHS.

    researchmap

  • Participation of Epstein-Barr virus in the pathogenesis of malignant lymphoma

    Grant number:09470051  1997 - 1999

    Japan Society for the Promotion of Science  Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (B)

    AKAGI Tadaath, OKA Takashi, YOSHINO Tadashi, HAYASHI Kazuhiko

      More details

    Grant amount:\2800000 ( Direct expense: \2800000 )

    1. Malignant lymphoma and Epstein-Barr virus (EBV)
    (1) EBV infected lymphocytes were frequently found in cat-scratch disease
    (2) Frequency of EBV-infected noneoplastic lymphocytes or lymphoma cells was evaluated in non-Hodgkin's lymphomas.
    (3) An EBV-positive NK cell line was established from a patient with NK cell lymphoma/leukemia.
    (4) High frequency of a 30-bp deletion of EBV LMP1 gene was detected in United States, Brazilian and Japanese Hodgkin's disease and reactive lymphoid tissue.
    (5) A mantle cell lymphoma cell line, SP-53, was successfully infected with EBV, and the biological character of EBV0infected SP53 cells was examined.
    2. Experimental animal model of human EBV carcinogenesis : Malignant lymphoma was easily induced in rabbits by oral or intravenous inoculation of EBV-related simian herpesviruses from different sources. The genomic structures of these simian herpesviruses were analyzed and compared with human EBV. The simian EBV-related herpesviruses had a genomic structure showing high homology to each other in the IR1 and EBNA-1 regions ; however, the Si-IIA EBV DNA had only 82% nucleotide homology to human EBV DNA in the IR1 region and 53% homology in the EBNA-1 regions
    3. EBV infection to human nasopharyngeal carcinoma cells : After EBV infection, EBV-negative nasopharyngeal carcinoma cells showed augmentation of in vitro invasiveness and tumorigenicity to nude mice.

    researchmap

▼display all